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ABSTRACT OF THE DISSERTATION
Microgravity Exerts an Age-Dependent Effect on
Cardiovascular Progenitor Cell Development
by
Jonathan Baio
Doctor of Philosophy, Graduate Program in Anatomy
Loma Linda University, June 2018
Dr. Mary Kearns-Jonker, Chairperson
The heart and its cellular components are profoundly altered by missions to space
and injury on Earth. Increasing evidence has identified that one such alteration induced
by spaceflight is the promotion of the efficacious use of stem cells in therapies on Earth.
For this reason, neonatal and adult human cardiovascular progenitor cells (CPCs) were
cultured aboard the International Space Station (ISS). Subsequently, we assessed the
effects of mechanical unloading on developmental properties and signaling. Spaceflight
induced the expression of genes that are typically associated with an earlier state of
cardiovascular development. In particular, in neonatal CPCs, we measured increased
expression of pre-cardiac and developmental regulatory (Bmp and Tbx) genes; decreased
expression of mesodermal derivative markers, including endothelial tube formation; and
enhanced proliferative potential, as indicated by cell growth and cell cycle analysis.
Interestingly, these changes were not observed in adult CPCs. To understand the
mechanism by which such changes occurred in neonatal CPCs, we assessed the
expression of mechanosensitive small RhoGTPases. Given the effect of these molecules
on intracellular calcium levels, we evaluated changes in non-canonical Wnt/calcium
signaling. ISS-cultured CPCs exhibited elevated levels of calcium handling and signaling

xvii

genes, which corresponded to activation of protein kinase C alpha (PKCα), a calciumdependent protein kinase, and Akt, a regulator of stem cell self-renewal, after 30 days. To
explore the effect of calcium induction in neonatal CPCs, we activated PKCα using
hWnt5a treatment on Earth, which resulted in an induction of early cardiovascular
developmental marker expression. Interestingly, markers of the sinoatrial node, which
may represent embryonic myocardium maintained in its primitive state, were induced by
culture of neonatal CPCs aboard the ISS, which was modeled on Earth, at least in part,
using the calcium signaling activators angiotensin II and hWnt5a. To test whether such
signaling could induce sinoatrial nodal gene development on Earth, we treated neonatal
CPCs with angiotensin II and observed the reliable induction of a sinoatrial nodal
phenotype. We found that, in neonatal CPCs, spaceflight induces PKCα and Akt
signaling, promotes the induction of an earlier developmental state, and highlights
signaling events that may underpin biological pacemaker development on Earth.

xviii

CHAPTER ONE
INTRODUCTION
Heart failure impacts 2% of adults in developed countries (McMurray, 2005) and
results in death within one year in 35% of patients (National Clinical Guideline Centre,
2010). There is no cure for heart failure and so treatment relies upon symptom
management and the prevention of disease progression. Heart failure can arise due to
myocardial infarction, in which the working myocardium dies following artery blockage
and reduced access to nutrients and oxygen. Since the human heart lacks a significant
natural capacity to regenerate injured or damaged heart muscle (Kikuchi et al., 2012),
injuries to cardiac tissue often significantly impact a person’s quality of life. In an effort
to identify methods to repair damaged myocardium, the transplantation of cardiovascular
progenitor cells (CPCs), which retain the ability to differentiate into heart muscle tissue,
has been the subject of intensive research. As these studies have evolved, their use in
engineering other cardiovascular tissue, such as a biological pacemaker, has progressed
as well. Ultimately, research into the biology of CPCs will yield important insights into
novel treatments for cardiac repair.

Progenitor Cells for Cardiovascular Repair
Cardiovascular progenitor cells represent a population of multipotent stem cells
that reside in the heart through adulthood and exhibit an ability to differentiate into
various cardiovascular lineages. CPCs can be derived from primary sources, including
the human heart, or can be induced via small molecule-mediated differentiation of
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pluripotent or embryonic stem cells, with several markers having been identified on these
cells (Table 1).
Cardiovascular progenitor biology is intimately related to the molecular processes
that guide the development of cardiac tissue. Yet, given the complexity of cardiovascular
development, there are several markers that can be used to identify various
cardiovascular precursor cells in vitro, as shown in Table 1. In these studies, various
methods have been used for the selection of cell markers, including magnetic bead
sorting for a particular marker (e.g., PDGFRα in Chong et al. (2013) or c-Kit in Li et al.
(2012)). Thus, these reports are limited in their ability to discuss the levels of expression
of the identified markers beyond what is detectable using their specified system of
isolation. Accordingly, it is possible that such studies excluded cell types that expressed
these markers at lower levels. As we discuss later, the overlap in developmental staging
and marker expression documented in the studies included in Table 1 may be clarified by
a greater understanding of the molecular markers of the various stages of cardiogenesis
and the pathways used to drive this process.
Notably, controversy still exists regarding the true constitution of a cardiac
progenitor. One laboratory concluded that “resident c-kit(+) cells in the heart are not
cardiac stem cells” based upon the inability of c-kit-labeled cells to co-localize with
Nkx2.5 or develop into cardiomyocytes that express troponin T (Sultana et al., 2015).
Meanwhile, lineage tracing of progenitors that express Isl1, a LIM homeodomain
transcription factor, indicated that Isl1-positive cells give rise to the outflow tract, right
ventricle, and much of the atria in the developed heart (Cai et al., 2003).
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Table 1. Cell types identified or speculated as being cardiovascular progenitors
Progenitor Name
Expression Profile
Cardiospheres
CD34 /45
Central: c-kit+/Nkx2.5+
Peripheral: CD31+/90+/105+/133+

Reports
Davis et al., 2009

Cardiosphere-derived c-Kit+/CD29+/90+/105+/45-/34-/31-/133- Li et al., 2012
c-kit+
c-kit+
Sandstedt et al., 2010
 Vascular: KDR+/CD31+
+/Bearzi et al., 2009
 Myogenic: αSA
Isl1+/c-Kit+ Fetal

Isl1+/c-Kit+

Serradilfalco et al., 2011

Isl1+/c-Kit+ Neonatal Isl1+/c-Kit+/SSEA-1+/
& Adult
MESP1+/PDGFRα+/
KDR+/CXCR4+/CXCR7+

Fuentes et al., 2013
Baio et al., 2018

Isl1+ hESC-derived

Isl1+/Nkx2-5+/KDR+/CD82+
Gata4+/Tbx1+/Tbx20+

Moretti et al., 2006
Takeda et al., 2018

Sca-1+

Sca-1+/GATA4+/NKX2-5+/c-Kit+/-/cd31-

Oh et al., 2003
Wang et al., 2006

SSEA-1+ hESCderived

SSEA-1+/MESP1+/Oct4+
SSEA-1+/Isl1+

Blin et al., 2010a
Menasché et al., 2015

Abbreviations: CPC, cardiovascular progenitor cells; CXCR4, C-X-C Motif Chemokine
Receptor 4; ESC, embryonic stem cells; KDR, kinase-insert domain receptor; MESP1,
mesoderm posterior protein 1; PDGFR, platelet-derived growth factor receptor alpha;
SCA-1, stem cell antigen-1; SSEA-1, stage-specific embryonic antigen 1
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While both c-Kit and Isl1 are expressed during the process of cardiogenesis, their coexpession with additional markers allow for a more precise definition of the
developmental staging of the cell under study. Furthermore, several of the markers
defined above may also be helpful in identifying a population of cardiovascular
progenitors that exhibit enhanced efficacy in repair, as discussed below. These
considerations first require a brief review of the anatomical and molecular events
underpinning heart development.

Cardiovascular Development
The Heart Fields
The broad pattern of human heart formation has been well known for decades.
Following gastrulation, two, bilateral populations of cranial lateral plate mesoderm
develop and fuse at the midline to form the primitive heart tube (Mjaatvedt, 2001). The
cardiogenic mesoderm that forms this primitive heart tube is termed the primary heart
field. In the early 2000s, a second region of pharyngeal mesoderm was observed to
contribute to the elongation of the heart tube. This region, the second heart field, gives
rise to tissue that is found at the inflow tract, including parts of the atria and, perhaps, the
sinoatrial node (SAN). Notably, the origins of the SAN are still the subject of intensive
debate. Indeed, an avian model of cardiovascular development demonstrated that the
SAN uniquely arises from the “tertiary heart field,” or a mass of mesoderm that is not
located within, but rather posterior to, the second heart field (Bressan, 2013).
Following the linear heart tube stage (i.e., prior to heart tube looping), the second
heart field also contributes to the outflow tract (Kelly, 2012). Cranial and caudal folding
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moves this anteriorly-located cardiogenic plate to the region of the putative thorax. Due
to restrictions on growth that are conferred by both the persistence of dorsal mesocardium
as well as the developing body walls and diaphragm, the heart tube begins to loop,
ultimately forming the inverted, multi-chambered conical shape. Importantly, neural crest
cells from the fourth and sixth pharyngeal arches migrate and transform into mesenchyme
to contribute to the development and septation of the outflow tract of the heart
(Bradshaw, 2009). Therefore, in addition to the tissue of the mesoderm-derived primitive
heart tube and of the second heart field, ectoderm-derived, neural crest tissue also
contributes to heart formation (Sadler, 2012).
Throughout this process, nearby tissues secrete morphogens, thereby establishing
gradients that modulate heart formation. Briefly, lateral ectoderm and endoderm secrete
FGFs and BMPs that support cardiac growth ventrally while neuroectoderm-derived
WNT inhibits cardiac growth dorsally (Bruneau, 2012). This process of gross, anatomical
cardiogenesis is driven by an underlying cascade of molecular events.

Molecular Cardiogenesis
This gradient of morphogens is intimately involved in the molecular events that
drive heart formation. An abbreviated version of the molecular events driving
cardiogenesis from a pluripotent state is shown in Figure 1 (Gessert & Kühl, 2010; den
Hartogh et al., 2015). Progenitor cells used in cardiac stem cell therapies (Table 1) reflect
a particular stage of development and thus are limited in their potential applications. As
discussed below, consideration of the developmental staging of the progenitor used for
transplantation is related to the efficacy of treatment. The schematic shown herein is a
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simplified rendering of the events of embryogenesis and include exogenous reagents used
in the laboratory to guide these processes for the specific purpose of generative
cardiovascular derivatives. For example, Activin A ligand does not have a defined role in
mouse embryogenesis (Matzuk et al., 1995), but its signaling pathway is active during
early gastrulation (Cheng et al., 2003). Thus, our rendering of cardiogenesis simply
serves to both situate the myriad of cardiovascular progenitor cells used for therapies in a
developmental context and highlight the potential of each stage to produce various
cardiovascular derivatives. Although a thorough discussion of the topic of stem cell
plasticity at each stage of development is beyond the scope of this dissertation, the
importance of a sufficiently early developmental state in cardiac repair has been
highlighted in clinical trials and case reports, as discussed below.

Cardiovascular Progenitor Cell Uses in Regenerative Medicine
The use of a cardiac progenitor that has direct cardiomyogenic potential, such as
endogenous CPCs, during transplantation may facilitate regeneration. Current clinical
trials involving cardiovascular progenitors to stimulate repair in damaged heart tissue are
promising (Bolli, 2011; Makkar, 2012; Gerbin, 2015); however, they are stymied by a
failure of cells to engraft into the host tissue and by the use of progenitor types that are
restricted in potency (Hong, 2014). Therefore, identifying the molecular events that
promote enhanced stemness and regenerative potential in CPCs will benefit stem cell-
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Smooth Muscle Cell
SMA+/ACTA2 +/MYH11 +
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Figure 1. Molecular cardiogenesis is guided by spatiotemporally regulated
morphogens and transcription factors
Morphogens and extracellular contact-mediated inductive cues activate signaling pathways
that induce mesoderm development, subsequent commitment to the cardiac lineage, and
the ultimate development of definitive cardiovascular derivatives. These pathways have
been manipulated in vitro to culture cardiomyocytes from induced pluripotent, embryonic,
and cardiovascular progenitor cells. Although several markers have been identified, the
precise temporal regulation of each of these markers remains largely unknown.
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based cardiac repair. Additionally, the successful use of autologous CPC sources to
regenerate heart tissue in a predominately adult population requires additional
understanding of the differences between adult and neonatal CPCs. Our laboratory has
previously documented differences in age-dependent expression of microRNAs related to
MAPK signaling, cytoskeleton regulation, adherens junction expression, and focal
adhesion maintenance (Fuentes, 2013). As will be discussed later, several of these
processes are affected by spaceflight. Moreover, while the functional shortcomings of
adult CPCs require further elucidation, they are not the only barrier to effective cardiac
regeneration based upon autologous cell therapy.
Identifying the appropriate progenitor type that can be used in transplantation is
still the subject of debate that has immense implications for cardiovascular repair.
Previous studies that employed hematopoietic stem cells (Murry, 2004; Balsam, 2004)
and mesenchymal stem cells (MSCs; Dixon, 2009) raised concerns over the myogenic
capacity of these cell types. Godier-Furnemont, et al. (2011) employed MSCs in one such
study. While enhanced angiogenic potential was noted, the authors acknowledged that
cardiomyogenic differentiation of MSCs was unlikely. Employing these progenitor types
that are not closely related to cardiac derivatives have resulted in underwhelming clinical
trials (Segers, 2008). Since cardiomyocyte proliferation is limited, it has been challenging
to transplant myocytes and achieve tissue-like cell densities (Sreejit, 2013; Dubois, 2010;
Beitnes, 2009). In addition to cell lineage, research into the developmental status of the
stage has provided encouraging results both in large animal models and human cases.
Interestingly, recent evidence has emerged that a progenitor cell that represents an
early cardiovascular progenitor may facilitate myocardial repair. In a study of repair
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Table 2. Animal studies, case reports, and clinical trials of stem cell-based cardiovascular
repair
Cell source
KDR+/PDGFR+
hESC-derived CPCs
SSEA-1+/MESP1+/Oct4+
hESC-derived CPCs
SSEA-1+/Isl1+
hESC-derived CPCs
c-Kit+ cardiospheres

c-Kit+ Adult CPCs

Dev Stage
Early
Early
Early

Outcome
(vs Control)
+28% FS
(at 28 days)
-20% Scar Size
(at 2 months)
+10% LVEF
(at 3 months)

Study
Rodent
(Fernandes et al., 2015)
Non-Human Primate
(Blin et al., 2010)
Case Report in Human
(Menasché et al., 2015)
Human: CADUCEUS
(Malliaras et al., 2014)

Late
Unchanged LVEF
(at 1 year)
+2% LVEF
(at 6 months)
Late

(Makkar et al., 2012)
a

+13.7 ± 4.5% LVEF
(at 12 months)
+7.6 ± 2.4% LVEFa
(at 4 months)
MSCs

Late

MSCs

Late

c-Kit+ CPCs

Late

Nkx2-5+/SIRPα+b
iPSC-derived CPCs
CD34low
BMC-derived MSCs
CD34low/CD133low
BMCs
BMCs

Late
Late
Late
Late

+8% EFa
(at 12 months)
+5% EFa
(at 6 months)
+8% EFa
(at 12 months)
+4% FS
+8% LVEF
(at 35 days)
+4% LVEF
(at 4 weeks)
Unchanged LVEF/EF
(at 30 days)
-3% LVEF
(at 6 months)
Unchanged Measures

a

Human: SCIPIO
(Chugh et al., 2012)
(Bolli et al., 2011)
Human: POSEIDON
(Hare et al., 2017)
(Hare et al., 2012)
Human: TRIDENT
(Hare et al., 2017)
Rodent
(Tang et al., 2010)
Rodent
(Ja et al., 2015)
Human: TAC-HFT
(Heldman et al., 2014)
Human: LateTIME
(Traverse et al., 2011)
Human: FOCUS-CCTRN
(Perin et al., 2012)

No control group included; bIn the context of cardiovascular development, signalregulatory protein alpha (SIRPα) is indicative of a cardiomyocyte population (Dubois,
2011).
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following myocardial infarction in nun-human primates, Blin et al. (2010) studied the
efficacy of an early-stage cardiovascular progenitor that expressed stage-specific
embryonic antigen 1 (SSEA-1), mesoderm posterior 1 (MESP1), and OCT4. The
researchers observed differentiation of these early cells into ventricular cardiomyocytes,
thereby healing approximately 20% of the scar tissue. The use of such a progenitor was
demonstrated to be efficacious in a rodent model of myocardial repair (Bellamy, 2015).
Meanwhile, Menasché et al. (2015) reported the first clinical case report of treatment
using this early cardiovascular progenitor cell type. In brief, transplantation of SSEA-1and Islet1-expressing CPCs derived from embryonic stem cells resulted in improved
cardiovascular function. As shown in Table 2, studies of stem cell-based cardiovascular
repair have revealed an emerging pattern in which an earlier cardiovascular progenitor
more effectively improves cardiovascular function.
Ultimately, increasingly strong evidence supports the use of progenitors that are
only nascent in their commitment to the cardiovascular lineage in promoting
cardiovascular repair. Moreover, recent evidence involving early CPCs that express
Mesp1, SSEA-1, and Islet1 suggests that the developmental timing of cells used in such
therapies is critical to the regeneration of cardiovascular function (Blin, 2010; Menasché,
2015). Thus, research in cardiovascular regenerative medicine must also consider
methods that enhance the regenerative potential of CPCs, possibly through the induction
of an early developmental state.
Efforts to identify and produce an earlier developmental state in stem cell
populations have largely been studied in vitro. Yet, traditional cell culture conditions do
not reflect the complex biomechanical processes of embryogenesis in utero. One major
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difference between two-dimensional in vitro culture and the developing embryo is the
presence of a buoyancy force generated by amniotic fluid that counteracts the effects of
gravity (Andreazzol, 2017). One magnetic resonance imaging-based study estimated that,
up until approximately the 21st week of gestation, the embryo and fetus develop in
conditions that resemble neutral floating (Sekulic, 2005). Moreover, the human embryo
does not undergo skin keratinization (i.e., body wall “hardening”) until after
approximately gestational week 20 (Underwood, 2005), thus indicating that the buoyancy
force generated by the amniotic fluid is transmitted to the fluid inside the embryo. Thus,
to the extent that intracellular densities of embryonic cells are of the same density as the
amniotic fluid (Valles, 2002), the embryo in utero experiences conditions of relative
weightlessness, or reduced gravity. For this reason, researchers have turned their attention
to recapitulating the physics of intrauterine development more closely. Research by the
laboratory of Alan Flake has demonsrated that a biomimetic uterus can effectively
facilitate proper development in extremely premature lamb (Partridge, 2017). Elsewhere,
three-dimensional cultures and microgravity have been studied to understand how such
conditions can promote stem cell development and function.

Stem Cells and Reduced Gravity Conditions
Humankind has long been interested in our expanded presence in space. Although
only a handful of astronauts ever spend time in orbit, the technology that is developed by
NASA for spaceflight has been broadly shared with society. Such advances have
impacted many facets of human society on Earth, including transportation, public safety,
health and medicine, and computer technology. With advances in the life science research

12

capacity of the National Lab aboard the International Space Station (Blaber, 2014),
biologists have become empowered to similarly advance stem cell research for the benefit
of society both in space and on Earth. In the context of cardiac stem cell therapies, as
further discussed below, microgravity increasingly appears to represent one avenue by
which a desirable stem cell population can be achieved.
In reviewing the myriad studies regarding stem cells under simulated
microgravity or aboard a space-bound vessel, several trends have emerged. First, stem
cells exhibit reduced terminal derivative and enhanced self-renewal and stemness marker
expression during exposure to reduced gravity conditions (Blaber, 2015; Fuentes, 2015).
Second, upon return to normal gravity conditions, microgravity-exposed cells are more
readily able to differentiate into neurons (Chen, 2011), bone nodules (Blaber, 2014), or
cardiomyocytes (Jha, 2016). As researchers continue to explore the adaptation of stem
cells to reduced gravity conditions, the prospect of engineering tissue using microgravityexposed progenitors has increased. However, a greater understanding of the mechanism
by which stem cells adapt to reduced gravity conditions is needed in order to enjoy the
benefits of microgravity-cultured stem cells in clinics on Earth.

Mechanotransduction under Microgravity
Across models and culture systems, molecular biologists have increasingly
identified the role of small RhoGTPases in mediating the response of cells to a reduced
gravity environment (Meyers, 2006; Louis, 2015). RhoA and CDC42 are small
RhoGTPases that associate with the actin cytoskeleton (Cenni, 2003), participate in the
non-canonical Wnt planar cell polarity pathway (Komiya, 2008), and modulate
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intracellular calcium potentiation (Kim, 2009). Other experiments have identified
alterations to small RhoGTPases, such as the suppression of RhoA in MSCs, in response
to SMG (Seki, 2006). Elsewhere, researchers have reported the involvement of the
primary cilium, which coordinates the early molecular events of cardiogenesis (Clement,
2009), as a sensor of cell-cell contact and altered mechanical stress (Moorman, 2007).
Interestingly, RhoA activity was found to be related to ciliogensis (Pan, 2007), further
supporting the hypothesis that small RhoGTPases have an important role in cardiac
development.
Ultimately, this reduction in RHOA expression logically follows from the reduced
mechanical stress that is expected under microgravity conditions. Furthermore,
mechanotransduction-induced changes in RhoA expression would be expected to impact
calcium handling. Indeed, substrate rigidity (or the lack thereof in this context), has been
shown to directly impact calcium oscillations within MSCs. Using fluorescence
resonance energy transfer, Kim et al. (2009) observed changes to Ca2+ oscillation in
accordance with changes to the stiffness of the MSC culture environment. Similarly, we
found that calcium pathway genes and those related to calcium handling were expressed
at higher levels under SMG (Baio, 2018). Meanwhile, the modification of signaling
pathways related to calcium, either as an important secondary or mediating molecule,
directly impacts the ability of CPCs to differentiate or maintain pluripotency (Tonelli,
2012; Apati, 2016). Such findings indicate that research into the molecular events
underpinning the adaptation of stem cells to reduced gravity conditions will have
implications for regenerative medicine here on Earth.
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Potential Therapeutic Benefits of Reduced Gravity
Research in our own laboratory has shown that simulated microgravity (SMG)
impacts the developmental profile of human cardiovascular progenitor cells (Fuentes,
2015). In particular, earlier cardiac developmental genes were induced in neonatal CPCs
following exposure to SMG for 6-7 days. The observation that a sufficiently early,
cardiac-committed progenitor exhibits enhanced efficacy upon transplantation in vivo
(Bellamy, 2015; Blin, 2010; Menasché, 2015) prompts molecular biologists to further
explore the potential therapeutic use of reduced gravity conditions in advancing stem cell
therapies. Initial research into the mechanism governing these observations indicated that
small RhoGTPases and Wnt signaling as being some of the systems affected by the
simulated microgravity environment. Elsewhere, the effect of mechanical unloading on
mouse embryonic stem cells (ESCs) has been shown to impact differentiation and
stemness, with experiments by Blaber et al. (2015) demonstrating that embryoid bodies
retain markers of self-renewal and exhibit reduced definitive germ layer marker
expression when flown in space. However, in the same studies, when mechanically
unloaded embryoid bodies returned to Earth, they were able to differentiate more readily
into contractile cardiomyocyte colonies. Similarly, Jha et al. (Jha, 2016) found that
human induced pluripotent stem cells more readily differentiate into cardiomyocytes
using three-dimensional culture coupled with transient, early exposure to SMG. These
separate experiments may represent a similar phenomenon in which a low gravity culture
promotes an enhanced state of stemness under SMG or microgravity (MG) that results in
increased differentiation ability when the cells are returned to normal gravity conditions.
Thus, stem cell therapies relevant to cardiac repair may be improved by manipulating the
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mechanisms relevant to mechanical signaling in cardiovascular progenitors. In particular,
inducing enhanced stemness in cardiovascular progenitors may facilitate a
correspondingly enhanced clinical effect upon transplantation.
Alterations in mechanical sensing molecules, such as the small RhoGTPases, are
believed to be involved in the molecular adaptation to microgravity (MG; Meyers, 2005;
Louis, 2015). Importantly, these molecules are also able to impact intracellular signaling
pathways, such as calcium oscillations, which subsequently can activate AKT (Gocher,
2014) and extracellular-signal regulated kinase (ERK; Schonwasser, 1998). In the context
of cardiogenesis, these processes are critical to maintaining a balance between inductive
and proliferative cues (Romorini, 2016; Pucéat, 2005). Therefore, manipulating the
normal gravity environment of early CPCs may highlight important mechanisms by
which early cardiac progenitors develop or expand. Such insights may be applied to
further understand cardiovascular development and to enhance the outcomes of stem cellbased regenerative therapies. Therefore, the application of findings from microgravity
experiments to Earth-based experiments may help overcome the shortcomings of current
clinical trials involving the use of CPCs for cardiac repair.

Sinoatrial Nodal Induction under Reduced Gravity
Two lines of evidence support the application of reduced gravity-mediated
signaling events to sinoatrial nodal development. First, the induction of an earlier
developmental state logically supports the development of sinoatrial nodal cells, which
are hypothesized to be myocardial cells maintained in an embryonic state (Bakker, 2010).
Second, recent studies of CPCs in our laboratory (Baio, 2018) and a recent study of
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neural crest progenitors (Hatzistergos, 2018) both demonstrated that simulated
microgravity induced the expansion of mesoderm-derived pacemaker sinoatrial nodal
cells.
In considering the first line of evidence, several studies have shown that an early
developmental state may provide, or simply constitute, the appropriate cell source for
biological pacemaker development. In an avian model, Bressan et al. (2013) used fate
mapping to determine that sinoatrial nodal cells were observed to already be specified
shortly after gastrulation prior to the onset of cardiogenesis within a region that was
observed to be Nkx2-5- and Isl1-negative. Meanwhile, the Keller group recently reported
a method of generating sinoatrial nodal-like pacemaker cells in Nkx2-5-negative
cardiomyocytes (Protze, 2017). In this way, both groups demonstrate that developmental
timing is critical to the development of this pacing structure. Finally, studies of definitive
sinoatrial nodal cells indicate that primitive myocardium features, such as a simple
ultrastructure, small cell size, dearth of mitochondria, and low contractility, persist in the
definitive structure (Bakker, 2010).
Studies of stem cells under reduced gravity conditions both directly and indirectly
hint at the developmental pathways that may be involved in sinoatrial nodal development.
Indeed, as stated previously, pacemaker cell expansion under simulated microgravity has
been observed directly by Hatzistergos et al. (2018) and indirectly in our laboratory
(Baio, 2018). Furthermore, the observation by Bressan et al. (2013) that pacemaker cells
are specified shortly after gastrulation and prior to the onset of cardiogenesis in a
population of Nkx2-5- and Isl1-negative cells is mirrored by a similar reduction in
Nkx2.5 and Isl1 expression in CPCs under SMG (Baio, 2018). Moreover, calcium
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signaling, which has an integral role in the process of CPC adaptation to spaceflight
(Baio, 2018), is activated in the developing cardiac conduction system through Wnt7a
(Gessert, 2010), which mobilizes intracellular calcium (Thrasivoulou, 2013). Finally, a
recently published study from the laboratory of Ann C. Foley that sought to clarify the
mechanism underpinning SAN induction found that MAP3K7, or TGFß-activated kinase
1, overexpression in mouse embryonic stem cells faithfully induced sinoatrial node
development (Brown, 2017). Similarly, MAP3K7, is inducible via TGFß signaling,
which was found to be induced in CPCs under SMG (Baio, 2018). As an important aside,
MAP3K7 activation via TGFß signaling can induce cardiac hypertrophy when
overexpressed in myocardium (Zhang, 2000), but apparently promotes sinoatrial nodal
development when overexpressed in a sufficiently early progenitor cell. Thus, the
application of simulated microgravity-inspired signaling to sinoatrial nodal cell
development likely requires an appropriately early progenitor cell.
When considered together, both lines of evidence support the emerging
hypothesis that sinoatrial nodal cells represent a de-/un-differentiated state of cardiac
development (Bakker, 2010). Thus, findings from the study of CPCs under reduced
gravity conditions will serve as the basis for the induction of sinoatrial nodal cells on
Earth. In this way, a foundational understanding of the molecular biology and physiology
of SAN cells is central to several components of this dissertation.

18

TropT; Cxn43

Hcn4; Cxn45

Figure 2. Putative molecular embryology of the SAN (Christoffels, 2010)
Using animal models over previous decades, several key transcriptional factors have
been involved in the ultimate expression of the HCN family of genes. Yellow
indicates mesenchymal precursor tissue while gray indicates sinus horn myocardium
and dark blue indicates atrial myocardium. rvv: right venous valve; raw: right atrial
wall.
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Sinoatrial Node Molecular Development
While most cells that express Nkx2.5 eventually become heart tissue, not all heart
cells are Nkx2.5-positive. Indeed, as discussed below, cells that are destined to become
the sinoatrial node (Mommersteeg, 2007; Espinoza-Lewis, 2009) have been shown to be
absent of Nkx2.5. Although the sinoatrial node is located at the inflow tract that is
formed, in part, by the second heart field, it is molecularly unlike the other derivatives of
this region of cardiogenic mesoderm. Therefore, whether the second heart field expresses
Nkx2.5 is less significant than the observation that its inhibition in the putative tissue of
the sinoatrial node allows for the expression of the sinoatrial node gene program. As
shown in Figure 2, the Tbx5-mediated induction of Shox2 results in Nkx2.5 inhibition,
thereby allowing for Hcn4 and Tbx3 expression and, ultimately, sinoatrial node
formation (Munshi, 2012). Furthermore, Tbx3 then inhibits, through Shox mediation,
atrial genes, such as Cx40 and Cx43, which encode for connexin proteins, as well as
ANF, the atrial natriuretic factor that is involved in the homeostatic control of blood
pressure through water and ion secretion regulation (Mommersteeg, 2007; Widmaier,
2008; Boogerd, 2011). Paradoxically, Nkx2.5 expression can function synergistically
with Tbx5 to promote the expression of Cx40 and Cx43 in other portions of the cardiac
conduction system, such as the atrioventricular node (Munshi, 2012). The location of
Shox2 expression participates in determining the mechanism of interaction between
Nkx2.5 and Tbx5. In the inflow tract, Tbx5 regulates Shox2 expression, thereby allowing
for Nkx2.5 inhibition and Bmp4 expression (Puskaric, 2010), which supports sinoatrial
node development. Additionally, Isl1, a gene that is expressed ubiquitously in CPCs,
including those of the second heart field (Bu, 2009; Cai, 2003), induces BMP expression,
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thereby facilitating Tbx3 expression (Yang, 2006). The ultimately atria-apposed
sinoatrial node may also make use of Isl1-expressing tissue of the second heart fieldderived right atrium to induce this BMP expression. Despite this relationship between the
second heart field and the sinoatrial node gene Tbx3, it has been suggested that the avian
sinoatrial node arises from a mass of mesoderm that is not located within, but rather
posterior to, the second heart field (Bressan, 2013). This tertiary heart field utilizes Wnt
signaling to specify pacemaking cells shortly after gastrulation. Since Wnt is observed to
inhibit cardiac development (Bruneau, 2012), it is possible that the necessary inhibition
of cardiac features, including gap junctions and atrial natriuretic factor production, for
sinoatrial node development (Mommersteeg, 2007) occurs via a Wnt-mediated
mechanism in addition to the evidenced role for Tbx3 in inhibiting atrial genes.
Alternatively, Wnt suppression, as occurs in the outflow tract due to a gradient of Hopx
expression that works with BMP through Smad proteins to suppress Wnt, promotes
cardiomyocyte formation (Jain, 2015).
Finally, the right-sided sinoatrial node is prevented from isomerizing (i.e.,
developing on the left) through the early expression of the Pitx2 homeobox gene
(Mommersteeg, 2007). Briefly, Pitx2c positively regulates miR-106b expression, which
directly represses sinoatrial node genes, including Shox2 and Tbx3 (Wang, 2014).
For this reason, the sinoatrial node appears to develop in a manner that is
molecularly distinct from other cardiac tissue. In fact, it is presently believed to develop
from a unique population of heart tissue wherein Wnt expression prevails, thereby
participating in the inhibition of the expression of otherwise default cardiac genes (e.g.
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Nxk2.5). These unique, non-cardiac features must be considered while identifying
precursor cells and developing an ex vivo sinoatrial node.

Current Progress in Creating a Biological Pacemaker
Presently, significant progress has been made concerning the isolation and
characterization of endogenous CPCs (Bearzi, 2009; Davis, 2009; Fuentes, 2013;
Menasché, 2015; Moretti, 2006). Nevertheless, no literature to date has reported the
isolation of sinoatrial nodal cells without having first performed an induction technique
using an exogenous agent or gene therapy. This may be due to the rarity of the relevant
cells. Indeed, the sinoatrial node is only comprised of approximately 10,000 cells that are
highly specialized to regulate the contraction of the approximately five billion
cardiomyocytes of the human heart (Kapoor, 2013).
In 2004, Rosen et al. issued a list of ideal characteristics of a biological
pacemaker. Their work highlighted the need for the regenerated pacemaker to respond to
autonomic regulation, thereby allowing for the heart to continuously couple cardiac
output with a variable metabolic demand. Therefore, it is necessary to ensure that
autonomic coupling pathways are preserved in the exogenously produced biological
pacemaker.
The in vivo transfer of genes has resulted in the successful generation of sinoatrial
nodal cells. Tse et al. (2006) demonstrated the effectiveness of gene-based therapy for
correcting automaticity generation and maintenance by transfecting a mutated form of
HCN1, which favors channel opening into guinea pig hearts. Similarly, Potapova et al.
(2004) transfected human mesenchymal stem cells with mHCN2 and injected these
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transformed cells into the left ventricle of the canine heart, thereby producing left-sided,
spontaneous automaticity. Recently, Tbx18 transduction in guinea pig cardiomyocytes
resulted in the generation of sinoatrial nodal cells in vitro and in vivo (Kapoor, 2013).
While these gene-based therapies have reliably produced intrinsic and automated
biological pacemaker activity that has limited autonomic sensitivity, their potential
contribution to neoplasia has not been documented. For this reason, the use of nontransformed sinoatrial nodal cells may yield clinically-relevant therapies. For example, a
recent study that cultured c-kit-positive mouse CPCs in angiotensin II-supplemented
growth media reported the promotion of pacemaker-like cell differentiation (Xue, 2015).
This study makes use of the presence of angiotensin-II receptors (ATRs) in the
developing and adult heart (Hein, 2002). ATRs also are central mediators of cardiac
tissue remodeling during heart failure (Tadevosyan, 2012). The angiotensin II receptor is
a G-protein coupled receptor that is expressed throughout several types of tissues,
including in the conduction system of the heart (Saito, 1987). Furthermore, these
receptors are denser in the neonatal heart than in the healthy adult heart (Urata, 1989).
The characterization of the angiotensin II receptors in rodent models has shown that its
activation produces increases in ERK phosphorylation, nuclear [Ca++] levels,
proliferation, and transcription (Tadevosyan, 2012). While the role of angiotensin-II and
the ATR in SAN development have not been explored, several researchers have observed
effects of angiotensin-II administration on cardiomyocyte electrical properties in rodents.
These include decreases in gap junction conductance (De Mello, 1995, 1996) and
alterations in the expression of connexin 43 (Severs, 1994). Moreover, intracellular
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injection of angiotensin-II decreased the inward calcium current, which suggests the
involvement of angiotensin-II in cardiac contractility (De Mello, 1998, 2004).
Meanwhile, another study circumvented the need to induce or transfect cells by
excising a porcine sinoatrial node and cultured the homogenized cells on a collagenbased scaffold (Wan, 2009). While this study demonstrated the feasibility of utilizing a
scaffold for ex vivo cell attachment, no molecular or physiological studies were
conducted to confirm the persistence of functional sinoatrial nodes.
These gene therapy-based and chemical cocktail induction strategies have been
effective in furthering the understanding of the molecular significance of several families
of genes in the sinoatrial nodal cell lineage, they are limited in their clinical suitability.
Concerns over neoplasia or ectopic growths of tissue have prevented the wider
application of cellular transformation in vivo; however, it has been observed that
transgenic expression of the reprogramming cytokine TNF-α abolished any neoplastic
growths (Behfar, 2007). Similarly, the absence of a relevant preclinical animal model
(e.g. sheep or pig) presents a barrier for the eventual use of an exogenously produced
sinoatrial node. Furthermore, effective transgenic induction of the growth of sinoatrial
nodal cells still only transforms approximately 10%-20% of a progenitor population,
while the remaining cells develop into cardiomyocytes. Whether these cells are truly
pacemaking (i.e., sinoatrial nodal) cells or simply cardiomyocytes with sinoatrial-nodal
like properties requires further characterization and functional testing (Barbuti, 2015).
Recent work by the laboratories of Keller (Protze, 2017) and Foley (Brown, 2017)
has produced important advances in the field of sinoatrial nodal development. Both
laboratories treated embryonic (the Foley lab) or induced pluripotent (the Keller lab) stem
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cells to induce cardiomyocytes that exhibit functional profiles characteristic of
spontaneously depolarizing sinoatrial nodal cells. Whereas the former group
overexpressed MAP3K7 to achieve this end (Brown, 2017), the latter group titrated
Bmp4 treatment at the onset of cardiogenic mesoderm induction to create a sinoatrial
nodal-like cell (Protze, 2017). Interestingly, working cardiomyocytes, which exhibit high
contractility, exhibit a morphology that differs from that of sinoatrial nodal cells (Bakker,
2010). However, the enriched population of SAN-like cardiomyocytes generated by
Brown et al. (2017) and Protze et al. (2017) follows from observations in other labs that
such cells can be produced in smaller percentages as a byproduct of inducing ventricular
cardiomyocytes from ESCs using a standard protocol of temporally regulated
moprhogens (Jha, 2016). Future work is needed to clarify whether such cells are
functionally capable of serving as a biological pacemaker over a prolonged period of
time, or whether they will revert into a ventricular- or atrial-like cardiomyocyte upon
transplantation. Nevertheless, the use of human-derived CPCs as seeds for the
development of an ex vivo sinoatrial node is possible.

Preamble
Spaceflight and simulated microgravity may promote the efficacious use of stem
cells in therapies on Earth. Yet, in the context of cardiovascular progenitor cells (CPCs),
the molecular events underpinning adaptation to microgravity remain unknown. The
unique extracellular environment fostered by microgravity impacts key aspects of
cardiogenesis, modifies early developmental gene expression, and induces expression of
the sinoatrial nodal gene program. Therefore, in characterizing the molecular events by
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which CPCs adapt to reduced gravity conditions, it is possible to identify key upstream
elements that can be used to induce sinoatrial nodal gene expression and promote the
development of a biological pacemaker.
Thus, we first identified changes in CPC development and function following
spaceflight as well as assessed its implications for CPC applications on Earth. In Chapter
2, we characterize the developmental profile changes of CPCs following culture aboard
the International Space Station. We present our findings regarding the key signaling
components of the molecular events observed under microgravity and recapitulate
portions of these key signaling events on Earth in Chapter 3. These findings are then
extended in Chapter 4 to development of sinoatrial nodal cells. The physiology of treated
cells, including pacing potential and responsiveness to autonomic regulation via
treatment with epinephrine, was then assessed.
In clarifying portions of the molecular events underpinning the response of
cardiovascular progenitor cells to reduced gravity conditions, we identify novel avenues
for advancing the use of stem cells in regenerative medicine, including biological
pacemaker development, on Earth.
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CHAPTER TWO
CULTURE ABOARD THE INTERNATIONAL SPACE STATION ENHANCES
THE PROLIFERATIVE POTENTIAL OF CARDIOVASCULAR PROGENITOR
CELLS AND INDUCES AN EARLIER DEVELOPMENTAL STATE

This chapter has been previously published in:

Baio JM, Martinez AF, Silva I, Hoen C, Countryman S, Bailey L, Hasaniya N, Pecaut
MJ, Kearns-Jonker M. Cardiovascular Progenitor Cells Cultured Aboard the
International Space Station Exhibit Altered Developmental and Functional
Properties. Submitted.
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Abstract
The heart and its cellular components are profoundly altered by missions to space
and injury on Earth. Further research, however, is needed to characterize and address the
molecular substrates of such changes. For this reason, neonatal and adult human
cardiovascular progenitor cells (CPC) were cultured aboard the International Space
Station. Upon return to Earth, we measured changes in the expression of microRNAs and
of genes related to mechanotransduction, cardiogenesis, cell cycling, DNA repair, and
paracrine signaling. We additionally assessed endothelial tube formation, cell cycling,
and migratory capacity of CPCs. Changes in microRNA expression were predicted to
target extracellular matrix interactions and Hippo signaling in both neonatal and adult
CPCs. Genes related to mechanotransduction (YAP1, RHOA) were downregulated, while
the expression of cytoskeletal genes (VIM, NES, DES, LMNB2, LMNA), non-canonical
Wnt ligands (WNT5A, WNT9A), and Wnt/calcium signaling molecules (PLCG1, PRKCA)
was significantly elevated in neonatal CPCs. Increased mesendodermal gene expression
along with decreased expression of mesodermal derivative markers (TNNT2, VWF, and
RUNX2), reduced readiness to form endothelial tubes, and elevated expression of Bmp
and Tbx genes, were observed in neonatal CPCs. Both neonatal and adult CPCs exhibited
increased expression of DNA repair genes and paracrine factors, which was supported by
enhanced migration. While microgravity affects cytoskeletal organization and migration
in neonatal and adult CPCs, only neonatal CPCs experienced increased expression of
early developmental markers and an enhanced proliferative potential. Efforts to
recapitulate the effects of microgravity on Earth by regulating processes described herein
may be a promising avenue for cardiac repair.
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Introduction
Changes to the cardiovascular system during spaceflight have prompted
molecular biologists to understand the mechanisms of cellular adaptation to microgravity.
As a result, researchers have begun to identify therapeutic benefits, such as enhanced
stemness, following the application of microgravity (MG) and simulated microgravity
(SMG) to a variety of stem cell types. Therefore, increased understanding of the response
of cardiovascular progenitor cells (CPCs) to microgravity may not only benefit human
health in space, but also provide insights into novel cardiovascular stem cell therapies
that can be applied on Earth.
Recent research in our own laboratory has shown that neonatal human CPCs
cultured under SMG exhibit increased expression of markers of early cardiovascular
development and pluripotency (i.e., MESP1, T (Brachyury), and POU5F1 (OCT4)) as
well as broad changes to microRNA expression (Fuentes, 2015). The changes in
microRNA expression experienced by CPCs under SMG mirrored the expression of
similar microRNAs in human embryonic stem cells (ESC) under normal conditions of
early cardiovascular development, thereby suggesting that SMG induces an epigenetic
environment that favors an earlier development status. Such a state appears increasingly
beneficial for cardiovascular repair. For example, the efficacy of multipotent stem cells
expressing Isl1+ and SSEA-1+ in ameliorating the symptoms of severe heart failure was
recently demonstrated in one patient (Menasché. 2015). Furthermore, KEGG analysis
indicated that the microRNAs down-regulated in CPCs by SMG target several signaling
pathways, such as MAPK and Wnt, which are relevant to well-characterized repair
mechanisms or cardiac stem cell proliferation mechanisms in the heart. For example,
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non-canonical Wnt ligands (i.e., Wnt2b, Wnt5a, and Wnt9a) have been shown to be
associated with the injury response in neonatal rodent heart tissue (Mizutani, 2016).
Therefore, our observations suggest that SMG may foster a developmental state and
signaling events that could enhance the use of CPCs for cardiovascular repair. This is
supported by one recent study by Jha et al. (2016), which demonstrated that human
induced pluripotent stem cells more readily differentiate into cardiomyocytes following
three-dimensional (i.e., embryoid) culture coupled with SMG. In the context of our
findings, these experiments may highlight a potential phenomenon in which a low gravity
culture promotes an enhanced state of stemness that results in increased differentiation
potential when the cells are returned to normal gravity conditions.
It is currently believed that small RhoGTPases act as transducers of the
mechanical alterations that are observed under conditions of microgravity (Meyers, 2005;
Louis, 2015). As actors in the planar cell polarity Wnt pathway, they have central roles in
cytoskeletal remodeling. Along with the Hippo pathway and calcium signaling, small
RhoGTPases represent one potential molecular substrate of gravity sensing. Notably, in
the context of cardiogenesis, these processes are central to maintaining multipotency or
directing differentiation (Pucéat, 2005). Despite the early reports of the effects of
microgravity on stem cells, much is unknown about the mechanisms by which CPCs
respond to a reduced gravity environment or how these cell types develop enhanced
stemness. Hence, we are not yet able to leverage the therapeutic potential of altered
gravity conditions here on Earth. While current clinical trials to stimulate repair in
damaged heart tissue are promising (Bolli, 2011; Makkar, 2012; Gerbin, 2015), they are
stymied by a failure of cells to engraft into the host tissue and by the use of progenitor
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types that are restricted in potency (Hong, 2014). Therefore, identifying the molecular
events that promote enhanced stemness and regenerative potential in CPCs under reduced
gravity conditions will benefit stem cell-based cardiac repair.
The successful use of autologous CPC sources to regenerate heart tissue in a
predominately adult population requires additional understanding of the differences
between adult and neonatal CPCs. Our laboratory has previously documented differences
in age-dependent expression of microRNAs related to MAPK signaling, cytoskeleton
regulation, adherens junction expression, and focal adhesion maintenance (Fuentes,
2013). The relationship between these processes and the age-dependent response of CPCs
to reduced gravity remain unknown, but they imply deficits in the intracellular
transduction of environmental cues in the functional shortcomings of adult CPCs.
Therefore, in this study, clonal lines of neonatal and adult human CPCs were
cultured aboard the International Space Station (ISS). We sought to identify changes in
these CPCs in response to the reduced gravity conditions that impact signaling,
development, and stemness. We then characterized the divergent response of neonatal
and adult CPCs to spaceflight. We present components of the adaptive cellular response
to a reduced gravity environment and their implications for enhancing the regenerative
potential of neonatal and adult CPCs.

Materials and Methods
Ethics Statement/Cell Isolation and Expansion
CPCs were isolated from cardiac tissue of neonates (1 day – 1 month) or adults
(57 – 72 years), as previously described (Fuentes, 2013). The Institutional Review Board
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of Loma Linda University approved the protocol for use of tissue that was discarded
during cardiovascular surgery, without identifiable private information, for this study
with a waiver of informed consent. Briefly, atrial tissue was cut into small clumps
(approximately 1.0 mm3) then enzymatically digested using collagenase (Roche,
Indianapolis, IN) at a working concentration of 1.0 mg/mL. The resulting solution was
then passed through a 40-µm cell strainer. Cells were cloned in a 96-well plate by
limiting dilution to a final concentration of 0.8 cells per well to create populations for
expansion. Cells were then screened for the co-expression of Isl1 and c-Kit. Clonal CPC
cultures were selected for other markers of early cardiac development (KDR and
PDGFRA) and then maintained using growth media comprised of 10% fetal bovine
serum (Thermo Scientific, Waltham, MA), 100 µg/mL penicillin-streptomycin (Life
Technologies, Carlsbad, CA), 1.0% minimum essential medium non-essential amino
acids solution (Life Technologies, Carlsbad, CA), and 22% endothelial cell growth media
(Lonza, Basel, Switzerland) in Medium 199 (Life Technologies, Carlsbad, CA).
Mycoplasma contamination was tested using the MycoAlert Mycoplasma Detection Kit
(Lonza, Basel, Switzerland) following the manufacturer’s protocol.

Developmental Marker Detection Using Flow Cytometry
Progenitor cell populations were fluorescently labeled with antibodies, as
recommended by their respective manufacturers, and then analyzed using a
MACSQuant® analyzer (Miltenyi Biotec, Auburn, CA). Briefly, for developmental
marker detection, CPCs were incubated with Viobility 405/520 before being washed in
1X PBS (Life Technologies, Grand Island, NY) containing 0.5% BSA (Research

41

Products International Corp, Mt. Prospect, IL) and 2mM EDTA (Sigma Aldrich, St.
Louis, MO). Then, CPCs were stained for cardiac-related stem cell surface markers
(PDGFRα, CXCR4, c-Kit, and SSEA1). CPCs were then fixed in 4% PFA (Sigma
Aldrich, St. Louis, MO), permeabilized in 0.1% Tween-20 (Sigma Aldrich, St. Louis,
MO), blocked in 0.6 M glycine (Sigma Aldrich, St. Louis, MO) solution containing 10%
BSA (Research Products International Corp, Mt. Prospect, IL), and stained for
intracellular, cardiac-related stem cell surface markers (Isl1 and Mesp1). For directed
differentiation assays, cells were stained for TropT after being fixed in 4% PFA (Sigma
Aldrich, St. Louis, MO), permeabilized in 0.1% Tween-20 (Sigma Aldrich, St. Louis,
MO) or directly for vWF or SMA. Stained CPCs were then analyzed using a
MACSQuant® analyzer (Miltenyi Biotec, Auburn, CA). Quantification of data was
performed using FlowJo software version 10 (Ashland, OR). Compensation was
performed using UltraComp eBeads (Life Technologies, Grand Island, NY) following the
manufacturer’s protocol. Briefly, one drop of compensation beads were incubated with
each antibody individually for 30 minutes at 4ºC and then detected using the same
MACSQuant® analyzer just prior to experiments requiring compensation. FlowJo was
then used to generate a compensation matrix, which was applied to all experimental data.
Information concerning antibodies, isotype controls, and reagents used in antibody
labeling is provided in Table 3.

Directed Differentiation of Cardiovascular Progenitor Cells
To validate the ability of neonatal and adult CPCs to differentiate into cells of the
cardiovascular lineage, directed differentiation assays were performed, as described in Le
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et al. (2018) and Smits et al. (2009). In brief, to generate cardiomyocytes, CPCs were
cultured in growth media (see above) until 85% confluent. CPC growth media was then
replaced with differentiation media (47% IMDM, 47% Ham’s F12 with GlutaMAX,
2.0% penicillin-streptomycin, 2.0% horse serum, 1.0% minimum essential medium nonessential amino acids solution, and 1.0% insulin-transferring selenium (all reagents from
Life Technologies, Carlsbad, CA) containing 5 µM 5-Azacytidine (Sigma, St. Louis,
MO), which was refreshed daily for three days. Then, 1 ng/mL TGF-β (R&D Systems,
Minneapolis, MN) and 0.1 mM ascorbic acid (Acros Organics, Geel, Belgium) in fresh
differentiation media was added routinely until day 14, at which time cells were stained
for TropT or placed in TRIzol® reagent (Life Technologies, Carlsbad, CA) for gene
expression analysis. To generate endothelium, CPCs were cultured in growth media (see
above) until 85% confluent, at which time the growth media was replaced with
endothelial cell growth media (Lonza, Basel, Switzerland) containing 25 ng/mL Bmp4
(R&D Systems, Minneapolis, MN) and 50 ng/mL Vegf (R&D Systems, Minneapolis,
MN) for two days. The media was then replaced with endothelial cell growth media
(Lonza, Basel, Switzerland) containing 50 ng/mL Vegf and cultured for four days. Then,
cells were regularly fed endothelial cell growth media (Lonza, Basel, Switzerland) until
day 14, at which time cells were stained for vWF, placed in TRIzol® reagent (Life
Technologies, Carlsbad, CA) for gene expression analysis, or seeded onto Matrigel for
tube formation assay analysis, as described below. Finally, to generate smooth muscle
cells, CPCs were cultured in growth media (see above) until 85% confluent, at which
time the growth media was replaced with DMEM (Life Technologies, Carlsbad, CA)
containing 4.5 g/L D-glucose, 2% fetal bovine serum (Thermo Scientific, Waltham, MA),
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and 50 ng/mL PDGF-BB (R&D Systems, Minneapolis, MN). This media was regularly
replaced until day 14, at which time cells were stained for smooth muscle actin or placed
in TRIzol® reagent (Life Technologies, Carlsbad, CA) for gene expression analysis.
Antibodies used for flow cytometry analysis are included in Table 4.

Biocell Seeding and Spaceflight
Neonatal and adult CPCs were seeded into Biocells (BioServe Space
Technologies, Boulder, CO) at two seeding densities (7,500 cells or 5,000 cells) and
loaded into self-contained environments containing 5% CO2 and 95% air. They were then
flown aboard SpaceX CRS-11 to the US National Lab on the ISS where they were placed
in an incubator containing 5% CO2 and 95% air. Fresh media was provided every four to
five days while aboard the ISS (Figure 5). At 12 days, the Biocells that were seeded with
7,500 cells were flooded with RNA Protect (Qiagen, Valencia, CA) and stored at -80ºC.
At 30 days, the Biocells seeded with 5,000 cells were fed and returned to Earth. Cloneand passage-matched ground controls were fed and treated in parallel with the feeding
schedule and activities performed by astronauts aboard the ISS.

Post-Flight Sample Processing
Upon landing and retrieval of the payload, live cells were trypsinized, counted,
and used to assess cell cycle, migration, and endothelial tube formation, as well as to
prepare protein lysates. Biocells containing cells fixed and frozen in RNA Protect were
thawed at room temperature. The RNA Protect was removed and centrifuged at 10,000g
at 4ºC for 10 minutes. Biocells were disassembled and the culture membranes were then
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rinsed with TRIzol® reagent (Life Technologies, Carlsbad, CA). RNA was purified from
the RNA protect samples using the RNeasy Mini Kit (Qiagen, Valencia, CA), per the
manufacturer’s instructions, while total RNA was purified from TRIzol® reagent using
isopropanol- and ethanol-based precipitation. cDNA was generated and RT-PCR was
performed as described below.

RT2 MicroRNA Profiler Array and miRNA RT-PCR
MicroRNA array profiling was performed as previously described (Fuentes,
2015). Briefly, the miScript II RT Kit (Qiagen, Valencia, CA) was used to convert 500 ng
of total RNA into cDNA, which was diluted, added to miScript SYBR Green PCR master
mix and 10X universal primer mix (Qiagen, Valencia, CA), and run on human
development and differentiation miScript plates (MIHS-103ZA; Qiagen, Valencia,
CA). Fold changes were determined for each clone using the Qiagen Data Analysis
Center (http://www.qiagen.com/us/shop/ genes-and-pathways/data-analysis-centeroverview-page/) using all available housekeeping genes. Since this analysis center
performs only a two-tailed Student’s t-test to calculate P-values, all fold changes for
individual clones were exported to Prism and analyzed, as described below. Individual
primers for SNORD96a, SNORD72, hsa-miR-100-5p, and hsa-miR-99a-5p
(SABiosciences, Valencia CA) were also used (Table 5). The average Ct value of
SNORD96a and SNORD72 was used as a housekeeping control. The PCR conditions for
the microRNA arrays and individual microRNA assays were: 95°C for 15 minutes and 40
cycles of 94°C for 15 seconds, 55°C for 60 seconds, and 70°C for 30
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Table 3. Antibodies used to identify CPCs for experiments aboard the ISS
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Antibody

Manufacturer

Isotype

Conc.

Species

Clone

Cat. No.

Lot No.

Mesp1-DyLight 405

Novus Biologicals

IgG

0.8mg/mL

Rabbit

2030B

Isotype-DyLight405

Novus Biologicals

IgG

1.05mg/mL

Rabbit

Viobility 405/520

Miltenyi Biotec

n/a

n/a

n/a

NBP236463V
n/a

CKNQ01-1050317-V
31908-050317V
5170315796

Islet1
Fluorescein Labeling Kit
Isotype-FITC

Abcam
Novus Biologicals
BioLegend

0.5mg/mL

Mouse
n/a
Mouse

1H9
10934
MOPC-21

PDGFRα-PE

BioLegend

100ug/mL

Mouse

16A1

323505

B192368

Isotype-PE

BioLegend

200ug/mL

Mouse

MOPC-21

400113

B214532

CXCR4-PE/Vio770

Miltenyi Biotec

IgG1
n/a
IgG1
kappa
IgG1
kappa
IgG1
kappa
IgG1

MAB921
9V
NBP236463V
130-109814
ab86472
707-0030
400107

82.5ug/mL

n/a

REA649

5170503056

REA CtRl-PE/Vio770

Miltenyi Biotec

IgG1

20ug/mL

n/a

REA293

cKit-DyLight650

Novus Biologicals

500ug/mL

Mouse

2B8

Isotype-AlexaFluor 647
SSEA1-APC/Vio770

R&D Systems
Miltenyi Biotec

IgG2B
kappa
IgG2B
IgG1

10ug/mL
8.25ug/mL

Rat
n/a

141945
REA321

REA Ctrl-APC/Vio770

Miltenyi Biotec

IgG1

30ug/mL

n/a

REA293

130-109887
130-104616
NB10077477C
IC013R
130-104992
130-104618

0.83mg/mL

GR273015-3
1BS3384
B199152

5170201559
B147020-A
AEIU0114121
5161207356
5170201560

Table 4. Antibodies used in directed differentiation assays
Antibody
TropT-PE
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Isotype-PE

Manufacturer
Miltenyi
Biotec
BD Pharmigen

Isotype
IgG1

vWF-AlexaFluor
657

Novus
Biologicals

IgG1
kappa
IgG1
kappa

IsotypeAlexaFluor 647
αSMA-PerCP

R&D Systems

IgG2B

Novus
Biologicals

IgG2a
kappa

Isotype-PerCP

Miltenyi
Biotec

IgG1

Conc.
10
µg/mL
0.5
mg/mL
0.75
mg/mL

Species
n/a

10
µg/mL
0.4
mg/mL

Rat

55
µg/mL

Mouse
Mouse

Mouse

Mouse

Clone
REA4
00
MOPC
-21
3E2D1
0

Cat. No.
130-106746
556650

Lot No.
5160426814

NBP234535AF6
47

74501PABX1605
19120816AF647
AEIU011412
1
591PABX1706
19-090617PCP
5110906188

14194 IC013R
5
1A4/as NBP2m1
34522PCP
IS521F5

130-094968

19587

Individual Clones
(Biocell Group A)

Biocell Seeding

Cells Pooled
(Biocell Group B)

Four unique adult
or neonatal clones
Experiment Timeline
Day 0

Day 3

Launch
(37ºC &
5% CO2)

Arrives to
ISS

Day 24

Media
Change
(Biocell
Group B)

Day 8

Day 12

Day 16

Day 20

Media
Change
(Biocell
Group B)

Media
Change
(Biocell
Group B)

Fixation
(Biocell
Group A)

Media
Change
(Groups
A & B)

Media
Change
(Groups
A & B)

Media
Change
(Biocell
Group B)

Day 27

Day 30

Day 31 – Return to Lab

Return to
Earth
(37ºC &
5% CO2)

Group A
RNA Purification
Group B
Endothelial Tube Assay
Cell Cycle Analysis
Migration Assay
Protein Isolation
RNA Purification

Media
Change
(Biocell
Group B)

Figure 3. ISS Experiment Schematic
An outline of the experimental design for culture aboard the ISS, including how cell culture
systems were prepared prior to launch and a timeline of experiments once aboard the ISS.
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seconds. Differences in fold changes between ground- and ISS- cultured CPCs were then
analyzed as described in the statistics sub-section.

MicroRNA Targeting Prediction
KEGG analysis was performed using DIANA mirPath version 3 and TarBase v7.0
for microRNAs that were found to be significantly altered in neonatal and adult CPCs.
Results were merged by pathway union after controlling for error rate due to multiple
comparisons via selecting the “correct for FDR” feature. After removing categories
related to cancer, neurological diseases, and viruses/pathogenesis, the KEGG categories
whose p-values were less than 0.05 were reported.

RT2 Profiler Array
We used custom array plates (CLAH22469A; Qiagen, Valencia, CA) per the
manufacturer’s instructions to measure gene expression changes in ISS-cultured adult and
neonatal CPCs that were relevant to Wnt, ERK, BMP/Smad, and Notch signaling;
cytoskeletal maintenance; calcium handling; apoptosis and cell cycle; cardiac
development and stemness; and regeneration. Briefly, 2 µg of RNA was reverse
transcribed into cDNA, as described above, and then thoroughly mixed with 2X RT2
SYBR Green Mastermix and RNase- and DNase-free water before being loaded into the
profiler array plate. Samples were amplified in the iCycler iQ™5 PCR Thermal Cycler
(Bio-Rad, Hercules, CA) using a protocol of 95°C for 10 minutes and 40 cycles of 95°C
for 15 seconds and 60°C for one minute. Fold changes were determined for each clone
individually using the Qiagen Data Analysis Center (http://www.qiagen.com/
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Table 5. Primer pair sequences used in RT-PCR experiments
The catalog number, manufacturer, and name of microRNA primers that were not originally
included in microarray plates as well as gene names and sequences (reported 5’ to 3’)
included in experiments.
Gene

Forward Sequence (5’ to 3’)

Reverse Sequence (5’ to 3’)

ACTA2

AGCTTTCAGCTTCCCTGAACA

TACAGAGCCCAGAGCCATTG

ACTIN

TTTGAATGATGAGCCTTCGTCCCC

GTCTCAAGTCAGTGTACAGGTAAGC

ATM

GGGCGAGCCGCAAACGCTAA

TTCGGCCCGTCGGAGCAAAC

E2F1

GACCATCAGTACCTGGCCGAGAG

GACGACACCGTCAGCCGAGTG

HGF

CACGAACACAGCTTTTTGCC

TGATCCCAGCGCTGACAAAT

HMOX1

CTCTCGAGCGTCCTCA

ACTATCAGACAATGTTGT

HSP70

TGACCAAGATGAAGGAGATCG

GTCAAAGATGAGCACGTTGC

IGF1

CAGAGCAGATAGAGCCTGCG

CAGGTAACTCGTGCAGAGCA

MESP1

TAGGCCTCAGCGAGGAGAGT

TCCCTTGTCACTTGGGCTCC

MLC2V

GGTGCTGAAGGCTGATTACGTT

TATTGGAACATGGCCTCTGGAT

MYH11

CAAATACGCGGATGAGAGGGA

CTCATGGACGTTCTTGCCCA

NKX2-5

CGCCGCTCCAGTTCATAG

GGTGGAGCTGGAGAAGACAGA

PECAM1

AACGGAAGGCTCCCTTGATG

TAAGAACCGGCAGCTTAGCC

POU5F1

AACCTGGAGTTTGTGCCAGGGTTT

TGAACTTCACCTTCCCTCCAACCA

RAD23A

GTATCGGAGCAGCCGGCCAC

TCCCCAGGGGGCTCGTTCAG

RAD50

CTACGGCTTTGCGTCCCCGG

ACACCAGCTTTCCCCGC

SDF1A

CTACAGATGCCCATGCCGAT

GTGGGTCTAGCGGAAAGTCC

SOX2

AACCAGCGCATGGACAGTTA

GACTTGACCACCGAACCCAT

TERT

AGAGTGTCTGGAGCAAGTTGC

CGTAGTCCATGTTCACAATCG

TNNT2

GTGGGAAGAGGCAGACTGAG

ATAGATGCTCTGCCACAGC

TP53INP1

CACAACAACAAAAGGACTTGGACT

TTGAGCTTCCACTCTGGGAC

TXNIP

TCAGTATTGCAGGGCTTGGC

GTCTCTTGAGTTGGCTGGCT

VEGFA

CAGCGAAAGCGACAGGGGCA

GCTGGAGCACTGTCTGCGCA

VWF

ACACCTGCATTTGCCGAAAC

ATGCGGAGGTCACCTTTCAG

YAP1

TCCCAGATGAACGTCACAGC

TCATGGCAAAACGAGGGTCA

Symbol

MicroRNA

Catalog
Number

Manufacturer

hsa-miR-99a-5p

Hs_miR-99a_2

MS00032158

Qiagen

hsa-miR-100-5p

Hs_miR-100

Ms00031234

Qiagen

SNORD72

Hs_SNORD72_11

MS00033719

Qiagen

SNORD96A

Hs_SNORD96A_11

MS00033733

Qiagen
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us/shop/genes-and-pathways/data-analysis-center-overview-page/) using GAPDH and
ACTB (β-actin) as housekeeping genes. Since this analysis center performs only a twotailed Student’s t-test to calculate P-values, all fold changes for individual clones were
exported to Prism and analyzed, as described below.

Quantitative RT-PCR
Changes in the expression of select genes were analyzed using RT-PCR. RNA
was isolated from CPCs as described above. cDNA was prepared using 2 µg of RNA
with Superscript III (Life Technologies, Carlsbad, CA). Quantitative real-time
polymerase chain reaction (qRT-PCR) was performed using Go-Taq® qPCR Mastermix
(Promega, Madison, WI) and the iCycler iQ™5 PCR Thermal Cycler (Bio-Rad,
Hercules, CA) following a protocol of 94°C for 10 minutes and 45 cycles of 94°C for 15
seconds, 52–68°C (depending on the primer) for 60 seconds, and 72°C for 30 seconds.
RT-PCR products were visualized using 1–2% agarose gel electrophoresis and low mass
DNA ladder (Invitrogen, Carlsbad, CA). Primers were designed using the National
Center for Biotechnology Information Primer-BLAST program and obtained from
Integrated DNA Technologies (Coralville, IA). Primers used in experiments are listed in
Table 5.

Endothelial Tube Formation Assay
Matrigel (Trevigen, Gaithersburg, MD) was added to a 96-well plate (50μL/well)
and hardened in a humidified, 5% CO2 incubator at 37ºC for 1 hour. Cells (20,000/well)
were then incubated for seven hours in EGM-2 media (Lonza Allendale, NJ) before being
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stained with Calcein AM (Fisher Scientific, Pittsburg, PA) for 30 minutes. Their ability to
form capillary-like networks was measured using an EVOS imaging system
(ThermoFisher Scientific, Waltham, MA) and quantified with ImageJ (v1.47f, NIH,
Bethesda, MD).

Cell Cycle Analysis
Aliquots of 250,000 cells were fixed with 70% ethanol overnight, incubated for
60 minutes with RNAse A (Fisher Scientific, Pittsburg, PA), and stained with propidium
iodide, prior to running samples on a MACSquant analyzer (Miltenyi Biotec, Auburn,
CA) and analyzing cell cycle progression using the Dean-Jett-Fox model in the cell cycle
analysis tool of FlowJo software (Ashland, OR).

Migration Assay
CPCs were trypsinized, counted, and resuspended in starving medium that
contained IMDM with GlutaMAX (ThermoFisher Scientific, Waltham, MA), 1% InsulinTransferrin-Selenium (Life Technologies, Carlsbad, CA), and 0.5% FBS (Thermo
Scientific, Waltham, MA). 50,000 CPCs were plated in the top chamber of a 96-well
transwell migration assay (Corning, Union City, CA) with 8 micron pores. Standard CPC
growth medium supplemented with 100ng/mL of SDF-1α (Life Technologies, Grand
Island, NY) was used in the bottom chamber as a chemoattractant. After 6 hours,
migrated cells in the bottom chamber were stained using Calcein AM (Fisher Scientific
Pittsburg, PA) and quantified using a FLX800 fluorescent plate reader (Bio-Tek,
Winooski, VT).
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Statistical Analysis
The Shapiro-Wilk test for normality was used to test the normality of data
distribution. We then performed a two-tailed, paired t-test to compare the mean of all
normally distributed data. Non-normally distributed data were compared using a
Wilcoxon matched-pairs signed rank text. For cell cycle, migration, and endothelial tube
formation assay, samples in each group were pooled and either a two-tailed, unpaired ttest or Mann-Whitney U test was used to compare the mean of normally or non-normally
distributed data, respectively. All data are reported as the mean ± the standard error of the
mean. Prism 7 version 7.02 (GraphPad, La Jolla, CA) was used for all statistical analyses.
P values < 0.05 were assumed to indicate statistical significance.

Results
CPCs Exhibit Markers of Early Mesodermal Development
CPCs were clonally isolated, expanded, screened for the co-expression of Isl1 and
c-Kit, assessed for viability, and ultimately selected for experiments based upon the
expression of early developmental markers (Mesp1, PDGFRα, and SSEA1) along with
the chemokine receptor CXCR4. Representative adult and neonatal clones are shown in
Figure 4. Clonal lines of CPCs obtained from neonatal and adult patients were then flown
aboard the ISS for 12 days and fixed in RNAprotect during orbit (Figure 3).
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PDGFRα

Isl1

CXCR4

c-Kit

SSEA1

CXCR4

PDGFRα

Isl1

SSEA1

c-Kit

c-Kit

CXCR4

PDGFRα

Isl1

Mesp1

Mesp1

Neonatal CPC

Adult CPC

Unstained

Figure 4. CPCs express markers of early mesodermal development
Neonatal (blue) and adult (red) CPC clones were screened for the co-expression of Isl1 and
c-Kit, assessed for viability, and then ultimately selected for experiments based upon the
co-expression of early developmental markers (Mesp1, PDGFRα, KDR, and SSEA1) along
with the chemokine receptor CXCR4.
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CPCs Differentiate Into All Three Major Cardiovascular Lineages
To validate the identity of neonatal and adult CPCs, cells expressing markers of
early mesoderm were treated with directed differentiation protocols for two weeks before
being assessed for relvant gene and protein expression using RT-PCR and flow
cytometry, respectively (Figure 5A). CPCs were treated with 5-azacytidine and Tgfβ to
induce cardiomyocytes, which subsequently expressed elevated levels of cardiomyocyte
markers TNNT2, MLC2V, and the protein TropT (Figure 5B-C). Separately, CPCs were
treated with Vegfa, Bmp4, and endothelial growth media to induce endothelial cells,
which subsequently expressed elevated levels of endothelial markers VWF, PECAM1,
and the protein vWF (Figure 5D-E). Endothelial tubes were then formed from endothelial
cells (Figure 5F). Finally, cells were treated with Pdgf-BB in DMEM containing 4.5 g/L
glucose to induce smooth muscle cells, which subsequently expressed elevated levels of
smooth muscle cell markers ACTA2, MYH11, and the protein αSMA (Figure 5G-H).

Microgravity Mediates Changes to Expression of microRNAs That Target Membrane
Synthesis and Extracellular Interactions
In an effort to understand the relevant signaling events of a reduced gravity
environment, we performed microarray analysis to measure broad alterations to
transcriptional control. Of the 88 microRNAs analyzed, 14 exhibited significant
alterations in levels of expression among neonatal and adult CPCs (n=3 unique clones per
age per group for all miRs, except miR-99a and miR100, which were measured in
biological and technical triplicates, Figure 6). KEGG analysis by age group (Table 6)
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Figure 5. Neonatal and adult CPCs can differentiate into all major cardiovascular
lineages
To validate the identity of CPCs used in experiments, directed differentiation protocols
were used for cardiomyocyte, endothelial, and smooth muscle pathway induction (A).
Cardiomyocyte (B-C), endothelial cell (D-E), endothelial tube (F), and smooth muscle cell
(G-H) induction was screened after 14 days by RT-PCR and flow cytometry. Gene
expression patterns for the mesodermal marker MESP1 and differentiation markers were
measured in each unique differentiation experiment. n=3–9 replicates. Data: mean ± SEM,
*p<0.05, **p<0.01, ***p<0.001.
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Neonatal Ground
Neonatal ISS
Adult Ground
Adult ISS

Figure 6. Microgravity alters microRNA expression in neonatal and adult early CPCs
Neonatal and adult CPCs both exhibited significant alterations in microRNA expression
following 12 days of culture aboard the ISS. KEGG analysis (Table 6) indicated likely
targeting of ECM interactions, membrane metabolism, and Hippo signaling by these
microRNAs. n=3–9. Data: mean ± SEM, *p<0.05, **p<0.01, ***p<0.001.
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Table 6. KEGG analysis of targets of significantly altered microRNAs
Following spaceflight, neonatal and adult CPCs were screened for changes to microRNA
expression, which were then assessed using KEGG pathway analysis.
Neonatal CPC KEGG Analysis Results
KEGG pathway
Fatty acid biosynthesis
ECM-receptor interaction
Hippo signaling pathway
Cell cycle
Lysine degradation
Glycosphingolipid biosynthesis - lacto and
neolacto series
p53 signaling pathway
Protein processing in endoplasmic reticulum
Endocytosis
Thyroid hormone signaling pathway
Adult CPC KEGG Analysis Results
KEGG pathway
Fatty acid biosynthesis
ECM-receptor interaction
Hippo signaling pathway
Lysine degradation
Adherens junction
Cell cycle
TGF-beta signaling pathway
Protein processing in endoplasmic reticulum
Fatty acid metabolism
p53 signaling pathway
Endocytosis
FoxO signaling pathway
RNA transport
Thyroid hormone signaling pathway
Estrogen signaling pathway
Ubiquitin mediated proteolysis
Signaling pathways regulating pluripotency of
stem cells
Glycosaminoglycan biosynthesis - chondroitin
sulfate / dermatan sulfate
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P-Value
0
0
1.94E-13
1.56E-05
2.80E-05

Genes
2
14
43
43
16

miRNAs
1
2
3
3
2

0.000139519
0.002223088
0.02048608
0.02304169
0.04192693

2
25
51
52
34

2
3
2
2
2

P-Value
0
0
0
1.11E-16
1.26E-10
2.97E-09
3.00E-08
4.16E-08
3.36E-06
2.40E-05
0.000157412
0.000502794
0.0013397
0.003808595
0.003832405
0.00920295

Genes
4
19
87
28
51
72
49
99
16
41
76
51
73
48
29
70

miRNAs
2
4
8
6
5
3
5
4
2
4
3
3
2
3
3
3

0.009475487

56

3

0.01175345

9

2

indicated that fatty acid biosynthesis, extracellular matrix (ECM)-receptor interactions,
and Hippo signaling were the most significantly affected targets of these microRNAs.

Cytoskeletal Maintenance Is Altered in Neonatal,
But Not Adult, CPCs Under Microgravity
Since the pathways targeted by the significantly dysregulated microRNAs affect
cytoskeletal remodeling and mechanotransduction pathways (Figure 7A), we sought to
measure changes in the expression of YAP1, a gene that encodes a critical Hippo
signaling molecule; small RhoGTPases; and cytoskeletal molecules. YAP1 was
significantly down-regulated in neonatal CPCs (fold change: 0.243 ± 0.833, n=3 unique
clones each measured in triplicate per group, P=0.004; Figure 7B) and modestly
upregulated in adult CPCs (fold change: 2.629 ± 0.186, n=2 unique clones each measured
in triplicate per group, P=0.006; Figure 8A). Among small RhoGTPases, only RhoA was
significantly downregulated in neonatal CPCs (fold change: 0.152 ± 0.087, n=3 unique
clones per group, P=0.010; Figure 7C), while the cytoskeletal genes VIM, NES, DES,
LMNB2, and LMNA were all significantly upregulated (fold changes: 5.180 ± 1.227,
P=0.031; 21.460 ± 5.729; P=0.023; 6.005 ± 1.447, P=0.026; 5.096 ± 1.163, P=0.024;
10.420 ± 2.930, P=0.033; respectively; n=3 unique clones per group) following
spaceflight (Figure 7D). Meanwhile, in adult CPCs, only NES expression decreased
significantly (fold-change: 0.279 ± 0.137, n=3 unique clones per group, P=0.006) (Figure
8B & C).
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Figure 7. Microgravity impacts expression of genes involved in mechanotransduction
and cytoskeleton maintenance in neonatal CPCs
Integrin and mechanical signaling impact Hippo activity and small RhoGTPases, which
function along the Wnt planar cell polarity pathway (A). YAP1 expression was significantly
reduced in neonatal CPCs (B). RHOA, a small RhoGTPase, was expressed at significantly
lower levels (C) CPCs. Accordingly, cytoskeletal gene expression was significantly
upregulated (E). Data are reported as the mean ± SEM, n=3–6 per group, *p<0.05,
**p<0.01.
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Figure 8. Microgravity generally does not impact the expression of genes involved in
mechanotransduction and cytoskeleton maintenance in adult CPCs
YAP1 expression was significantly upregulated in adult CPCs (A). Small RhoGTPase
gene (B) and cytoskeletal gene (C) expression was not significantly modulated by
spaceflight. Data are reported as the mean ± SEM, n=3 per group, **p<0.01.
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Microgravity Enhances Non-Canonical/Ca2+
Signaling Gene Expression in Neonatal CPCs
Given the role of small RhoGTPases in non-canonical, planar cell polarity Wnt
signaling, we sought to assess the expression of genes involved in the calcium and
canonical Wnt pathways. (Figs 9-10). In doing so, we observed significantly increased
expression of GSK3B (fold-change: 6.798 ± 1.133, n=3 unique clones per group,
P=0.036) in neonatal CPCs (Figure 9A) and significantly increased expression of
CTNNB1 (fold-change: 1.891 ± 0.121, n=3 unique clones per group, P=0.018) in adult
CPCs (Figure 10A). Since Gsk3β sequesters β-catenin for degradation in the cytoplasm,
thereby suggesting suppression of canonical Wnt signaling in neonatal CPCs and the
promotion of canonical Wnt signaling in adult CPCs, we measured non-canonical Wnt
ligand expression and that of genes in the Wnt/Ca2+ pathway. We measured significantly
increased WNT5A and WNT9A expression (fold changes: 36.440 ± 8.258, P=0.050;
17.110 ± 3.411; P=0.042, respectively; n=3 unique clones per group) in neonatal CPCs
(Figure 9B) and significantly decreased WNT9A expression (fold-change: 0.393 ± 0.170,
n=3 unique clones per group, P=0.023) in adult CPCs (Figure 10B). This was supported
by significantly increased expression of PLCG1 and PRKCA (fold changes: 14.110 ±
1.468, P=0.012; 11.520 ± 2.974, P=0.0241; respectively; n=3 unique clones per group)
and a general increase in ITPR1 expression (fold changes: 2.668 ± 0.623, P=0.055;
10.240 ± 4.393; P=0.1034, respectively; n=3 unique clones per group) in neonatal (Figure
9C), but not adult (Figure 10C), CPCs.
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Figure 9. Genes involved in the non-canonical Wnt/Ca2+ pathway are expressed at
higher levels in neonatal CPCs
Canonical Wnt signaling genes were measured in neonatal (A) CPCs along with noncanonical Wnt ligands (B). Genes involved in the non-canonical Wnt/calcium pathway
were elevated in neonatal (C) CPCs. Data are reported as the mean ± SEM, n=3 per group,
*p<0.05.
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Figure 10. Genes involved in the non-canonical Wnt/Ca2+ pathway are not expressed
at higher levels in adult CPCs
Canonical Wnt signaling genes were measured in adult (A) CPCs along with non-canonical
Wnt ligands (B). Genes involved in the non-canonical Wnt/calcium pathway were
unchanged in adult (C) CPCs. Data are reported as the mean ± SEM, n=3 per group,
*p<0.05.
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Neonatal CPCs Exhibit Increased Expression of Genes
Involved in Pre-Mesodermal Development
Calcium and Wnt signaling have central roles in cardiogenesis. For this reason,
we sought to assess the transcription of markers of various stages of cardiac development.
We observed that the expression of genes involved in embryonic stem cell self-renewal
(POU5F1, NANOG, SOX2), mesodermal specification (FOXC1, MESP1, T), and early
cardiogenesis (GATA4, KIT, PDGFRA, ISL1, KDR) increased, while NKX2-5 expression
decreased, in neonatal CPCs (n=3 unique clones per group, Figure 11). In this population,
the expression of genes involved in early mesodermal specification were the most
significantly elevated. Conversely, adult CPCs generally exhibited decreased or
unchanged expression of genes involved in early developmental processes, with the
exception of PDGFRA (n=3 unique clones per group, Figure 11). Furthermore, increased
telomerase activity, as indicated by enhanced TERT expression, was observed in neonatal
CPCs following spaceflight (fold change: 6.782 ± 2.000, n=9 per group (three unique
clones each measured in triplicate), P=0.020). Despite experiencing no change in
expression in genes related to development, adult CPCs expressed higher levels of TERT
expression (fold change: 21.150 ± 10.610, n=6 (three unique clones each measured in
triplicate), P=0.007).

Expression of BMP4 and TBXs 3, 5, and 18 Is
Elevated Under Microgravity in Neonatal CPCs
These modifications to the expression of genes involved in cardiogenesis
motivated us to measure the changes in the expression of genes in the Bmp, Smad, and
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Figure 11. Spaceflight induces early mesodermal gene expression in neonatal CPCs
Markers of development were measured in neonatal and adult CPCs following 12 days of
culture aboard the International Space Station. Gene expression analysis indicated that
early mesodermal markers (i.e., FOXC1, MESP1, and T) were elevated in expression in
neonates, but not in adults. Data are reported as the mean. *p<0.05.
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Figure 12. Spaceflight modifies TBX, Smad, and BMP expression patterns
The expression of members of the BMP, Smad, and TBX families of genes was measured
after 12 days of culture aboard the ISS and was found to be elevated significantly in
neonatal CPCs and modestly in adult CPCs. Data are reported as the mean.
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Tbx families, which have important roles in pre- and early mesodermal development. We
measured elevated expression of BMP4, TBX3, TBX5, and TBX18, and a general increase
in BMP2 expression in neonatal CPCs (Figure 12). In adult CPCs, SMAD1 exhibited a
significant increase in expression, while SMAD2 and TBX18 exhibited general increases
in expression (Figure 12).

Microgravity Reduces Endothelial Tube Formation and
Terminal Mesodermal Derivative Marker Expression in Neonatal CPCs
Given the elevated expression of early to pre-mesodermal genes in neonatal, but
not adult, CPCs, we sought to measure whether MG enhances or reduces mesodermal
derivative marker expression. Following 30 days in orbit, CPCs returned to Earth and
were immediately assayed for endothelial tube formation capacity. Unlike adult CPCs,
neonatal CPCs exhibited a significantly reduced ability to form tubes (n=3 measurements
of four pooled clones per age per group, Figure 13). Representative images of tube
formation of neonatal ground (Figure 13C) and ISS (Figure 13D) as well as adult ground
(Figure 13E) and ISS (Figure 13F) samples reflect this age-dependent response of CPCs
to spaceflight. Similarly, expression of the cardiomyocyte marker TNNT2, endothelial
marker VWF, and osteoblast marker RUNX2 were all significantly reduced in neonatal,
but not adult, CPCs after 12 days in orbit. Interestingly, sinoatrial nodal markers HCN4
and SHOX2 exhibited elevated expression in neonatal CPCs and reduced expression in
adult CPCs (n=3 unique clones per age per group, Figure 14).
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Figure 13. Spaceflight reduces the propensity for neonatal CPCs to readily form
endothelial tubes
Following culture in biocells on the ground or the ISS for 30 days, CPCs were placed in
endothelial growth media and incubated on Matrigel for 7 hours to facilitate endothelial
tube formation. The area covered by the tubes that formed (A) and the number of branches
(B) were quantified using ImageJ for neonatal ground (C) and ISS (D) CPCs as well as for
adult ground (E) and ISS (F) CPCs (ruler = 1000µm). Data are reported as the mean ±
SEM, n=3 measurements of four pooled clones, ***p<0.001.
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Figure 14. Spaceflight reduces the propensity for neonatal CPCs to express markers
of terminal mesodermal derivatives
Changes in gene expression relevant to mesodermal derivatives were measured in CPCs
cultured aboard the ISS for 12 days, indicating decreased expression of cardiomyocyte,
endothelial, and osteogenic markers and increased expression of sinoatrial nodal markers.
Data are reported as the mean ± SEM, ***p<0.001.
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ISS-Cultured Neonatal CPCs Proliferate More Rapidly
Than Adult or Ground-Control CPCs
To understand how these changes in early development marker expression affect
proliferative potential, cell cycling was assessed using flow cytometry. The Dean-JettFox model was fitted to fluorescence intensity curves generated for propidium iodidestained neonatal and adult CPCs (n=3 measurements of four pooled clones per age per
group; Figure 15A). Adult CPCs exhibited a significant decrease in the percentage of
cells in the G1/G0 phase (ISS vs Ground: 70.9% vs 60.6%, p=0.003) and neonatal CPCs
exhibited a significant increase in the percentage of cells in the G2/M phase (ISS vs
Ground: 13.5% vs 17.17%, p=0.050; Figure 15B). Neonatal CPCs were more frequently
in the G2/M phase both on the ground and following culture aboard the ISS.
Interestingly, neonatal CPCs exhibited increases in CDKN2A (fold change: 14.080 ±
2.604, n=3 unique clones per group, p=0.037), E2F1 (fold change: 9.012 ± 2.390, n=9
(three unique clones each measured in triplicate), p=0.010), and PLK1 (8.509 ± 1.542,
n=3 unique clones per group, p=0.040) (Figure 15C). These modulators of cell cycling
were not significantly altered in adult CPCs (Figure 15D). Upon return to Earth, Biocells
cultured aboard the ISS or on the ground contained 1,126,000 ± 176,000 or 152,300 ±
46,700 neonatal CPCs. Meanwhile, Biocells seeded with adult pools that were cultured
aboard the ISS or on the ground contained 407,300 ± 92,700 or 246,000 ± 26,000 adult
CPCs, respectively (Figure 15E). As expected from cell cycle data, the cell counts after
30 days in space were markedly larger in the neonatal CPC population (n=2
measurements of four pooled clones per age per group). Viability of CPCs upon return to
Earth after 30 days of culture was not adversely affected (Figure 15F).
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Figure 15. Cell cycling and proliferation are enhanced following spaceflight in
neonatal CPCs
Following 30 days of culture aboard the ISS, CPCs were fixed, stained with propidium
iodide, and measured using flow cytometry. The Dean-Jett-Fox model was then applied to
the histogram of propidium iodide fluorescence intensity for ground- and ISS-cultured
CPCs (A). Upon analysis (B), adult CPCs exhibited a significant decrease in the percentage
of cells in the G1/G0 and neonatal CPCs exhibited a significant increase in the percentage
of cells in the G2/M phase. This was supported by increased expression of CDKN2A, E2F1,
and PLK1, which function to regulate G1/S arrest, overcome G1/S arrests, and promote
G2/M progression, respectively, in neonatal (C), but not adult (D), CPCs. Despite enhanced
proliferation (E), viability was not adversely affected (F). Data are reported as the mean ±
SEM, n=3 measurements of four pooled clones per group for cell cycling analysis; n=3–9
per group for all gene expression data, *p<0.05, **p<0.01, ***p<0.001.
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DNA Repair Transcripts Increased Following Spaceflight
The broad alterations experienced by CPCs and the possibility of exposure to
radiation in the extraterrestrial environment prompted us to consider possible cellular
stress response mechanisms, including the expression of DNA repair gene programs. We
measured increased expression of genes involved in DNA repair, as indicated by elevated
levels of ATM (fold change: 10.852 ± 3.446, n=9 (three unique clones each measured in
triplicate), P=0.021), RAD23 (fold change: 7.943 ± 0.789, n=9 (three unique clones each
measured in triplicate), P<0.001), and RAD50 (fold change: 21.250 ± 8.656, n=9 (three
unique clones each measured in triplicate), P=0.033) (Figure 16A). Adult CPCs generally
exhibited increased expression of DNA repair genes (Figure 16B); however, only ATM
(fold change: 23.910 ± 0.682, n=9 (three unique clones each measured in triplicate),
P=0.001) expression was significantly elevated.

75

A

Neonatal

B

Adult

Figure 16. DNA repair genes are induced by spaceflight in an age-independent
manner.
DNA repair gene expression was elevated, as indicated by increased levels of ATM,
RAD23, and RAD50 expression (A). Adult CPCs generally exhibited increased DNA repair
genes; however, only ATM expression was significantly increased (B). Data are reported
as the mean ± SEM, n=6–9 per group, *p<0.05, **p<0.01, ***p<0.001.
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Stress Response, But Not Apoptosis, Genes Are Induced in CPCs
Given the broad induction of transcripts associated with DNA repair, we sought to
characterize the impact of other stressors that could influence cellular function during
spaceflight. Neonatal CPCs exhibited a 25-fold increase (P<0.05) in NOTCH1 expression
(Figure 17A-B), which confers protection as part of the adaptive cardiac stress response
(Croquelois, 2008). In considering oxidative stress and that associated with spaceflight
(Figure 17C-D; Cubano, 2001; Versari, 2013; Zupanska, 2013), we found that HSP70
was elevated in both neonatal (12-fold, P<0.01) and adult (20-fold, P<0.05) CPCs, while
TXNIP, TP53INP, and HMOX1 were all induced only in adult CPCs (21-fold, P<0.01;
2.2-fold, P<0.05; 3.2-fold, P<0.001; respectively). Ultimately, neither adult not neonatal
CPCs exhibited an induction of transcripts associated with the apoptosis pathway (Figure
17E-F). As discussed previously, neither proliferation nor viability was reduced in either
age group.

Adult and Neonatal CPCs Both Exhibit a
Greater Migratory Capacity after ISS Culture
In addition to changes in the regulation of differentiation, cytoskeletal alterations
were anticipated to occur in response to MG. For this reason, we measured the migratory
capacity of ISS-cultured CPCs using a Transwell migration assay. Both neonatal and
adult CPCs that were cultured aboard the ISS migrated at significantly higher levels in
response to SDF-1α stimulation (Neonate (ISS vs Ground): 2963 ± 15 cells vs 1972 ± 69
cells; n=5 measurements of four pooled clones per group; P=0.008; Adult (ISS v
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Figure 17. CPCs exhibit minimal induction of genes involved in stress response
pathways
Given the harsh nature of the extraterrestrial environment, we sought to assess the impact
of spaceflight on stress pathways. We measured changes in gene expression pertinent to
the cardiac (neonatal, A; adult, B) and oxidative (neonatal, C; adult, D) stress response as
well as apoptosis activation (neonatal, E; adult, F) in adult and neonatal CPCs flown aboard
the ISS for 12 days. n=3 biological replicates. Data: mean ± SEM, *p<0.05, **p<0.01,
***p<0.001.
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Figure 18. CPCs have enhanced migratory capacity following spaceflight
Both neonatal and adult CPCs that were cultured aboard the ISS migrated at significantly
higher levels in response to SDF-1α stimulation (A). Similarly, SDF1A expression was
elevated in both neonatal (B) and adult (C) CPCs following exposure to low Earth orbit.
VEGFA expression was also significantly elevated in neonatal CPCs (B), while most other
paracrine and growth factors generally increased regardless of age. Data are reported as the
mean ± SEM, n=6–9 per group, **p<0.01, ***p<0.001.
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Ground): 2247 ± 28 cells vs 1394 ± 52 cells; n=5 measurements of four pooled clones per
group; P<0.001) (Figure 18A). Similarly, SDF1A transcripts were elevated in both
neonatal (Figure 18B) and adult (Figure 18C) CPCs following exposure to low Earth
orbit (Neonate: 31.950 ± 10.770-fold increase, n=9 (three unique clones each measured in
triplicate), P=0.0039; Adult: 36.480 ± 16.150-fold increase, n=9 (three unique clones
each measured in triplicate), P=0.0078). VEGFA transcripts were also significantly
elevated in neonatal CPCs (15.78 ± 5.283-fold increase; n=9 (three unique clones each
measured in triplicate); P=0.0068).

Discussion
In this study, we found that microgravity exerts broad effects on the
developmental status, proliferative potential, and migratory ability of CPCs, some of
which occurred in an age-dependent manner. In particular, neonatal CPCs exhibited
increased expression of early developmental markers, enhanced proliferative potential,
and increased migratory capacity under MG. Meanwhile, adult CPCs experienced little
change in the expression of genes indicative of their developmental state, but exhibited
changes to migratory capacity. These findings suggest that broad cytoskeletal
modifications resulting from reduced mechanotransduction impart improved migratory
and adhesion capabilities regardless of age, but that neonatal CPCs are able to propagate
or experience additional intracellular signaling events (e.g., calcium signaling) that
modify their developmental status. As we have shown elsewhere, one important
difference between adult and neonatal CPCs is their epigenetic (i.e., microRNA)
environment (Fuentes, 2013).
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Several microRNAs were observed to be differentially regulated in response to
spaceflight in neonatal and adult CPCs. Interestingly, the predicted targets of these
microRNAs included activators and repressors of several pathways. A detailed inspection
of the putative targets under each pathway impacted by the microRNAs identified in this
study revealed the targeting of genes relating to Wnt signaling (FZD3, FZD5, FZD7,
FZD8), cytoskeletal regulation (ACTB, ACTG1, LAMC3), cardiovascular development
(TGFBR1, BMP2, BMP5, SMAD7), integrin function (ITGB4, ITGAV), extracellular
proteins (COL4A2, COL5A1, COL1A1, COL1A2, COL4A1), and Hippo signaling
(TEAD1, YAP1, LATS1). Interestingly, miR-16, whose expression was generally elevated
in neonatal CPCs and repressed in adult CPCs, directly targets YAP1, which could
account, at least in part, for the age-dependent response of CPCs to spaceflight. However,
since KEGG analysis only identifies broad categories of genes (i.e., functional categories)
that are likely targets of the microRNAs under study, further experiments are warranted
to identify the cumulative impact of these microRNAs on signaling in space flown CPCs.
These results motivated us to assess the overall impact of spaceflight on YAP1, an
effector of Hippo signaling that functions with TAZ to regulate transcription. Activation
of Hippo kinases, such as through a loss of microRNA-mediated repression or through
reduced mechanical signaling, results in elevated levels of phosphorylated Yap1 and Taz.
This prevents translocation of these transcriptional activators to the nucleus. Similarly,
the application of SMG to bone mesenchymal stem cells prevented TAZ translocation to
the nucleus, thereby preventing the expression of RUNX2 and inhibiting osteogenesis
(Chen, 2016). Similarly, the decreased expression of YAP1 and RUNX2 observed in this
experiment indicate that spaceflight reduces mechanotransduction in neonatal CPCs.
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In addition to broadly targeting the Hippo signaling pathway and ECM
interactions, select microRNAs that were modified by MG are known to be critically
involved in cardiac development. For example, miR-142-3p is involved in targeting
genes involved in early cardiac development, such as TBX5 (Chen, 2017). Meanwhile,
miR-302, which targets the type II BMP receptor to regulate early cardiogenic events, is
repressed by Bmp4 in a Smad-dependent manner (Kang, 2012). Interestingly, we
observed both generally reduced expression of miR-302c and a generally elevated
expression of BMP4 in CPCs exposed to MG. Moreover, studies have demonstrated a
direct mechanistic role of certain microRNAs in cardiac regeneration. As neonatal mice
age, their cardiomyocytes lose their proliferative potential in a manner that is
concomitant with increased let-7 family expression (Porrello, 2011), thereby indicating a
relationship between let-7 over-expression and reduced proliferative potential. Indeed,
let-7c along with miR-99/100, which were significantly down-regulated in neonatal
CPCs, are also critically down-regulated during cardiomyocyte proliferation in a
zebrafish model after ventricle amputation (Aguirre, 2014). As part of the amputation
injury response, zebrafish cardiomyocytes near the site of injury undergo sarcomeric
structure disassembly as a form of limited de-differentiation to prepare myocytes for selfrenewal. PLK1, which was upregulated in CPCs cultured aboard the ISS, is involved in
this process (Jopling, 2010). Interestingly, these changes to the cytoarchitecture of
cardiomyocytes and subsequent limited de-differentiation appear to resemble the effects
of SMG (Fuentes, 2013) and MG on CPCs.
Our laboratory has previously measured changes in microRNA expression in
neonatal CPCs induced by SMG (Fuentes, 2013). In comparing those findings to the
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microRNA changes induced by culture aboard the ISS, we found miR-99a and -100 as
well as members of the let-7 family, all of which are implicated in differentiation and
developmental regulation, exhibit significantly reduced expression under both conditions.
Elsewhere, we have compared the effects of spaceflight and SMG on the induction of
signaling in neonatal CCPs and observed similar activation of calcium and Akt signaling.
When considered together these findings suggest that reduced gravity conditions readily
alter the developmental properties of neonatal CPCs, possibly through reduced
mechanotransduction (Baio, 2018).
Alterations to microRNA expression as well as changes to ECM interactions in
MG-treated CPCs highlight the significance of the environment in directing
differentiation. For example, a single population of mesenchymal stem cells can express
neurogenic, myogenic, or osteogenic transcription factors when cultured on soft,
moderately stiff, or stiff matrices, respectively (Engler, 2006). In our experiments, we
observed elevated expression of mesendodermal-stage developmental markers in
neonatal CPCs. It is likely that ECM interactions prompted cytoskeleton remodeling
while modifying intracellular signaling pathways such that proliferation and stemness
were enhanced. Similar experiments in different cell types involving SMG or a low Earth
orbit cell culture system have demonstrated that reduced gravity conditions modify the
differentiation potential of stem cells. Mouse ESCs flown as embryoid bodies during the
Space Tissue Loss Experiment exhibited a decrease in the expression of markers of
terminal germ layer derivatives while maintaining expression of stem cell renewal
markers (Blaber, 2015). However, upon return to Earth, these mouse ESCs differentiated
more readily into colonies of contracting cardiomyocytes. Mesenchymal stem cells
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cultured under conditions of SMG exhibit a reduction in the expression of markers of
cartilage and osteoblast formation (Yuge, 2006; Dai, 2007), while also demonstrating
enhanced proliferation potential and the maintenance or enhancement of stemness under
SMG (Yuge, 2006; Zhang, 2015).
In addition to the expression of genes that are indicative of an earlier stage of
development, neonatal CPCs exhibited both a reduced capacity to readily form
endothelial tubes and decreased expression of mesodermal derivative markers (i.e.,
cardiomyocte, endothelium, and osteoblast) under MG.
This concomitant induction of mesendodermal markers and Tbx gene expression
reflects the potential therapeutic value of the MG environment for cardiac repair. The
critical role of the Tbx family in cardiac development has been well documented
(Plageman, 2005) and its application to cellular therapies for cardiac repair is beginning
to be explored. For example, SSEA-1+ early cardiovascular progenitors expressing T,
TBX5, and TBX18, were shown to engraft into non-human primate myocardium
following infarction (Blin, 2010). Meanwhile, Tbx5 and Tbx18 are expressed in highly
migratory and proliferative proepicardial cell lineages (Tanaka, 2004; Hatcher, 2001).
These studies have demonstrated an increasingly appreciated observation that Tbx
expression is related to the engraftment and function of CPCs following transplantation.
Beyond directing developmental events via alterations in intracellular signaling,
disrupted cytoskeletal organization impacts migration. In other models, cytoskeletal reorganization induces the expression of CXCR4, the SDF-1α chemokine receptor (Lin,
2016). As seen in our experiments, both neonatal and adult CPCs exhibited elevated
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expression of SDF1A, which correlates to the age-independent increase in migratory
capacity of CPCs following spaceflight.
Interestingly, the age-dependent changes in developmental status following
culture aboard the ISS suggest fundamental differences in adult CPCs. While KEGG
analysis demonstrated that functionally similar pathways are likely affected in both adult
and neonatal CPCs, only the latter population experienced significant changes to the
expression of cytoskeletal genes and early developmental markers. This trend was
supported by the significantly increased cell cycle and proliferation patterns observed
only in neonatal CPCs. Broad differences have already been reported to exist between
adult and neonatal CPCs, including at the genetic/epigenetic (Fuentes, 2013) and
proteomic levels (Sharma, 2017). In particular, the secretome of adult CPCs was found to
exhibit a greater number of proteins related to anti-proliferation, pro-apoptosis, and
senescence. Meanwhile, the secretome of neonatal CPCs exhibited higher levels of
telomerases as well as proteins related to cell cycle, proliferation, and anti-apoptosis
(Sharma, 2017). Similarly, we observed age-disparate responses to spaceflight in nearly
all of these categories. In the context of this experiment, microRNA dysregulation may
have exerted a greater effect on neonatal CPCs given their relatively higher levels of
expression of genes related to these processes. Nevertheless, the prospective use of CPCs
in autologous cardiac stem cell therapies in a predominately adult population requires that
these functional differences be elucidated.
As humans prepare to expand our presence in space, it is imperative to deepen our
understanding of the nature of cellular adaptation to reduced gravity so that we may
develop mechanisms by which these molecular changes in cardiac cell types can be
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countered. Meanwhile, on Earth, we can further explore the therapeutic potential of these
adaptations for cardiac repair.
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CHAPTER THREE
PROTEIN KINASE C ALPHA SIGNALING IS ACTIVATED
BY REDUCED GRAVITY CONDITIONS AND
VIA TREATMENT WITH WNT5A ON EARTH

This chapter has been previously published in:

Baio JM, Martinez AF, Bailey L, Hasaniya N, Pecaut MJ, Kearns-Jonker M. Spaceflight
Activates Protein Kinase C Alpha Signaling and Modifies the Developmental
Stage of Human Neonatal Cardiovascular Progenitor Cells. Stem Cells and
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Abstract
As demonstrated in chapter two, neonatal cardiovascular progenitor cells (CPCs)
experience alterations to gene expression and function in response to reduced gravity
conditions. Furthermore, culture of neonatal CPCs aboard the International Space Station
(ISS) was observed to promote migration and foster proliferation. Thus, the potential
therapeutic benefit of culturing stem cells under conditions of simulated microgravity or
spaceflight merit identifying the molecular events underpinning CPC adaptation to space.
Therefore, following 12 and 30 days of culture aboard the ISS, neonatal CPCs were
assessed for changes in gene expression and signaling activation. In doing so, we
observed that ISS-cultured CPCs exhibited elevated levels of calcium handling and
signaling genes, which corresponded to protein kinase C alpha (PKCα), a calciumdependent protein kinase, activation after 30 days. Additionally, Akt was activated,
whereas phosphorylated Erk levels were unchanged. To explore the effect of calcium
induction in neonatal CPCs, we activated protein kinase C alpha (PKCα) using hWnt5a
treatment on Earth. Subsequently, early cardiovascular developmental marker levels were
elevated. These findings demonstrate that calcium signaling is both sensitive to reduced
gravity conditions and involved in directing the developmental profile of early
cardiovascular progenitor cells.
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Introduction
The effects of spaceflight on cardiovascular progenitor cells (CPCs) critically
impacts processes related to development and mechanotransduction via extracellular
matrix interactions. Such findings relate to our observations under simulated
microgravity, in which earlier developmental genes (Fuentes, 2015) and genes involved
in non-canonical Wnt/Ca2+ signaling (Baio, 2018) were induced. Similar research that
exposed neural crest progenitors to simulated microgravity observed increased AXIN2
and GSK3β expression, whose protein products inhibit canonical Wnt signaling
(Hatzistergos, 2018). In addition to the induction of non-canonical Wnt ligands, small
RhoGTPases, such as RhoA, are intimately involved in calcium potentiation or inhibition
(Kim, 2009). Thus, the more broadly observed involvement of RhoA in stem cell
responses to simulated microgravity (Meyers 2005; Pan, 2007; Seki, 2006) likely
implicate alterations to calcium activity in vivo. In the context of cardiogenesis, studies
performed in both embryos and ESC-derived cardiomyocytes have shown a critical role
of Ca2+ in regulating multiple steps of heart formation (Pucéat, 2005). Meanwhile, the
modification of signaling pathways related to calcium, either as an important secondary
or mediating molecule, directly impacts the ability of CPCs to differentiate or maintain
pluripotency (Tonelli, 2012; Apati, 2016). Thus, we speculated that calcium activity may
be intimately related to the response of early CPCs to reduced gravity conditions.
For this reason, we sought to elucidate the role of calcium signaling in the response
of CPCs to spaceflight and to identify peripheral pathways that may be involved in this
process. We also sought to extend these space-borne observations to in vitro experiments
on Earth.
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Materials and Methods
Ethics Statement/Cell Isolation and Expansion
The Institutional Review Board of Loma Linda University approved the protocol
for use of tissue that was discarded during cardiovascular surgery, without identifiable
private information, for this study with a waiver of informed consent. CPCs were isolated
from cardiac tissue of neonates (1 day – 1 month), as previously described (Fuentes,
2013). Briefly, atrial tissue was cut into small clumps (approximately 1.0 mm3) then
enzymatically digested using collagenase (Roche, Indianapolis, IN) at a working
concentration of 1.0 mg/mL. The resulting solution was then passed through a 40-µm cell
strainer. Cells were cloned in a 96-well plate by limiting dilution to a final concentration
of 0.8 cells per well to create populations for expansion. Then, clones were screened for
the co-expression of Isl1 and c-Kit and supplemented with growth media comprised of
10% fetal bovine serum (Thermo Scientific, Waltham, MA), 100 µg/mL penicillinstreptomycin (Life Technologies, Carlsbad, CA), 1.0% minimum essential medium nonessential amino acids solution (Life Technologies, Carlsbad, CA), and 22% endothelial
cell growth media (Lonza, Basel, Switzerland) in Medium 199 (Life Technologies,
Carlsbad, CA). The MycoAlert PLUS Mycoplasma Detection Kit (Lonza, Basel,
Switzerland) was used to test for mycoplasma contamination.
Progenitor cell populations were fluorescently labeled with antibodies, as
recommended by their respective manufacturers, and then analyzed using a MACSQuant®
analyzer (Miltenyi Biotec, Auburn, CA). Quantification of data was performed using
FlowJo software version 10 (Ashland, OR). Isotype controls and unstained cell populations
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were used to define positive and negative gates. Antibodies used for cytometric analysis
are described in Table 3.

Biocell Seeding and Spaceflight
For experiments described herein, neonatal CPCs were seeded into 8 polystyrene
Biocells (BioServe Space Technologies, Boulder, CO) containing 20 mL of growth
media. Biocells were loaded into self-contained environments containing 5% CO2 and
95% air, and flown aboard SpaceX CRS-11 to the US National Lab on the ISS. Three
days after launch, the Biocells arrived at the national lab, where they received fresh
growth media and were placed in an incubator containing 5% CO2 and 95% air.
Thereafter, fresh media was provided every four to five days while aboard the ISS
(Figure 3). Biocells were seeded with CPCs derived from four unique neonates (1 day to
1 month) before being fixed at 12 days after arrival to the ISS with RNA Protect (Qiagen,
Valencia, CA) and stored at -80ºC or fed and returned to Earth at 30 days after arrival to
the ISS for immediate processing. Clone- and passage-matched ground controls were fed
and treated in parallel with the feeding schedule and activities performed by our astronaut
collaborator aboard the ISS.

Post-Flight Sample Processing
Upon landing and retrieval of the payload, live cells were trypsinized, counted,
and used to generate protein lysates. Biocells containing cells fixed and frozen in RNA
protect were thawed at room temperature. The RNA protect was removed and centrifuged
at 10,000g at 4ºC for 10 minutes. Biocells were disassembled and the culture membranes
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were then rinsed with TRIzol® reagent (Life Technologies, Carlsbad, CA). RNA was
purified from RNA protect samples using the RNeasy Mini Kit (Qiagen, Valencia, CA),
per the manufacturer’s instructions, while total RNA was purified from TRIzol® reagent
using isopropanol- and ethanol-based precipitation. cDNA was generated and RT-PCR
was performed as described below.

Gene Expression Profiler Array
We used custom array plates (CLAH22469A; Qiagen, Valencia, CA) per the
manufacturer’s instructions to measure gene expression changes in ISS-cultured adult and
neonatal CPCs that were relevant to Wnt, ERK, BMP/Smad, and Notch signaling;
cytoskeletal maintenance; calcium handling; apoptosis and cell cycle; cardiac
development and stemness; and regeneration. Briefly, 2 µg of RNA was reverse
transcribed into cDNA, as described above, and then thoroughly mixed with 2X RT2
SYBR Green Mastermix and RNase- and DNase-free water before being loaded into the
profiler array plate. Samples were amplified in the iCycler iQ™5 PCR Thermal Cycler
(Bio-Rad, Hercules, CA) using a protocol of 95°C for 10 minutes and 40 cycles of 95°C
for 15 seconds and 60°C for one minute. Fold changes were determined for each clone
individually using the Qiagen Data Analysis Center (http://www.qiagen.com/
us/shop/genes-and-pathways/data-analysis-center-overview-page/) using GAPDH and
ACTB (β-actin) as housekeeping genes. Since this analysis center performs only a twotailed Student’s t-test to calculate P-values, all fold changes for individual clones were
exported to Prism and analyzed, as described below.
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Quantitative RT-PCR
cDNA was prepared using 2 µg of RNA with Superscript III (Life Technologies,
Carlsbad, CA). Quantitative real-time polymerase chain reaction (qRT-PCR) was
performed using Go-Taq® qPCR Mastermix (Promega, Madison, WI) and the iCycler
iQ™5 PCR Thermal Cycler (Bio-Rad, Hercules, CA) following a protocol of 94°C for 10
minutes followed by 45 cycles of 94°C for 15 seconds, 52–68°C (depending on the
primer) for 60 seconds, and 72°C for 30 seconds. RT-PCR products were visualized
using 1–2% agarose gel electrophoresis and low mass DNA ladder (Invitrogen, Carlsbad,
CA). Primers were designed using the National Center for Biotechnology Information
Primer-BLAST program and obtained from Integrated DNA Technologies (Coralville,
IA). Primers used in experiments are listed in Table 7.

Protein Simple-Based Western Blotting
Following detachment, CPCs were homogenized using RIPA buffer containing
phosphatase inhibitor cocktail (Millipore, Temecula, CA), followed by centrifugation at
14,000 g for 15 minutes at 4°C and collection of the supernatant for analysis. Total
protein concentrations were determined using the Pierce Micro BCA Protein Assay Kit
(Thermo Scientific, Rockford, IL). A capillary-based western blotting system
(ProteinSimple Wes, San Jose, CA) was used to assess protein expression. All procedures
were completed according to the manufacturer’s instructions and default settings. The
concentration of protein lysates, antibodies used in experiments, and antibody dilutions
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Table 7. Primer pairs used in RT-PCR for ISS experiments (5’ to 3’)
Gene
ACTIN
CAMK2A
CCND1
cMYC
GAPDH
JUN
MAPK1
MAPK3
MAPK10
NFKB1
PDGFRA
PIK3CA
PLCG1
PRKCA
RELA
TGFB1
WNT3A
WNT5A
WNT9A
WNT11
DUSP3
POU5F1
MESP1
TBX3
HXN4
SHOX2
NKX2-5
TBX5

Forward Sequence
TTTGAATGATGAGCCTTCGTC
CCC
GTCCAGTTCCAGCGTTCAGTT
TGCTGGAGTCAAGCCTGCGC
AAGACAGCGGCAGCCCGAAC
TGCACCACCAACTGCTTAGC
GTCCGCACTGATCCGCTCCG
TTCCCAGTTCTTGACCCCTG
ACCTACCTAAGGAGCGGCTG
TTGCACTCTGACCATGTTGGT
G
GCAGATGGCCCATACCTTCAA
GCGCAATCTGGACACTGGGA
AACAATGCCTCCACGACCAT

Reverse Sequence
GTCTCAAGTCAGTGTACAGGT
AAGC
GTGGGGATTCAGGATGGTGG
AGGACATGCACACGGGCACG
TGGGCGAGCTGCTGTCGTTG
GGCATGGACTGTGGTCATGAG
GGGCTGCGCGCACAAGTTTC
GTACATACTGCCGCAGGTCA
GGCCTCAGCAAAGGAGAGAG
TCATCAACCATCCACTTCCTGT
CT
TTGTGAAGCTGCCAGTGCTA
ATGGGGTACTGCCAGCTCAC
TCACGGTTGCCTACTGGTTC
AGTCCATTGTCCACCACAAAC
GCCCGACATCTGCCAAAGAA T
TTTTCCCGGGCAACGACTC
CGCACCCGGACAAGAAAAAG
GCGAGAGGAGCACAGATACC GGGGTTGTTGTTGGTCTGGA
GGGCTACCATGCCAACTTCT
GACACAGAGATCCGCAGTCC
CTGCCTGAGGGTGGGCTTTT
TGGAACCTTCCCAGCTCGAC
CTTCGCCCAGGTTGTAATTGA CTGCCAAAAACAGAGGTGTTA
AGC
TCC
CAGCAGCAAGTTCGTCAAGC
TTGCCCACCTCATGGAAAG
TCAGAATGTTCTGCGGGACC
CCGAGTTCACTTGACGAGGC
ATGCACGTCAACACCAATGC
ATGCTCAGGGCAGACTTGAC
AACCTGGAGTTTGTGCCAGGG TGAACTTCACCTTCCCTCCAAC
TTT
CA
TAGGCCTCAGCGAGGAGAGT TCCCTTGTCACTTGGGCTCC
TGGCCTACCATCCGTTCCTA
GGACATCCACTGTTCCCCAG
CAGCCTCTTACGCCTGTTAC
CCAGGAGTTGTTCACCATGTTG
CTTACGGCGTTCGTCTCCAA
GACACCTCCGTCAGTCGC
CGCCGCTCCAGTTCATAG
GGTGGAGCTGGAGAAGACAGA
CTCAGTCCCCCGGAACAAC
CACGTACCTCCCAGCTCAAG
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are indicated in Table 8. A positive control for phosphorylated Akt (Cell Signaling
Technology, Danvers, MA; catalog number 9273S, lot number 20) was diluted 1:2. The
anti-rabbit and anti-mouse secondary antibodies included in the Wes Detection Module
kit (ProteinSimple, San Jose, CA) were used. All data were analyzed with the Compass
Software associated with the Wes instrument (ProteinSimple, San Jose, CA). Data were
exported to Prism for further analysis, as described below.

hWnt5a Treatment of CPCs
Neonatal CPCs were grown until approximately 85% confluent and treated with
100ng/mL recombinant human/mouse Wnt5a (R&D Systems, Minneapolis, MN) in CPC
growth media for 1 hour, a concentration and duration that were previously shown to
induce protein kinase C activity (Koyanagi, et al, 2009). Cells were then washed with
PBS and placed in TRIzol® reagent or formed into protein lysates, as described by
Abrahamsen, et al. (2013). RT-PCR and western blotting were performed, as described
above.

Statistical Analysis
The Shapiro-Wilk test for normality was used to test the normality of data
distribution. Student’s t-test was used to compare the mean of all normally distributed
data. Non-normally distributed data were compared using a Wilcoxon matched-pairs
signed rank text. For protein expression analysis, either Student’s t-test or Mann-Whitney
U test was used to compare the mean of normally or non-normally distributed data,
respectively. All data are reported as the mean ± the standard error of the mean. Prism 7
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version 7.02 (GraphPad, La Jolla, CA) was used for all statistical analyses. P values <
0.05 were assumed to indicate statistical significance.

Results
Flight aboard the ISS Activates PKCα in Neonatal CPCs
Observations under both simulated microgravity (SMG) and after culture aboard
the International Space Station (ISS) prompted us to determine whether calcium handling
and signaling were altered by spaceflight. We evaluated the expression of genes involved
in regulating intracellular calcium levels and subsequent signaling events in neonatal
CPCs after flight aboard the ISS and observed significantly elevated levels of RYR2
(5.265 ± 1.508-fold change, P<0.05, n=3), CACNA1S (8.059 ± 1.771-fold change,
P<0.05, n=3), and CAMK2A (5.979 ± 1.289-fold change, P<0.05, n=3) (Figure 19A).
Changes in calcium handling at 12 days suggested an ultimate induction of calcium
signaling at 30 days, which was supported by significantly elevated levels of PLCG1
(6.041 ± 0.527-fold change, P<0.01, n=3), PRKCA (4.482 ± 0.617-fold change, P<0.01,
n=3), and CAMK2A (3.982 ± 0.540-fold change, P<0.01, n=3) transcripts (Figure 19B).
Moreover, we assessed a significant increase in phosphorylated protein kinase C alpha, a
calcium-dependent protein kinase C (P-PKCα: 1.448 ± 0.065-fold change, P<0.01; PPKCα/PKCα: 1.298 ± 0.058-fold change, P<0.05; P-PKCα/GAPDH: 1.466 ± 0.088-fold
change, P<0.05; n=3–4) after 30 days of ISS culture (Figure 20A-B). Such ISS-mediated
changes to calcium signaling may have a direct impact on cardiogenesis, as shown in the
schematic in Figure 20C.
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Table 8. Antibodies used for western blot experiments of ISS-cultured and hWnt5a-treated neonatal CPCs
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Antibody

Manufacturer

Sample Used

Species

Clone

0.4 mg/mL
0.04 mg/mL
0.4 mg/mL
0.04 mg/mL
0.4 mg/mL

Antibody
Dilution
1:50
1:50
1:10
1:25
1:10

GAPDH
AKT (pan)
Phospho-AKT (Ser473)
p44/42 MAPK (Erk1/2)
Phopsho-p44/42 MAPK
(Erk1/2) (Th202/Ty204)
PKCα
Phospho-PKCα/β II
(Thr638/641)

Cell Signaling
Cell Signaling
Cell Signaling
Cell Signaling
Cell Signaling
Cell Signaling
Cell Signaling

Catalog No. Lot No.

Mouse
Rabbit
Rabbit
Rabbit
Rabbit

D4C6R
C67E7
D9E
137F5
D13.14.4E

97166T
4691S
4060S
4695S
4370S

3
17
23
14
12

0.04 mg/mL
0.04 mg/mL

1:25
1:10

Rabbit
Rabbit

Polyclonal
Polyclonal

2056T
9375T

4
4
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Figure 19. Spaceflight activates protein kinase C alpha in neonatal CPCs after 12 days
After 12 days aboard the ISS, neonatal CPCs were fixed and induction of genes involved
in calcium handling was measured via RT-PCR (A). Calcium handling alterations at 12
days led to the induction of genes involved in calcium signaling at 30 days (B). n=3 per
group for RT-PCR; *p<0.05, **p<0.01, ***p<0.001. Fold changes are shown as the mean
± S.E.M.
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Figure 20. Spaceflight activates protein kinase C alpha in neonatal CPCs after 30 days
After 30 days aboard the ISS, protein lysates were made from pooled neonatal clones.
Phosphorylated PKCαβ, PKCα, and GAPDH protein levels were determined in technical
replicates (A-B). ISS-culture mediates changes to calcium signaling that impact
cardiogenesis (C) n=3 measurements of four pooled neonatal clones for protein analysis;
*p<0.05, **p<0.01, ***p<0.001. Fold changes are shown as the mean ± S.E.M.
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Flight aboard the ISS Activates Akt in Neonatal CPCs
These findings of increased expression of calcium-related signaling prompted us
to assess the role of calcium-sensitive pathways that are pertinent to stem cell physiology
(i.e., ERK and Akt). We assessed the expression of Akt-related signaling genes in
neonatal CPCs after 12 and 30 days of flight aboard the ISS. At 12 days, we observed
significantly elevated levels of PIK3CA (2.216 ± 0.343-fold change, P<0.01, n=9), cMYC
(4.811 ± 1.341-fold change, P<0.05, n=9) and NFκB1 (2.704 ± 0.528-fold change,
P<0.05, n=9). At 30 days, we observed significantly elevated levels of PIK3CA (7.764 ±
0.472-fold change, P<0.001, n=3), CCNDI (3.257 ± 0.195-fold change, P<0.01, n=3),
cMYC (3.297 ± 0.309-fold change, P<0.01, n=9), JUN (4.997 ± 0.213-fold change,
P<0.001, n=3), NFκB1 (5.935 ± 0.830-fold change, P<0.01, n=3), and RELA (2.799 ±
0.291-fold change, P<0.01, n=3) (Figure 21). Protein expression analysis revealed an
induction of phosphorylated Akt following spaceflight when normalized to GAPDH or
analyzed as total substrate (P-AKT: 1.573 ± 0.152-fold change, P<0.05; P-AKT/GAPDH:
1.812 ± 0.176-fold change, P<0.05; n=3) after 30 days of ISS culture (Figure 22A-B).
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Figure 21. Spaceflight activates Akt signaling in neonatal CPCs
After 12 and 30 days aboard the ISS, neonatal CPCs were fixed and gene expression along
the Akt pathway was measured via RT-PCR. n=3–9 per group for RT-PCR; *p<0.05,
**p<0.01, ***p<0.001. Fold changes are shown as the mean ± S.E.M.
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Figure 22. Spaceflight activates Akt signaling in neonatal CPCs
After 30 days aboard the ISS, neonatal CPCs were fixed and protein lysates were made
from pooled neonatal clones. Then, phosphorylated Akt, Akt, and GAPDH protein levels
were determined in technical replicates (A) and quantified (B). n=3–9 per group for RTPCR and n=3 measurements of four pooled neonatal clones for protein analysis; *p<0.05,
**p<0.01, ***p<0.001. Fold changes are shown as the mean ± S.E.M.
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ERK/MAPK is Not Activated in Neonatal CPCs by Spaceflight
This change in Akt activity prompted us to investigate whether ERK/MAPK
signaling was altered by spaceflight. We evaluated the expression of ERK/MAPK-related
signaling genes in neonatal CPCs after 12 and 30 days of flight aboard the ISS (Figure
23-24). At 12 days, we observed significantly reduced levels of DUSP3 (0.280 ± 0.126fold change, P<0.01, n=3), which encodes a phosphatase involved in the deactivation of
ERK/MAPK signaling. Interestingly, the targets of ERK/MAPK signaling were also
elevated: GRB2 (11.660 ± 2.709-fold change, P<0.05, n=3) and RAF1 (5.230 ± 0.762fold change, P<0.01, n=3) (Figure 23A-B). However, at 30 days, the induction of genes
along this signaling pathway was muted. Moreover, we observed no increase in
phosphorylated ERK after 30 days of ISS culture (Figure 24A-B).
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Figure 23. Spaceflight does not activate Erk signaling in neonatal CPCs
After 12 and 30 days aboard the ISS, neonatal CPCs were fixed and gene expression along
the ERK/MAPK pathway was measured via RT-PCR. At 12 days, ERK/MAPK pathway
(A) and target (B) gene expression was generally elevated; however, at 30 days, such
pathway gene expression was largely muted (A). n=3 per group for RT-PCR; *p<0.05,
**p<0.01. Fold changes are shown as the mean ± S.E.M.
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Figure 24. Spaceflight does not activate Erk signaling in neonatal CPCs
Protein lysates were generated from pooled neonatal clones after 30 days aboard the ISS
and phosphorylated ERK1/2, ERK1/2, and GAPDH protein levels were determined in
technical replicates (C-D). n=3 per group for RT-PCR and n=3–4 measurements of four
pooled neonatal clones for protein analysis; *p<0.05, **p<0.01. Fold changes are shown
as the mean ± S.E.M.
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Ca2+ Signaling Contributes to Induction of Genes Involved in Early Cardiogenesis
Given the role of calcium signaling in mediating the effects of spaceflight in
neonatal CPCs, we sought to assess the effects of such signaling on the ground. Neonatal
CPCs were treated with recombinant hWnt5a (100ng/mL) for 1 hour, which is a
concentration and duration that were previously shown to induce PKC activity
(Koyanagi, et al, 2009). We then investigated the induction of canonical and noncanonical Wnt ligands (Figure 25A) and calcium signaling genes (Figure 25B): WNT5A
(3.027 ± 0.087-fold change, P<0.01, n=3), WNT9A (4.587 ± 0.485-fold change, P<0.05,
n=3), WNT11 (3.713 ± 0.297-fold change, P<0.05, n=3), PLCG1 (4.609 ± 0.544-fold
change, P<0.05, n=3), PRKCA (28.190 ± 2.658-fold change, P<0.01, n=3), and CAMK2A
(342.700 ± 37.760-fold change, P<0.05, n=3). The induction of PKCα phosphorylation
indicated the presence of calcium activity (P-PKC/PKC: 1.635 ± 0.072-fold change,
P<0.05, n=3; (Figure 25C-D). This occurred concomitantly with the induction of early
developmental genes (Figure 25E), including the pluripotency marker POU5F1 (3.453 ±
0.194-fold change, P<0.05, n=3) and the mesodermal marker MESP1 (23.760 ± 1.230fold change, P<0.01, n=3).
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Figure 25. Non-canonical Wnt/Ca2+ signaling impacts the developmental phenotype of neonatal CPCs
Wnt5a treatment of neonatal CPCs for 1 hour induces expression of non-canonical Wnt ligands (A), genes involved in
the non-canonical Wnt/Ca2+ pathway (B), and calcium-dependent PKCα activation (C-D). Induction of genes along this
pathway occurred concomitantly with modifications in expression of markers of early cardiogenesis (E). n=3; *p<0.05,
**p<0.01, ***p<0.001. Changes in gene expression are shown as the mean ± S.E.M.

Sinoatrial Nodal Genes Are Induced by Calcium Pathway Activity
Increasing evidence indicates that sinoatrial nodal cells represent a population of
embryonic myocardium that retains its primitive phenotype (Bakker, 2010). For this
reason, we assessed the relationship between primordial cardiogenesis gene induction and
that of the sinoatrial nodal gene program in Wnt5-treated CPCs (Figure 26). We observed
significant increases in the expression of TBX3 (5.212 ± 0.917-fold change, P<0.05, n=3),
TBX5 (7.678 ± 0.178-fold change, P<0.01, n=3), SHOX2 (6.318 ± 0.813-fold change,
P<0.05, n=3), and HCN4 (9.489 ± 1.191-fold change, P<0.05, n=3) along with decreased
expression of NKX2-5 (0.237 ± 0.044-fold change, P<0.05, n=3).
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Figure 26. SAN gene induction via calcium signaling activation
Wnt5a treatment of neonatal CPCs induces sinoatrial nodal gene and protein expression.
The primordial phenotype of Wnt5a-treated CPCs included the induction of sinoatrial
nodal genes. n=3; *p<0.05, **p<0.01, ***p<0.001. Changes in gene expression are shown
as the mean ± S.E.M.
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Discussion
Culture aboard the ISS resulted in the activation of calcium-dependent protein
kinase C (PKCα) and Akt in neonatal CPCs. This increase in calcium signaling was
modeled in vitro on Earth using hWnt5a, a non-canonical ligand that promotes protein
kinase c activation. We observed an important role in calcium signaling in accounting for
the effects, at least in part, of spaceflight within neonatal CPCs.
Among the changes experienced by CPCs during spaceflight, we found that
calcium pathway genes and those related to calcium handling were expressed at higher
levels following culture aboard the ISS as well as under SMG, though to a more modest
extent. These changes in calcium extend beyond human CPCs. During spaceflight,
calcium loss is widely observed in astronauts and is usually linked to changes in bone
metabolism (Smith, 2012). Yet, in one animal model of SMG, mice were observed to
exhibit an increased incidence of arrhythmias along with alterations in intracellular
calcium handling, including ryanodine receptor (RyR2) phosphorylation (Respress,
2014). Moreover, short-duration atrial fibrillation, premature ventricular contractions, and
ventricular tachycardia have all been reported in astronauts during spaceflight (Anzi,
2014). Importantly, while the etiology of such cardiac events during spaceflight remains
unknown, disturbances in calcium handling may be an important contribution to cardiac
abnormalities in space.
Meanwhile, the modification of signaling pathways related to calcium, either as
an important secondary or mediating molecule, directly impacts the ability of CPCs to
differentiate or maintain pluripotency (Tonelli, 2012; Apati, 2016). The effect of calcium
signaling is dependent both on the pathway in which it is involved as well as the species
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under study, with mouse ESCs exhibiting far different responses to calcium-mediated
activity compared to human ESCs. For example, calcium signaling promotes
pluripotency in hESCs, while being affiliated with differentiation in mESCs (Tonelli,
2012). In the context of cardiogenesis, studies performed in both embryos and ESCderived cardiomyocytes have shown a critical role of Ca2+ in regulating multiple steps of
heart formation (Pucéat, 2005). For example, induction of Ca2+ oscillation promotes
proliferation and, upon transplantation, enhances engraftment and expansion (FerreiraMartins, 2009). In this way, our observed shift in expression of markers of early cardiac
development is likely the result, at least in part, of modified calcium signaling activity
within neonatal CPCs. Furthermore, research into Mesp1-expressing pre-cardiac
mesoderm derived from human ESCs exhibited enriched activity along the calcium,
extracellular matrix-receptor, and Wnt signaling pathways at day 5 of development (den
Hartogh, 2016), which is supported by our observed increase in markers of such a state of
development after culture aboard the ISS. Meanwhile, Akt signaling via calcium
activation has been well documented to promote the maintenance of pluripotency in
hESCs (Tonelli, 2012). Additionally, Akt signaling exerts a critical role in several cell
functions that are relevant to stem cell transplantation, migration, and cytokine
expression (Manning, 2007). Therefore, manipulating calcium signaling on Earth and
promoting Akt activation presents a novel therapeutic opportunity for cell-based cardiac
repair.
In addition to modifying intracellular calcium signaling, the expression of noncanonical Wnt ligands has been observed in association with the cryoinjury response of
the neonatal rodent heart (Mizutani, 2016). Since WNT5A and PRKCA gene expression
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induction is involved in the response of neonatal CPCs to SMG, we sought to assess the
potential role of Wnt5a in promoting enhanced stemness in CPCs. While preliminary,
these early results indicate a relationship between enhanced intracellular calcium
signaling as well as increased expression of markers of early cardiogenesis in neonatal
CPCs. The expression of early cardiogenic mesoderm markers indicates a potentially
earlier developmental state. In addition to being linked to enhanced therapeutic potential
following transplantation (Menasché, 2015; Behfar, 2010; Bartunek, 2013; Blin, 2010),
such an early developmental state may also provide the appropriate cell source for
biological pacemaker development. In an avian model, Bressan et al. used fate mapping
to determine that sinoatrial nodal cells were observed to already be specified shortly after
gastrulation prior to the onset of cardiogenesis within a region that was observed to be
Nkx2-5- and Isl1-negative (Bressan, 2013). Meanwhile, the Keller group recently
reported a method of generating sinoatrial nodal-like pacemaker cells in Nkx2-5-negative
cardiomyocytes (Protze, 2017). Similarly, we observed decreased NKX2-5 and ISL1
expression under both SMG and MG. When considered together, our findings using
simulated and real MG support the emerging hypothesis that sinoatrial nodal cells
represent a de-/un-differentiated state of cardiac development (Bakker, 2010). Moreover,
our observation that calcium signaling has an integral role in this process is mirrored by
observations that Wnt7a, which mobilizes intracellular calcium (Thrasivoulou, 2013), has
been observed in the developing cardiac conduction system (Gessert, 2010). Given the
observed changes to the expression of calcium handling genes and proteins, future studies
should assess the effect of SMG and ISS-culture on intracellular Ca2+ transients and the
electrophysiological properties of CPCs.
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Notably, the increased expression of sinoatrial nodal markers may reflect the
emerging hypothesis that this unique functional cell type develops from myocardium that
retains its primitive phenotype (Bakker, 2010). Accordingly, the concomitant increased
expression of sinoatrial nodal genes and decreased expression of other mesodermal
derivatives indicates that the reduced gravity conditions of spaceflight promote the
modest de-differentiation of neonatal CPCs. In our previous chapter, we documented an
significant decrease in the expression of microRNA-106b, which otherwise would repress
the induction of the sinoatrial nodal gene program. Additionally, the elevated expression
of Tbx proteins, particularly, Tbx3, overlaps with previous reports in the regulation of
pre-mesoderm (i.e., mesendoderm) gene expression (Weidgang, 2013). As described in
Baio et al. (2018), a similar induction of the sinoatrial nodal gene program was observed
in SMG-treated CPCs: TBX3 (141.600 ± 54.550-fold change, P<0.05, n=3), TBX5
(35.620 ± 4.667-fold change, P<0.05, n=3), HCN4 (48.510 ± 18.710-fold change,
P<0.05, n=3), and NKX2-5 (0.146 ± 0.042-fold change, P<0.001, n=3).
Importantly, many of these processes observed reduced gravity conditions are
dependent upon the developmental status of the cell. Indeed, later stages of cardiogenesis
and the incipient developmental cues of embryonic stem cells all respond differently to
calcium and Wnt signaling (Ueno, 2007; Cohen, 2008; Ozhan, 2015). Therefore,
understanding the effects of mechanical transduction and altered intracellular calcium
signaling within the myriad cell types that constitute the human body will help inform
medical interventions that will be necessary to sustain deep space missions. Meanwhile,
the molecular events that constitute microgravity sensing can be manipulated on Earth to
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facilitate regeneration. In doing so, microgravity-inspired, cell-based therapies can be
developed.
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CHAPTER FOUR
ANGIOTENSIN II TREAMENT OF NEONATAL
CARDIOVACULAR PROGENITOR CELLS INDUCES THE
DEVELOPMENT OF SINOATRIAL NODAL-LIKE CELLS

Abstract
The cardiac pacemaker has been used to treat arrhythmias that arise from
dysfunction of the sinoatrial node (SAN), which generates the pacing activity of the
heart. Though these pacemakers are limited in responsiveness to autonomic regulation
and require routine maintenance, no alternative therapies exist. Primordial Islet-1+
cardiovascular progenitor cells (CPCs) differentiate into functional pacemaker cells
during development. Transcription factors from the T-box family, including Tbx3, Tbx5,
and Tbx18, are implicated in this process. We have previously shown that simulated
microgravity, International Space Station culture, and hWnt5a treatment induced activity
along the phospholipase C (PLC)/protein kinase C alpha (PKCα)/calcium signaling axis
and that these conditions correlated with the induction of sinoatrial nodal-related gene
expression. Therefore, we induced PLC/PKCα/Ca2+ signaling via angiotensin II receptor
type I activation to differentiate Islet-1+ human neonatal-derived CPCs into functional
SAN cells that express the characteristic funny (i.e., pacemaker) current-carrying
hyperpolarization-activated cyclic nucleotide gated (Hcn4) channel. Following treatment
with angiotensin II for 72 hours, RT-PCR was used to assess expression of genes of the
SAN gene program, which was found to be induced. This resulted in a 7.75-fold increase
in Hcn4 protein induction, as indicated by western blotting. Furthermore, cardiomyocyte
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markers, including transcripts of TropT and Cxn43, were all significantly decreased in
expression. Treated CPCs were then stained with fluo4-AM, an intracellular calcium dye,
imaged using confocal microscopy, and observed for the presence of an auto-rhythmic
calcium flux. Electrophysiology recordings of treated cells in the whole cell, perforated
patch configuration revealed an action potential of -40 ± 1 mV, a slow maximum
upstroke velocity of dV/dtmax < 10 V/s, and an epinephrine sensitivity that accelerated the
number of action potentials from 1.05 ± 0.05 to 1.41 ± 0.05 per second.
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Introduction
Atrial arrhythmias represent a group of common medical conditions that annually
affect more than three million individuals in the United States (NHLBI, 2014). While
many of these patients can address these fibrillations through changes in lifestyle,
expanded access to resources related to health improvement, or with medication, over
180,000 annual patients still require an exogenous pacemaker (Greenspon, 2012). Many
complications can result from both implanting and using a pacemaker, including
infections during implantation, parenchyma erosion, hemo- and pneumothorax,
pacemaker migration or dislodgement, and venous thrombosis (Gul, 2011). Lead
displacement occurs in 5–10% of pacemaker recipients (National Pacemaker and ICD
database, 2001), while pacemaker syndrome (i.e., atrioventricular asynchrony) and other
long term complications of pacemakers are estimated to occur in approximately 2.7% of
patients (Trohman, 2004). For children who are born with a congenital arrhythmia,
pacemaker implantation must be performed regularly to keep pace with the developing
size of the child (Cho, 2015). Among all patients, magnetic interference, such as from
portable headphones (Lee, 2009) and magnetic resonance imaging scanners (Kalin,
2005), are clinical concerns due to their ability to induce asynchronous pacing. For this
reason, a biological pacemaker, such as a CPC-derived sinoatrial node, has been the
subject of recent research efforts.

Application of Reduced Gravity Conditions on Earth
Lessons for sinoatrial nodal development may be informed by studies of
cardiovascular precursors under conditions of microgravity. Simulated microgravity has
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been shown in our lab and elsewhere to result in the expansion of pacemaker cells or of
markers of the sinoatrial nodal gene program (Hatzistergos et al., 2018; Baio, 2018). We
also demonstrated in Baio et al. (2018) that TGFB1 expression was induced under these
conditions, which supports recent work by the laboratory of Ann C. Foley, who
demonstrated that MAP3K7, or TGFß-activated kinase 1, overexpression in mouse
embryonic stem cells faithfully induced sinoatrial node development (Brown, 2017).
Indirectly, the reduction in NKX2-5 expression in cardiovascular progenitors
during spaceflight indicates that reduced gravity conditions may prime the cell population
under study to assume a sinoatrial nodal gene expression profile. As shown in Bressan et
al. (2013) and Protze et al. (2017), pacemaker cells are specified shortly after gastrulation
and prior to the onset of cardiogenesis in a population of Nkx2-5-negative cells. This is
mirrored by a similar reduction in Nkx2.5 expression in SMG-treated CPCs, whose
sensitivity to gravity is modulated, at least in part, by calcium signaling (Baio, 2018).
Interestingly, calcium signaling has been shown to be activated in the developing cardiac
conduction system via Wnt7a induction (Gessert, 2010), which mobilizes intracellular
calcium (Thrasivoulou, 2013).
In particular, the association between sinoatrial nodal gene program induction and
calcium signaling under simulated microgravity (Baio, 2018), during culture aboard the
International Space Station, and following treatment with hWnt5a, indicates that calcium
potentiation may be one method of creating an enriched sinoatrial nodal cell population
on Earth. Various pathways can achieve this end, including non-canonical Wnt signaling
(e.g., Wnt5a) and angiotensin II receptor type I activation (Figure 27). While both
processes may be applied, the latter has been carefully studied in the cardiac context. In
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rodent models, angiotensin II receptor activation increases ERK phosphorylation, nuclear
[Ca++] levels, and proliferation (Tadevosyan, 2012). Moreover, angiotensin II receptor
type I activation and antagonism has been shown to modulate hyperpolarization
activated, cyclic-nucleotide gated potassium/sodium channel 4 (Hcn4) and the sinoatrial
nodal-characteristic funny current (Xu, 2009). Finally, pacemaker-like cells have been
shown to directly be induced from mouse cardiac progenitor cells via angiotensin II
treatment (Xue, 2015). Thus, we sought to test whether the sinoatrial nodal-like
phenotype that emerges following exposure of progenitor cells under reduced gravity
conditions is mediated, at least in part, by calcium signaling. The molecular biology of
sinoatrial nodal development has been discussed earlier (chapter one), while the
functional properties governing sinoatrial nodal cell function are described below.
Knowledge of these properties is foundational to verifying the authenticity of sinoatrial
nodal cell induction.

Functional Properties of the Sinoatrial Node
Beginning in the 1800s, the individual efforts of Jan E Purkinje, Wilhelm His, and Sunao
Tawara collectively initiated the elucidation of the conduction system of the heart
(Silverman, 2007). Then, in 1906, Martin Flack and Arthur Keith identified a structure
that was located at the junction of the superior vena cava and the right atrium of the heart
(Keith, 1907). Given its resemblance to the then-recently identified atrioventricular node
(Tawara, 1906), Flack and Keith identified this as the sino-auricular node (Silverman,
2007). Subsequent electrophysiology studies confirmed the postulated function of this
node as well as resulted in the use of its present name, the sinoatrial node (Lewis).
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Figure 27. Angiotensin II receptor type I activation
induces calcium signaling (Baio, 2018)
As in simulated microgravity, angiotensin II receptor type
I activation activates phospholipase C (PLCG1),
potentiates calcium, and activates protein kinase C alpha
(PRKC). Ultimately, broad cellular activities are modified,
including migration, proliferation, and development.
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The sinoatrial node initiates the cardiac conduction system in an automated
fashion. While other nodes, such as the atrioventricular node, have their own pacing
potential, they are suppressed by the higher frequency (60–100 bpm) of the sinoatrial
node. The higher frequency of sinoatrial node firing prevents downstream nodes from
reaching their pacing potential threshold (Vassalle, 1977). For this reason, the sinoatrial
node is often considered the pacemaker of the heart.
This automaticity is derived from a series of inward- and outward-directed ion
channels (Verkerk, 2007). As shown in Figure 28, following the conclusion of an action
potential, there is a slow, positive increase in voltage across the sinoatrial nodal cell
membrane (i.e., the pacing potential). When the pacing potential reaches the action
potential threshold, a new action potential is fired (Berne, 2004). This slow, positive
increase is an important feature of the sinoatrial node. Unlike the resting membrane
potential of cardiomyocytes, which is generally stable, the sinoatrial node’s resting
membrane potential is constantly and slowly increasing from an average potential of 70mV to the average threshold of -40mV (Sherwood, 2012). It is also here where the
autonomic nervous system can modulate the rhythm of the heart by accelerating
(sympathetic) or decelerating (parasympathetic) the increase in the resting membrane
potential (Brown, 1979; Bucchi, 2007; Di Francesco, 1991, 2010).
A variety of ion channels produce the electrical conduction activity of the sinoatrial node
(Cho, 2015; Verkerk, 2007), while the regulation of these ion channels, such as by
secondary signaling molecules, modulates its automaticity (Sah, 2014; Bucci, 2007).
During the slow pacing phase of the heart cycle, or diastolic depolarization in which
blood is filling the chambers prior to sinoatrial node action potential firing and signal
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propagation, inward ion currents are activated while outward ion currents are deactivated
(Verkerk, 2007). Among the currents that are produced by the activated channels of
diastolic depolarization, the hyperpolarization-activated pacemaker current, or the funny
current (If), is considered to be the principal component of the pacemaker and accounts
for the autonomic sensitivity of the sinoatrial node and is often implicated in age-related
heart conditions (Di Francesco, 1993, 2007; van Ginneken, 1991; Accili, 1997, Verkerk,
2003; Zicha, 2005). The hyperpolarization activated cyclic nucleotide gated potassium
channel 4 (Hcn4) is a molecular constituent of the pacemaker current-carrying channel
(Stieber, 2004), thereby contributing to its mixed potassium and sodium constitution. In
response to hyperpolarization (between -70 mV to -40 mV), the pacemaker current is
activated. Furthermore, the secondary messenger, cyclic adenosine monophosphate
(cAMP), regulates diastolic depolarization. In response to sympathetic activation, cAMP
levels increase, thereby increasing the rate of pacemaker current activation and
accelerating the pace of action potential firing in the sinoatrial node (Di Francesco, 1991,
2007). Additional currents that are produced by channel activation during diastolic
depolarization include the calcium-release activated sodium-calcium exchange current
(INCX), the sustained inward current (Ist), the sodium current (INa), and the T- and L-type
calcium currents (ICa,T and Ica,L) (Verkerk, 2007). Despite the work of Di Francesco and
his colleagues in characterizing the role of the pacemaker (i.e., funny) current in pacing,
there is controversy over the significance of this current. Other investigators have argued
that INa and Ica,L are the principle currents of the sinoatrial node (Boyett, 2000). Both
arguments are supported by substantial evidence, suggesting that these currents behave
synergistically, and perhaps in a location-specific manner, to contribute to the slight
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Figure 28. SAN pacing currents (Klabunde, 2011)
Ionic currents drive the gradual depolarization that is
characteristic of the SAN. If: funny current; iCa(T): T-type
calcium current; iCa(L): L-type calcium current; iK:
potassium current.
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increase in resting membrane potential that accounts for the automaticity of the sinoatrial
node.
Interestingly, it has been reported that a radial distribution of cell morphologies
exist in the sinoatrial node (Boyett, 2007). The most archetypal pacemaker cells exist in
the center, or leading pacemaking site, of the SAN. These cells are smaller, poorly
organized, and without many mitochondria. More peripherally, there are atrial-like cells
that are still involved in automated electrical conduction but interdigitate and function
synergistically with the surrounding atrial tissue. These peripheral cells are observed to
be larger and express connexin channel 40 (Cx40) as well as the sodium transporter,
NaV1.5. This radially organized and heterogeneous fine architecture of the SAN
facilitates its function as peripheral channels may be more resilient to hyperpolarization
currents that are derived from atrial tissue, thereby guaranteeing the unidirectional
propagation of the pacing potential. Histologically, an abundance of collagen and
fibroblasts and an underlying layer of atrial muscle have been observed, perhaps
conferring protection to the SAN against atrial wall stress (Boyett, 2000; Dhein, 2009).
Upon reaching the threshold potential for action potential initiation, the sinoatrial
node propagates the signal through connexin channel 45 (Cx45; Lo, 2000; Dhein, 2010)
into the adjacent atrial cells, thereby inducing atrial contraction and moving blood from
the atrium into the ventricles. The gradual intercellular coupling that is afforded by the
above-described spatial distribution allows the propagation of the action potential into the
atria (Boyett, 2000). This signal eventually arrives at the atrioventricular node, which
then descends, following a brief delay that allows the ventricles to fill with blood, down
the ventricles through the bundle of His to be terminally distributed through the Purkinje
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fibers as well as through the right and left bundle fibers. This final distribution of
electrical activity results in ventricular contraction by cardiomyocyte activity, which
moves blood from the heart to either the pulmonic or systemic circulation. These
cardiomyocytes rapidly depolarize following a rapid influx of sodium ions that is occurs
after rapid sodium channels open under the influence electrical activity that is transported
from neighboring cells through connexins. These sodium channels are then inactivated
while potassium and chlorine channels transiently open, allowing for a small decrease in
membrane potential that is characteristic of cardiomyocytes. The membrane potential
then plateaus due to a balance between an inward calcium current and an outward
potassium current. (Sherwood, 2012). Finally, cardiomyocytes experience a rapid
repolarization following the closure of the calcium current producing channels. While
cardiomyocytes are generally under the influence of the sinoatrial node, cardiomyocytes
can independently contract (Satin, 2004). Indeed, embryonic stem cell-derived
cardiomyocytes have already been shown to be able to develop self-generating rhythms
of contraction (Kehat, 2004).
The heart is susceptible to atypical pacing following exposure to adverse
conditions. For example, following hypoxia, persistent sodium current is observed to
increase after cardiomyocyte depolarization (Ju, 1996). Additionally, Weisfeldt et al.
(1974) demonstrated the loss of a healthy cardiac conduction cycle that was characterized
by a loss of complete relaxation following an action potential. Meanwhile, under
conditions of microgravity, such as during spaceflight, heart rate appears to be altered or
become variable, possibly due to changes in susceptibility to autonomic influence
(Migeotte, 2003; Xiao, 2004). Therefore, studies of pacing in CPC-derived sinoatrial
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nodal cells can intuitively be extended to include studies of automaticity in
cardiomyocytes following adverse conditions.
Therefore, we sought to develop cells that could ultimately form the basis for
biological pacemaker development in vitro. To achieve this end, we applied the
mechanisms observed in CPCs during spaceflight on Earth. We then screened the
induction of the sinoatrial nodal gene program and of Hcn4 protein. We concluded our
experiments with an assessment of sinoatrial nodal physiology using confocal
microscopy imaging of calcium flux and electrophysiology studies.

Materials and Methods
Ethics Statement/Cell Isolation and Expansion
CPCs were isolated from cardiac tissue of neonates (1 day – 1 month), as
previously described (Fuentes, 2013). The Institutional Review Board of Loma Linda
University approved the protocol for use of tissue that was discarded during
cardiovascular surgery, without identifiable private information, for this study with a
waiver of informed consent. Briefly, atrial tissue was cut into small clumps
(approximately 1.0 mm3) then enzymatically digested using collagenase (Roche,
Indianapolis, IN) at a working concentration of 1.0 mg/mL. The resulting solution was
then passed through a 40-µm cell strainer. Cells were cloned in a 96-well plate by
limiting dilution to a final concentration of 0.8 cells per well to create populations for
expansion. Cells were then screened for the co-expression of Isl1 and c-Kit. Clonal CPC
cultures were selected for other markers of early cardiac development (KDR and
PDGFRA) and then supplemented with growth media comprised of 10% fetal bovine
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serum (Thermo Scientific, Waltham, MA), 100 µg/mL penicillin-streptomycin (Life
Technologies, Carlsbad, CA), 1.0% minimum essential medium non-essential amino
acids solution (Life Technologies, Carlsbad, CA), and 22% endothelial cell growth media
(Lonza, Basel, Switzerland) in Medium 199 (Life Technologies, Carlsbad, CA).
Mycoplasma contamination was tested using the MycoAlert Mycoplasma Detection Kit
(Lonza, Basel, Switzerland) following the manufacturer’s protocol.

Angiotensin II Dilution and Dosage Titration
Angiotensin II (Sigma Aldrich, St. Louis, MO) was dissolved in cell culture grade
water and added to CPC growth media at concentrations of 1, 5, and 10 µM for 48, 72,
and 168 hours. The induction of TBX3 and HCN4 expression was measured via RT-PCR
and flow cytometry at all concentrations to determine that 10 µM of angiotensin II for 72
hours was the optimal treatment condition.

RNA Purification and cDNA Synthesis
Neonatal CPCs that were treated with angiotensin II were fixed in RNA Protect
(Qiagen, Valencia, CA). RNA was purified from the RNA Protect samples using the
RNeasy Mini Kit (Qiagen, Valencia, CA), per the manufacturer’s instructions. cDNA
was prepared using 2 µg of RNA with Superscript III (Life Technologies, Carlsbad, CA)
and used for gene expression analysis in quantitative RT-PCR experiments, as described
below.
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Quantitative RT-PCR
Quantitative real-time polymerase chain reaction was performed using Go-Taq®
qPCR Mastermix (Promega, Madison, WI) and the iCycler iQ™5 PCR Thermal Cycler
(Bio-Rad, Hercules, CA) following a protocol of 94°C for 10 minutes followed by 45
cycles of 94°C for 15 seconds, 52–68°C (depending on the primer) for 60 seconds, and
72°C for 30 seconds. RT-PCR products were visualized using 1–2% agarose gel
electrophoresis and low mass DNA ladder (Invitrogen, Carlsbad, CA). Threshold cycle
values were then analyzed for each individual clone using the comparative CT method
(Schmittgen, 2008).
Primers were designed using the National Center for Biotechnology Information
Primer-BLAST program and obtained from Integrated DNA Technologies (Coralville,
IA). Primers used in experiments are listed in Table 9.

Flow Cytometry
We used flow cytometry to measure the expression of Hcn4. Cells were labeled to
detect Hcn4 (ab85023; Abcam, Cambridge, MA; clone: S114-10). Isotype controls were
matched to the species, isotype, and conjugated fluorophore. Fluorescently labeled cells
were analyzed using MACSquant analyzer (Miltenyi Biotec, Auburn, CA) and FlowJo
software (FlowJo, Ashland, OR). Dead cells were gated out using forward-scatter and
side-scatter gating.
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Table 9. Primer pairs used in RT-PCR for SAN experiments (5’ to 3’)
Gene
Forward Sequence
Reverse Sequence
TTTGAATGATGAGCCTTCGTC GTCTCAAGTCAGTGTACAGGTA
ACTIN
CCC
AGC
AGTR1
TGCCTCCTCGCCAATGATTC
TGAAACTGACGCTGGCTGAA
GTGTTTAGGCACTAAGCAAG
GCTAGTAGTGGCAAGGGTGG
AGTR2
CTG
CAMK2A GTCCAGTTCCAGCGTTCAGTT GTGGGGATTCAGGATGGTGG
GJA1
CATTAGGGGGAAGGCGTGAG AGTCAGTCAAATCCCCCAACC
GJC1
GAGGTGGAGGAGAGGCGAG CCGAGCTGCCTTCTTGTCTG
HCN4
CAGCCTCTTACGCCTGTTAC
CCAGGAGTTGTTCACCATGTTG
NKX2-5
CGCCGCTCCAGTTCATAG
GGTGGAGCTGGAGAAGACAGA
PLCG1
GCCCGACATCTGCCAAAGAA AGTCCATTGTCCACCACAAACT
PRKCA
TTTTCCCGGGCAACGACTC
CGCACCCGGACAAGAAAAAG
SHOX2
CTTACGGCGTTCGTCTCCAA
GACACCTCCGTCAGTCGC
TBX18
GGTGGCAGGTAATGCTGACT ACTTGCATTGCCTTGCTTGG
TBX3
TGGCCTACCATCCGTTCCTA
GGACATCCACTGTTCCCCAG
TBX5
CTCAGTCCCCCGGAACAAC
CACGTACCTCCCAGCTCAAG
GTGGGAAGAGGCAGACTGA
TNNT2
G
ATAGATGCTCTGCCACAGC
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Protein Simple
Following treatment with angiotensin II and detachment, CPCs were
homogenized using RIPA buffer containing phosphatase inhibitor cocktail (Millipore,
Temecula, CA), followed by centrifugation at 14,000 g for 15 minutes at 4°C and
collection of the supernatant for analysis. Total protein concentrations were determined
using the Pierce Micro BCA Protein Assay Kit (Thermo Scientific, Rockford, IL). A
capillary-based western blotting system (ProteinSimple Wes, San Jose, CA) was used to
assess protein expression. All procedures were completed according to the
manufacturer’s instructions and default settings. Mouse, anti-Hcn4 antibody (1:10; cat
no. ab85023; Abcam, Cambridge, MA; clone: S114-10) and mouse IgG2b, anti-human βActin (1:50; cat no. 3700; Cell Signaling Technology, Danvers, MA; clone: 8H10D10)
were used with the anti-mouse detection module from ProteimSimple. All data were
analyzed with the Compass Software associated with the Wes instrument (ProteinSimple,
San Jose, CA). Data were exported to Prism for further analysis, as described below.

Calcium Handling Analysis
Fifty micrograms of Fluo4-AM dye (Life Technologies, Carlsbad, CA) was
dissolved in pluronic acid and 20% DMSO (Life Technologies) via sonication before
being resuspended in M199-supplemented growth media. Angiotensin II-treated CPCs
were then incubated with the dye for 1 hour and imaged using a LSM 710 NLO laserscanning, confocal microscope (Carl Zeiss Microscopy Gmblt, Jena, Germany) at a 20×
objective. All experiments were conducted at room temperature and in the absence of
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external electrical stimulation. Images were processed using ImageJ (v.1.49,
NIH, http://imagej.nih.gov/ij).

Electrophysiology
For electrophysiological characterization of sinoatrial nodal cells, angiotensin IItreated CPCs were seeded onto gelatin-coated coverslips and allowed to attach overnight
in CPC growth media. The action potentials of the sinoatrial nodal cells were then
measured in current-clamp mode at a 5 KHz sampling rate (Axopatch 1D, Molecular
Devices, San Jose, CA) and analyzed using AxoGraph. Borosilicate glass
microelectrodes were used with tip resistances of 5–8 MΩ when filled with pipette
solution. Spontaneous action potentials were recorded at 25°C using the perforated
patch method. Briefly, 10 µL of 50 mg/ 50 µL amphoteracin B (Sigma-Aldrich, St.
Louis, MO) in molecular biology grade DMSO (Corning, Corning, NY) was added to 1
mL of pipette solution, containing (mM): K-gluconate 130, Na-gluconate 10, NaCl 4,
HEPES 10, GTP-NaꞏH2O 0.3, and ATP-MgꞏH2O 4 (pH 7.4, adjusted with NaOH). The
bath solution contained (mM): NaCl 136, KCl, 5, MgCl2ꞏ6H2O 1, NaH2PO4ꞏ2H2O 0.3,
CaCl2ꞏ2H2O 1.8, D-glucose 10, HEPES 10 (pH 7.3, adjusted with NaOH).

Epinephrine Dilution
To test the responsiveness of CPC-differentiated sinoatrial nodal cells to
autonomic stimulation, bath solution was spiked to a working concentration of 5.5 µM
epinephrine (Lot: BCBK3982V; Sigma-Aldrich, St. Louis, MO), as described in
Taniguchi et al. (1981). Then, the membrane potential was recorded as described above.
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Statistical Analysis
The Shapiro-Wilk test for normality was used to test the normality of data
distribution. We then performed a two-tailed, paired t-test to compare the mean of all
normally distributed data. Non-normally distributed data were compared using a
Wilcoxon matched-pairs signed rank text. All data are reported as the mean ± the
standard error of the mean. Prism 7 version 7.02 (GraphPad, La Jolla, CA) was used for
all statistical analyses. P values < 0.05 were assumed to indicate statistical significance.

Results
Angiotensin II Receptor Type I Activation Induces
Calcium Signaling Gene Expression
To activate calcium signaling in neonatal CPCs using angiotensin II, we first
screened for the type 1 receptor, which functions via a G-protein coupled receptor to
activate protein kinase C activation and calcium potentiation (Venema, 1998). Since the
type 2 receptor is widely speculated to antagonize the type 1 receptor via
heterodimerazation (AbdAlla et al., 2001), we also screened CPCs to select neonatal
clones that primarily expressed the type 1 receptor (Figure 29A). Then, we treated cells
expressing this receptor with angiotensin II for 72 hours and measured the induction of
genes related to calcium signaling (Figure 29B): PLCG1 (3.613 ± 0.008-fold change,
P<0.001, n=3), PRKCA (7.493 ± 0.295-fold change, P<0.001, n=3), and CAMK2A (55.06
± 9.986-fold change, P<0.01, n=3).
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Figure 29. Neonatal cardiovascular progenitor cells expressing the type 1 angiotensin
II receptor exhibit calcium activation following treatment with angiotensin II
Neonatal cardiovascular progenitors were screened for the expression of the type 1
angiotensin II receptor (AGTR1) using PCR and gel electrophoresis. The clone that
expressed a higher ratio of the type 1 to type 2 (AGTR2) receptor (yellow box) was selected
for further experiments (A). Then, CPCs with this receptor were treated with angiotensin
II for 72 hours and calcium signaling gene expression was induced (B). n=3–6; **p<0.01,
***p<0.001. Changes in gene expression are shown as the mean ± S.E.M.
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Treatment of Neonatal Cardiovascular Progenitor Cells with Angiotensin II Induces
Expression of Sinoatrial Nodal Gene Program and Hcn4 Protein
Neonatal CPCs expressing the type I angiotensin II receptor were treated with
angiotensin II for 72 hours. Changes in gene expression indicated the induction of the
sinoatrial nodal gene program (Figure 30A): TBX3 (2.613 ± 0.2781-fold change, P<0.01,
n=3), TBX5 (1.456 ± 0.224-fold change, P=0.152, n=3), TBX18 (1.901 ± 0.025-fold
change, P<0.01, n=3), SHOX2 (2.273 ± 0.208-fold change, P<0.01, n=3), HCN4 (4.135 ±
0.495-fold change, P<0.001, n=12),and GJC1 (Cxn 45; 2.482 ± 0.256-fold change,
P<0.05, n=3). Meanwhile, the cardiomyocyte gene program was repressed (Figure 30B):
NKX2-5 (0.197 ± 0.025-fold change, P<0.001, n=9), TNNT2 (0.645 ± 0.087-fold change,
P<0.05, n=3), and GJA1 (Cxn 43; 2.482 ± 0.256-fold change, P<0.05, n=3). To confirm
the induction of Hcn4 protein, which carries the funny current that is characteristic of
pacemaker cells, we performed flow cytometry (Figure 30C) and western blot (Figure
30D). We observed a 7.75 ± 0.085-fold change in Hcn4 protein expression (Figure 30E).

Angiotensin II-Treated Cardiovascular Progenitor Cells
Exhibit Auto-rhythmic Calcium Flux
To test whether induced Hcn4 protein impacted the physiology of neonatal CPCs,
we incubated treated cells with Fluo4-AM to detect calcium flux. We observed the
generation of spontaneous auto-rhythmic calcium flux (Figure 31) in treated (black dots)
CPCs. Such calcium activity was not observed in untreated (red dots) CPCs. (n=8 per
group). Among treated CPCs, two trends emerged in spontaneous rhythm generation, as
indicated by black and blue trend lines.
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Figure 30. Angiotensin II treatment induces the expression of genes and proteins characteristic of sinoatrial nodal cells
Neonatal cardiovascular progenitors were treated with angiotensin II for 72 hours. Then, the expression of genes involved in
the sinoatrial nodal (A) and cardiomyocte (B) gene programs were measured by RT-PCR. Flow cytometry (C) and western
blotting (D) was used to determine the fold-change in the expression of Hcn4 protein (E). n=3–12; *p<0.05, **p<0.01,
***p<0.001. Changes in gene and protein expression are shown as the mean ± S.E.M.

Fluorescence Units

Frame Number
Figure 31. Angiotensin II treatment induces auto-rhythmic calcium flux
Neonatal cardiovascular progenitors were treated with angiotensin II for 72 hours,
incubated with Fluor4-AM, and imaged using confocal microscopy. The intensity of
calcium levels is indicated by the level of fluorescence. Black dots represent angiotensin
II-treated CPCs, with black and blue lines representing the two observed calcium flux
patterns. Red dots represent control CPCs. n=8 per group.
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Angiotensin II-Treated Cardiovascular Progenitor Cells
Have Functional Characteristics of Pacemaker Cells
Given that cardiomyocytes and various cardiac conduction system cell types (e.g.,
Purkinje fiber cells and atrioventricular node) exhibit auto-rhythmic currents, we
performed whole cell electrophysiology recordings using the perforated patch method.
Recording of angiotensin II-treated cells revealed an action potential of -40 ± 1 mV (n=9,
Figure 32A), a slow maximum upstroke velocity (dV/dtmax < 10 V/s), and an epinephrine
sensitivity that accelerated the number of action potentials from 1.05 ± 0.05 to 1.41 ±
0.05 per second (P<0.001, n=8; Figure 32B). Interestingly, the action potential duration at
50% of the maximum amplitude (APD50) of angiotensin II-treated CPCs was 289 ± 16
ms, which was relatively longer than the APD50 of SAN-like cells documented in Protze
et al. (2017). This was possibly due to the difference in temperature at which recordings
were performed (25°C versus 37°C). Notably, no sponteanously depolarizing membrane
potential was observed in untreated CPCs
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Figure 32. Pacemaker cell functional characteristics are induced in neonatal CPCs
following angiotensin II treatment
The electrophysiology of neonatal cardiovascular progenitors that were treated with
angiotensin II for 72 hours was recorded in the whole-cell, perforated-patch configuration.
Representative membrane potential curves before and after filtering are shown as well as
an analysis of action potential and maximum upstroke velocity (A). Epinephrine treatment
reduced the time required to generate an action potential, as shown in a representative
filtered membrane potential curve and by the increased number of action potentials per
second (B). n=8–9; ***p<0.001. Change in the action potential count is shown as the mean
± S.E.M. AP, action potential; APD50, action potential duration at 50% of the maximum
amplitude; SAN, sinoatrial node
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Discussion
In activating calcium signaling using angiotensin II, we were able to reliably
direct the induction of the sinoatrial nodal gene program, which correlated to elevated
Hcn4 protein expression and auto rhythmic calcium flux. Using angiotensin II to activate
calcium signaling follows from similar findings in our early population of neonatal
cardiovascular progenitors that were treated with hWnt5a or exposed to simulated
microgravity. This latter cell culture method has been shown to induce the sinoatrial
nodal gene program in neonatal CPCs (Baio, 2018) and neural crest progenitor cells
(Hatzistergos, 2018). Interestingly, non-canonical Wnt signaling, particularly Wnt11, is
critically involved in the regulation of neural crest cell development and migration (De
Calisto, 2005) along with the induction of CD166 (Gessert, 2006), which marks the
precursor population of sinoatrial nodal cells (Scanone, 2013). Thus, the use of
angiotensin II to induce non-canonical Wnt/Ca2+ signaling in early neonatal
cardiovascular progenitor cells logically follows from the observed activation of calcium
signaling under microgravity and the ability of non-canonical Wnt to enrich the sinoatrial
nodal precursor population. These findings merit further research into the mechanisms
governing the early events of sinoatrial node development, which will enable the ultimate
construction of a biological pacemaker.
Recent work by the laboratories of Keller (Protze, 2017) and Foley (Brown, 2017)
has produced important advances in the field of sinoatrial nodal development. Either
overexpression of the TGFβ-activated kinase MAP3K7 (Brown, 2017) and Bmp4
titration at the onset of cardiogenic mesoderm induction (Protze, 2017) were used to
create sinoatrial nodal-like cells. Interestingly, working cardiomyocytes, which exhibit
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high contractility, exhibit a morphology that differs from that of sinoatrial nodal cells
(Bakker, 2010). However, the enriched population of SAN-like cardiomyocytes
generated by Protze et al. (2017) follows from observations in other laboratories that such
cells can be produced in smaller percentages as a byproduct of inducing ventricular
cardiomyocytes from ESCs using a standard protocol of temporally regulated
moprhogens (Jha, 2016). Meanwhile, several working myocardial genes were found to be
repressed in Map3k7-overepxressing ESCs, supporting the work of Brown et al. (2017) in
generating sinoatrial nodal-like cells that are distinct from pacemaker-like
cardiomycoutes. Future work is needed to clarify whether such cells are functionally
capable of serving as a biological pacemaker over a prolonged period of time, or whether
they will revert into a ventricular- or atrial-like cardiomyocyte upon transplantation.
Nevertheless, the use of human-derived CPCs as seeds for the development of an ex vivo
sinoatrial node is possible.

153

References
AbdAlla S., Lother H., Abdel-tawab A.M., Quitterer U. (2001). The angiotensin II AT2
receptor is an AT1 receptor antagonist. J Biol Chem 276: 39721–39726.
Abrahamsen I., Lorens J.B. (2013). Evaluating Extracellular Matrix influence on
adherent cell signaling by Cold Trypsin Phosphorylation-specific Flow
Cytometry. BMC Cell Biology. 14(1): 36.
Accili, E.A., Robinson, R.B., Di Francesco, D. (1997). Properties and modulation of If in
newborn versus adult cardiac SA node. Am J Physiol. 272: H1549–52.
Anversa, P., Kajstura, J., Rota, M., Leri, A. (2013). Regenerating new heart with stem
cells. J. Clin. Invest. 123(1): 62-70.
Askar, A.T., Unzek, S., Popovic, Z.B., Goldman, C.K., Forudi, F., Kiedrowski, M.,
Rovner, A., Ellis, S.G., Thomas, J.D., DiCorleto, P.E., Topol, E.J., Penn, M.S.
(2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue
regeneration in ischaemic cardiomyopathy. Mechanisms of Disease. 362: 697703.
Awad, H.A., Wickham, M.Q., Leddy, H.A., Gimble, J.M., Guilak, F. (2004).
Chondrogenic differentiation of adipose-derived adult stem cells in agarose,
alginate, and gelatin scaffolds. Biomaterials. 25: 3211-22.
Baio JM, Martinez AF, Bailey L, Hasniya N, Pecaut MJ, Kearns-Jonker M (2018).
Spaceflight activates protein kinase C alpha signaling and modifies the
developmental stage of human neonatal cardiovascular progenitor cells. Stem
Cells Dev. In Press.
Barbuti, A., Baruscotti, M., DiFrancesco, D. (2007). The pacemaker current: from basics
to the clinics. Journal of Cardiovascular Electrophysiology. 18: 342-7.
Barbuti, A., Robinson, R.B. (2015). Stem cell-derived nodal-like cardiomyocytes as a
novel pharmacologic tool: Insights from sinoatrial node development and
function. Pharm. Rev. 67: 368-88.
Baruscotti, M., Bucchi, A., DiFrancesco, D. (2005). Physiology and pharmacology of the
cardiac pacemaker ("funny") current. Pharmacology & Therapeutics. 107: 59-79.
Becker, K.A., Ghule, P.N., Therrien, J.A., Lianm J.B., Stein, J.L., van Wijnen, A.J.,
Stein, G.S. (2006).
Behringer, R.R., Garry, D.J., Entman, M.L., Schneider, M.D. (2003). Cardiac progenitor
cells from adult myocardium: Homing, differentiation, and fusion after infarction.
PNAS. 100(21): 12313-8.

154

Behfar, A., Perez-Terzic, C., Faustino, R.S., Arrell, D.K., Hodgson, D.M., Yamada, S.,
Puceat, M., Niderlander, N., Alekseev, A.E., Zingman, L.V., Terzic, A. (2007).
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J.
Experimental Medicine. 204(2): 405-20.
Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara,
H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B.,
Anversa, P. (2003). Adult Cardiac Stem Cells Are Multipotent and Support
Myocardial Regeneration. 114: 763-76.
Benicky, J., Hafko, R., Sanchez-Lemus, E., Aguilera, G., Saavedra, J.M. (2012). Six
commercially available angiotensin II AT1 receptor antibodies are non-specific.
Cell. Mol. Neurobiol. 32(8): 1353-65.
Berne, R., Levy, M., Koeppen, B., Stanton, B. (2004). Physiology. Elsevier Mosby.
p. 276.
Boogerd, C.J., Wong, L.Y., van den Boogaard, M., Bakker, M.L., Tessadori, F., Bakkers,
J., ‘t Hoen, P.A., Moorman, A.F., Christoffels, V.M., Barnett, P. (2011). Sox4
mediates Tbx3 transcriptional regulation of the gap junction protein Cx43. Cell
Mol Life Sci. 68(23): 3949-61.
Boyett, M.R., Honjo, H., Kodama, I. (2000). The sinoatrial node, a heterogenous
pacemaker structure.
Bradshaw, L., Chaudhry, B., Hildreth, V., Webb, S., Henderson, D.J. (2009). Dual role
for neural crest cells during outflow tract septation in the neural crest-deficient
mutant Splotch(2H). J. Anat. 214(2): 245-57.
Bressan, M., Liu, G., Mikawa, T. (2013). Early mesodermal cues assign avian cardiac
pacemaker fate potential in a tertiary heart field. Science. 340: 744-8.
Brown, H.F., Di Francesco, D., Noble, S.J. (1979). How does adrenaline accelerate the
heart? Nature. 280: 235–236.
Bruneau, B.G. (2012). Heart Development. Current Topics in Developmental Biology:
100.
Bucchi A, Baruscotti M, Robinson RB, DiFrancesco D. (2007) Modulation of rate by
autonomic agonists in SAN cells involves changes in diastolic depolarization and
the pacemaker current. J Mol Cell Cardiol. 43(1): 39-48.
Burdon, T., Stracey, C., Chambers, I., Nichols, J., Smith, A. (1999). Suppression of SHP2 and ERK signaling promotes self-renewal of mouse embryonic stem cells. Dev.
Biol. 210(1): 30-43.

155

Cho, H.C. (2015). Pacing the Heart with Genes: Recent Progress in Biological Pacing.
Curr Cardiol Rep. 17: 65.
Chong, J.J.H., Yang, X., Don, V.W., Minami, E., Liu, Y-W, Weyers, J.J., Mahoney,
W.M., Van Biber, B., Cook, S.M., Palpant, N.J., Gantz, J.A., Fugate, J.A.,
Muskheli, V., Gough, G.M., Vogel, K.W., Astley, C.A., Hotchkiss, C.,
Baldessari, A., Pabon, L., Reinecke, H., Gill, E.A., Nelson, V., Kiem, H-P.,
Laflamme, M.A., Murry, C.E. (2014). Human embryonic-stem-cell-derived
cardiomyocytes regenerate non-human primate hearts. Nature. 510: 273-77.
Christoffels, V.M., Smits, G.J., Kispert, A., Moorman, A.F.M. (2010). Development of
the Pacemaker Tissues of the Heart. Circulation Research. 106: 240-54.
Daley, G.Q. (2012). The Promise and Perils of Stem Cell Therapeutics. Cell Stem Cell.
10(6): 740-9.
Daley, W.P., Peters, S.B., Larsen, M. (2008). Extracellular matrix dynamics in
development and regenerative medicine. J Cell Sci. 121: 155-64.
De Mello, W.C. (1995). The cardiac renin-angiotensin system: its possible role in cell
communication and impulse propagation. Cardiovasc Res. 29: 730–6.
De Mello, W.C. (1996). Renin-angiotensin system and cell communication in the failing
heart. Hypertension 27: 1267-72.
De Mello, W.C. (1998). Intracellular angiotensin II regulates the inward calcium current
in cardiac myocytes. Hypertension. 32: 976–82.
De Mello, W.C. (2011). Intracrine action of angiotensin II in the intact ventricle of the
failing heart: angiotensin II changes cardiac excitability from within. Mol. Cell
Biochem. 358: 309–15.
De Mello, W.C., Monterrubio, J. (2004). Intracellular and extracellular angiotensin II
enhance the L-type calcium current in the failing heart. Hypertension. 44: 360–
364.
Dhein, S. (2010). Cx30 in the sinus node of murine hearts just one connexin more, or
more? Evidence for a construction principle? Cardiovascular Res. 85: 7-8.
Di Francesco, D. (1993). Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol.
55: 455–72
Di, Francesco, D. (2010). The role of the funny current in pacemaker activity. Circ Res.
106(3): 434-46.
Di Francesco, D., Borer, J.S. (2007). The funny current: cellular basis for the control of
heart rate. Drugs. 67 (S2): 15-24.

156

Di Francesco, D., Tortora, P. (1991). Direct activation of cardiac pacemaker channels by
intracellular cyclic AMP. Nature. 351: 145-147.
Ding, Q., Xia, W., Liu, J.C., Yang, J.Y., Lee, D.F., Xia, J., Bartholomeusz, G., Li, Y.,
Pan, Y., Li, Z., Bargou, R.C., Qin, J., Lai, C.C., Tsai, F.J., Tsai, C.H., Hung, M.C.
(2005). Erk associates with and primes GSK-3beta for its inactivation resulting in
upregulation of beta catenin. Mol Cell. 19(2): 159-70.
Ellison, G.M., Torella, D., Dellegrottaglie, S., Perez-Martinez, C., de Prado, A.P.,
Vicinanza, C., Purushothaman, S., Galuppo, V., Ianconetti, C., Waring, C.D.,
Smith, A., Torella, M., Ramon, C.C., Gonzalo-Orden, J., Agosti, V., Indolfi, C.,
Galinanes, M., Fernandez-Vasquez, F., Nadal-Ginard, B. (2011). Endogenous
cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth
factor intracoronary injection fosters survival and regeneration of the infarcted pig
heart. J Am. Col. Cardiol. 58(9): 977-86.
Ellison, G.M., Vicinanza, C., Smith, A.J., Aquila, I., Leone, A., Waring, C.D., Henning,
B.J., Stirparo, G.G., Papait, R., Scarfo, M., Agosti, V., Viglietto, G., Condorelli,
G., Indolfi, C., Ottolenghi, S., Torella, D., Nadal-Ginard, B. (2013). Adult c-kitpos
cardiac stem cells are necessary and sufficient for -functional cardiac regeneration
and repair. Cell. 154(4): 827-42.
Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E. (2006). Matrix elasticity directs stem
cell lineage specification. Cell. 126: 677-89.
Espinoza-Lewis, et al. 2009. Shox2 is essential for the differentiation of cardiac
pacemaker cells by repressing Nkx2-5. Dev Biol. 327(2): 376-85.
Fuentes, T.I., Appleby, N., Raya, M., Bailey, L., Hasaniya, N., Stodieck, L., KearnsJonker, M. (2015). Simulated microgravity exerts an age-dependent effect on the
differentiation of cardiovascular progenitors isolated from the human heart. PLoS
ONE 10(7): e0132378.
Fuentes, T.I., Appleby, N., Tsay, E., Martinez, J., Bailey, L., Hasaniya, N., KearnsJonker, M. (2013). Human neonatal cardiovascular progenitors: Unlocking the
secret to regenerative ability. PLoS ONE 8(10): e77464.
Fuentes, T.I., Kearns-Jonker, M. (2013). Endogenous cardiac stem cells for the treatment
of heart failure. Stem Cells Cloning. 6:1-12.
Gaetani, R., Doevendans, P.A., Metz, C.H.G., Alblas, J., Messina, E., Giacomello, A.,
Sluijter, J.P.G. (2012). Cardiac tissue engineering using tissue printing technology
and human cardiac progeniot cells. Biomaterials. 33(6): 1782-90.
Gorman, J.H. III, Gorman, R.C., Plappert, T., Jackson, B.M., Hiramatsu, Y., St. JohnSutton, M.G., Edmunds, L.H. (1998). Infarct size and location determine

157

development of mitral regurgitation in the sheep model. J Thorac Cardiovasc
Surg. 115: 615–622.
Greenspon, A.J., Patel, J.D., Lau, E., Ochoa, J.A., Frisch, D.R., Ho, R.T., Pavri, B.B.,
Kurtz, S.M. (2012). Trends in permanent pacemaker implantation in the United
States from 1993 to 2009: increasing complexity of patients and procedures. J Am
College Cardiology, 60(16): 1540-5.
Guilak, F., Cohen, D.M., Estes, B.T., Gimble, J.M., Liedtki, W., Chen, C.S. (2009).
Control of Stem Cell Fate by Physical Interactions with the Extracellular Matrix.
Cell Stem Cell. 5(1): 17-26.
Gul, E.E., Kayrak, M. 2011. Common Pacemaker Problems: Lead and Pocket
Complications. Modern Pacemakers - Present and Future. Prof. Mithilesh R Das
(Ed.). ISBN: 978-953-307-214-2, InTech.
Guo, W.H., Frey, M.T., Burnham, N.A., Wang, Y.L. (2006). Substrate rigidity regulates
the formation and maintenance of tissues. J Biophys. 90: 2213-20.
Hadjipanayi, E., Mudera, V., Brown, R.A. (2009). Close dependence of fibroblast
proliferation on collagen scaffold matrix stiffness. J Tissue Eng. Regen. Med. 3:
77-84.
Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J., Kobilka, B.K. (2002). Behavioral and
cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in
mice. Nature. 377: 744-47.
Hou, X., Appleby, N., Fuentes, T., Longo, L.D., Bailey, L.L., Hasaniya, N., KearnsJonker, M. (2012). Isolation, characterization, and spatial distribution of cardiac
progenitor cells in the sheep heart. J Clin Exp Cardiolog. Suppl 6: 004.
Jain, et al. 2015. Integration of Bmp and Wnt signaling by Hopx specifies commitment of
cardiomyoblasts. Science. 358: 6242.
Jiyong, J, In, J.S., Min, S.Y., Suk, L.K., Heung soo, S., Moo, L.Y., Chul, K.H., KyungSoo, K. (2009). Transplantation of mesenchymal stem cells within a poly(lactideco-ɛ-caprolactone) scaffold improves cardiac function in a rat myocardial
infarction model. European J Heart Failure. 11(2): 147-53.
Jun H.S., Lee Y.M., Song K.D., Mansfield B.C., Chou .J.Y. (2011). G-CSF improves
murine G6PC3-deficient neutrophil function by modulating apoptosis and energy
homeostasis. Blood. 117(14): 3881–92.
Kalin, R., Stanton, M.S. (2005). Current clinical issues for MRI scanning of pacemaker
and defibrillator patients. PACE. 28: 326-8.

158

Keith, A., Flack, M. (1907). The Form and Nature of the Muscular Connections between
the Primary Divisions of the Vertebrate Heart. J Anat. Physiol. 41(3):172-89.
Kehat, I., Khimovich, L., Caspi, O., Gepstein, A., Shofti, R., Arbel, G., Huber, I., Satin,
J., Itskovitz-Eldor, J., Gepstein, L. (2004). Electromechanical integration of
cardiomyocytes derived from human embryonic stem cells. Nature
Biotechnology. 22: 1282-9.
Kelly, R.G. (2012). Chapter two – The Second Heart Field. Current Topics in
Developmental Biology. 100: 33-65.
Klabunde, R.E. (2011). Cardiovascular Physiology Concepts, 2nd ed. Baltimore:
Lippincott, Williams & Wilkins.
Krutzik P.O., Nolan G.P. (2003). Intracellular phospho-protein staining techniques for
flow cytometry: Monitoring single cell signaling events. Cytometry Part A. 55(2):
61–70.
Kunath, T., Saba-El-Leil, M.K., Almousailleakh, M., Wray, J., Meloche, S., Smith, A.
(2007). FGF stimulation of the Erk1/2 signaling cascade triggers transition of
pluripotent embryonic stem cells from renewal to lineage commitment.
Development. 134: 2895-902.
Lee, S., Fu, K., Kohno, T., Ransford, B., Maisel, W.H. (2009). Clinically significant
magnetic interference of implanted cardiac devices by portable headphones. Heart
Rhythm. 6: 1432-6.
Levenberg, S, Huang, N.F., Lavik, E., Rogers, A.B., Itskovitz-Eldor, J., Langer, R.
(2003). Differentiation of human embryonic stem cells on three-dimensional
polymer scaffolds. PNAS. 100(22): 12741-6.
Levenberg, S., Burdick, J.A., Kraehenbuehl, T., Langer, R. (2005). Neurotrophin-induced
differentiation of human embryonic stem cells on three-dimensional polymeric
scaffolds. Tissue Engineering. 11(3-4): 506-12.
Lewis, T. Lectures on the heart. New York: Paul B Hoeber, 191511–12.12.
Lewis, T. The mechanism and graphic registration of the heart beat. 3rd ed. London:
Shaw and Sons, 192563–69.69.
Li, J., Wang, G., Wang, C., Zhao, Y., Zhang, H., Tan, Z., Song, Z., Ding, M., Deng, H.
(2007). MEK/ERK signaling contributes to the maintenance of human embryonic
stem cell self-renewal. 75(4): 299-307.
Lin, B., Lu, T.Y., Yang, L. (2014). Hear the beat: decellularized mouse heart regenerated
with human induced pluripotent stem cells. Expert Rev Cardiovasc. Ther. 12(2):
135-7.

159

Lo, C.W. (2000). Role of gap junctions in cardiac conduction and development: insights
from the connexin knockout mice. Circ Res. 87: 346–8.
Lu, T.Y., Lin, B., Kim, J., Sullivan, M., Tobita, K., Salama, G., Yang, L. (2013).
Repopulation of decellularized mouse heart with human induced pluripotent stem
cell derived cardiovascular progenitor cells. Nature Communications. 4: 2307.
Maher, B. (2013). Tissue engineering: How to build a heart. Nature. 499: 20-22.
Matsuura, K., Nagai, T., Nishigaki, N., Oyama, T., Nishi, J., Wada, H., Sano, M., Toko,
H., Akazawa, H., Meng, X. Leslie, P., Zhang, Y., Dong, J. (2014). Stem cells in a
three-dimensional scaffold environment. Springerplus. 3:80.
Migeotte, P-F, Prisk, G.K., Paiva, M. (2003). Microgravity alters respiratory sinus
arrhythmia and short-term heart rate variability in humans. Am. J. Physiol. Heart
and Circ Physiol. 284(6): H1995-H2006.
Milanesi, R., Baruscotti, M., Gnecchi-Ruscone, T., Di Francesco, D. (2006). Familial
sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N
Engl J Med. 354:151–7.
Mjaatvedt, C.H., Nakaoka, T., Moreno-Rodriguez, R., Norris, R.A., Kern, M.J.,
Eisenberg, C.A., Turner, D., Markwald, R.R. (2001). The outflow tract of the
heart is recruited from a novel heart-forming field. Dev. Biol. 238: 97–109.
Mommersteeg, et al. (2007). Molecular Pathway for the Localized Formation of the
Sinoatrial Node. Circ Res. 100: 354-62.
Munshi, N.V. (2012). Gene regulatory networks in cardiac conduction system
development. Circ. Res. 110: 1525-1537.
National Pacemaker and ICD database. UK and Ireland. Annual Report. 2001.
Braunwald.
Oh, H., Bradfute, S.B., Gallardo, T.D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius,
J., Michael, L.H., Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal R.K.,
Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., Marshak,
D.R. (1999). Multilineage Potential of Adult Human Mesenchymal Stem Cells.
Science. 284(5411): 143-7.
Palpant, N.J., Pabon, L., Roberts, M., Hadland, B., Jones, D., Jones, C., Moon, R.T.,
Ruzzo, W.L., Bernstein, I., Zheng, Y., Murry, C.E. (2015). Inhibition of betacatenin signaling respecifies anterior-like endothelium into beating human
cardiomyocytes. Development. 142: 1-12.

160

Potapova, I., Plotnikov, A., Lu, Z., Danilo, P, Valiunas, V., Qu, J., Doronin, S.,
Zuckerman, J., Shlapakova, I.N., Gao, J., Pan, Z., Herron, A.J., Robinson, R.B.,
Brink, P.R., Rosen, M.R., Cohen, I.S. (2004). Circ. Res. 94: 952-9.
Protze SI, Liu J, Nussinovitch U, Ohana L, Backx PH, Hepstein L, Keller GM. (2017).
Sinoatrial node cardiomyocytes derived from human pluripotent cells function as
a biological pacemaker. Nat Biotechnol 35:56-68.
Puskaric, S., Schmitteckert, S., Mori, A.D., Glaser, A., Schneider, K.U., Bruneau, B.G.,
Blaschke, R.J., Steinbeisser, H., Rappold, G. (2010). Shox2 mediates Tbx5
activity by regulating Bmp4 in the pacemaker region of the developing heart.
Hum. Mol. Genet. 19(23): 4625-33.
Robinson, A.P., Rodgers, J.M., Goings, G.E., Miller, S.D. (2014). Characterization of
oligodendroglial populations in mouse demyelinating disease using flow
cytometry: Clues for MS pathogenesis. PLoS ONE 9(9): e107649.
Rodgers, J.M., Robinson, A.P., Rosler, E.S., Lariosa-Willingham, K., Persons, R.E.,
Dugas, J.C., Miller, S.D. (2015). Il-17A activates ERK1/2 and enhances
differentiation of oligodendrocyte progenitor cells. Glia. 63(5): 768-79.
Rosen, M.R., Bring, P.R., Cohen, I.S., Robinson, R.B. (2004). Genes, stem cells and
biological pacemakers. Cardiovascular Research. 64: 12-23.
Ruan, J-L., Tulloch, N.L., Saiget, M., Paige, S.L., Razumova, M.V., Regnier, M., Tung,
K.C., Keller, G., Pabon, L., Reinecke, H., Murry, C.E. (2015). Mechanical stress
promotes maturation of human myocardium from pluripotent stem cell-derived
progenitors. 33(7): 2148-57.
Sadler, T.W., Langman, J. (2012). Langman’s medical embryology. 12th ed. Philadelphia:
Wolters Kluwer Health/Lippincott Williams & Wilkens.
Sah, R., Mesirca, P., Van den Boogert, M., Rosen, J., Mably, J., Mangoni, M.E.,
Clapham, D.E. (2013). Ion channel-kinase TRPM7 is required for maintaining
cardiac automaticity. PNAS 111(17): 6528.
Saito, K., Gutkind, J.S., Saavedra, J.M. (1987). Angiotensin II binding sites in the
conduction system of rat hearts. Am. J. Physiol – Heart and Circ Phys. 253(6):
H1618-22.
Satin, J., Kehat, I., Caspi, O., Arbel, G., Itzhaki, I., Magyar, J., Schroder, E.A., Perlman,
I., Gepstein, L. (2004). Mechanism of spontaneous excitability in human
embryonic stem cell derived cardiomyocytes. J Physiol. 559(2): 479-96.
Sato, T., Nakaya, H., Kasanuki, H., Komuro, I. (2004). Adult Cardiac Sca-1-positive
Cells Differentiate into Beating Cardiomyocytes. J. Biol. Chem. 279(12): 1138491.

161

Scadden, D.T. (2006). The stem-cell niche as an entity of action. Nature. 441: 1075-9.
Scholzen, T., Gerdes, J. (2000). The Ki-67 protein: from the known and the unknown. J
Cell Physiol. 182(3): 311-22.
Schulze-Bahr, E., Neu, A., Friederich, P., Kaupp, U.P., Breithardt, G., Pongs, O.,
Isbrandt, D. (2003). Pacemaker channel dysfunction in a patient with sinus node
disease. J Clin Invest. 111:1537–45.
Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle
phase. J Cell Physiol. 209 (3):883-93.
Severs, N.J. (1994). Pathophysiology of gap junctions in heart disease. J. Cardiovasc.
Electrophysiol. 5: 462–75.
Sherwood, L. (2012). Human Physiology, From Cells to Systems. 8th ed. Cengage
Learning.
Silverman, M.E., Hollman, A. (2007). Discovery of the sinus node by Keith and Flack:
on the centennial of their 1907 publication. Heart 93(10): 1184-7.
Stieber, J., Hofmann, F., Ludwig, A. (2004). Pacemaker channels and sinus node
arrhythmia. Trends Cardiovasc Med. 14: 23–8.
Tadevosyan, A., Vaniotis, G., Allen, B.G., Hebert, T.E., Nattel, S. (2012). G proteincoupled receptor signaling in the cardiac nuclear membrane: evidence and
possible roles in physiological and pathophysiological function. J Physiol. 590(6):
1313-30.
Taniguchi J, Kokubun S, Noma A, Irisawa H. (1981). Spontaneously active cells isolated
from the sinoatrial and atrioventricular nodes of the rabbit heart. Jap J Phsyiol. 31:
547-558.
Tawara, S. (1906). Das Reizleitungssystem Des Säugetierherzens (The conduction
system of the mammalian heart) Jena: Gustav Fischer. (Translated into English by
Kozo Suma and Munehiro Shimada and published by Imperial College Press,
London, 2000).
Trohman, R.G., Kim, M.H., Pinski, S.L. (2004). Cardiac pacing: the state of the art.
Lancet. 364(9446): 1701-19.
Tse, H-F., Xue, T., Lau, C-P, Siu, C-W., Wang, K., Zhang, Q-Y., Tomaselli, G.F., Akar,
F.G., Li, R.A. (2006). Bioartifical sinus node constructed via in vivo gene transfer
of an engineered pacemaker HCN channel reduces the dependence on electronic
pacemaker in a sick-sinus syndrome model. Circulation. 114:1000-11.

162

Ueda, K., Nakamura, K., Hayashi, T., Inagaki, N., Takahashi, M., Arimura, T., Morita,
H., Higashiuesato, Y., Hirano, Y., Yasunami, M., Takishita, S., Yamashina, A.,
Ohe, T., Sunamori, M., Hiraoka, M., Kimura, A. (2004). Functional
characterization of a trafficking-defective HCN4 mutation, D553 N, associated
with cardiac arrhythmia. J Biol Chem. 279: 27194–8.
Urata, H., Healy, B., Stewart, R.W., Bumpus, F.M., Husain, A. (1989). Angiotensin II
Receptors in Normal and Failing Human Hearts. J Clin. Endocrinology and
Metabolism. 69(1): 54-66.
Urbanek, K., Rota, M., Cascapera, S., Bearzi, C., Nascimbene, A., De Angelis, A.,
Hosoda, T., Chimenti, S., Baker, M., Limana, F., Nurzynska, D., Torella, D.,
Rotatori, F., Rastaldo, R., Musso, E., Quaini, F., Leri, A., Kajstura, J., Anversa, P.
(2005). Cardiac stem cells possess growth factor-receptor systems that after
activation regenerate the infarcted myocardium, improving ventricular function
and long-term survival. Circulation Research. 97: 663-73.
van Ginneken, A.C.G., Giles, W. (1991). Voltage clamp measurements of the
hyperpolarization-activated inward current If in single cells from rabbit sino-atrial
node. J Physiol. 434: 57–83.
Vassalle, M. (1977). The relationship among cardiac pacemakers: Overdrive suppression.
Circulation Research. 41(3): 269–77.
Venema RC, H Ju, VJ Venema, B Schieffer, JB Harp, BN Lingʈ, DC Eatonʈ and MB
Marrero (1998). Angiotensin II-induced Association of Phospholipase C1 with the
G-protein-coupled AT 1 Receptor. J Biol Chem. 273: 7703-8.
Verkerk, A.O., Wilders, R., Coronel, R., Ravesloot, J.H., Verheijck, E.E.(2003). Ionic
remodeling of sinoatrial node cells by heart failure. Circulation. 108: 760–6.
Verkerk, A.O., Wilders, R., van Borren, M.M.G.J., Peters, R.J.G., Broekhuis, E., Lam,
K., Coronel, R., de Bakker, J.M.T., Tan, H.L. (2007). Pacemaker current (If) in
the human sinoatrial node. European Heart Journal. 28: 2472-78.
Waldo, K.L., Kumiski, D.H., Wallis, K.T., Stadt, H.A., Hutson, M.R., Platt, D.H., Kirby,
M.L. (2001). Conotruncal myocardium arises from a secondary heart field.
Development. 128(16): 3179-88.
Wan, J., Zhong, X., Liao, B., Wang, M., Deng, M. (2009). Primary culture of sinoatrial
node cells from suckling pigs and its co-culture with Col I fiber scaffold. Chinese
J of Reparative and Reconstructive Surgery. 23(8): 980-4.
Wang, H.B., Dembo, M., Wang, Y.L. (2000). Substrate flexibility regulates growth and
apoptosis of normal but not transformed cells. Am J Physiol Cell Physiol. 279:
C1345-50.

163

Wang, J., Bai, Y., Li, N., Ye, W., Zhang, M., Greene, S.B., Tao, Y., Chen, Y., Wehrens,
X.H.T., Martin, J.F. (2014). Pitx2-microRNA pathway that delimits sinoatrial
node development and inhibits predisposition to atrial fibrillation. PNAS.
111(25): 9181-86.
Watanabe, S., Umehara, H., Murayama, K., Okabe, M., Kimura, T., Nakano, T. (2006).
Activation of Akt signaling is sufficient to maintain pluripotency in mouse and
primate embryonic stem cells. Oncogene. 25: 2697-2707.
Widmaier EP, Raff H, Strang KT (2008). Vander's Human Physiology, 11th Ed.
McGraw-Hill. pp. 291, 509–10.
Xiao, X., Mukkamala, R., Sheynberg, N., Grenon, S.M., Ehrman, M.D., Mullen, T.J.,
Ramsdell, C.D., Willaims, G.H., Cohen, R.J. (2004). Effects of simulated
microgravity on closed-loop cardiovascular regulation and orthostatic intolerance:
analysis by means of system identification. J. App. Physiol. 96(2): 489-97.
Xu, F., Mao, C., Hu, Y., Rui, C., Xu, Z., Zhang, L. (2009). Cardiovascular effects of
losartan and its relevant clinical application. Curr. Med. Chem. 16(29): 3841-57.
Xue, C., Zhang, J., Lv, Z., Liu, H., Huang, C., Yang, J., Wang, T. (2015). Angiotensin II
promotes differentiation of mouse c-kit-positive cardiac stem cells into
pacemaker-like cells. Mol Med Rep. 11(5): 3249-58.
Yamaguchi, H., Hsu, J.L., Hung, M-C. (2012). Regulation of ubiquitination-mediated
protein degradation by survival kinases in cancer. Frontiers in Oncology. 2:15.
Yang, et al. (2006). Isl1Cre reveals a common Bmp pathway in heart and limb
development. Development. 133: 1575-85.
Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P.,
Smith, A. (2008). The ground state of embryonic stem cell self-renewal. Nature.
452: 519-23.
Zhang, G., Nakamura, Y., Wang, X., Hu, Q., Suggs, L.J., Zhang, J. (2007). Controlled
release of stromal cell-derived factor-1alpha in situ increases c-kit+ cell homing
to the infarcted heart. Tissue Engineering. 13(8): 2063-71.
Zicha, S., Fernandez-Velasco, M., Lonardo, G., L’Heureux, N., Nattel, S. (2005). Sinus
node dysfunction and hyperpolarization-activated (HCN) channel subunit
remodeling in a canine heart failure model. Cardiovasc. Res. 66: 472–81.

164

CHAPTER FIVE
COMMENTS
In this dissertation, we presented findings of the effects of reduced gravity
conditions on neonatal cardiovascular progenitor cells. In this concluding chapter, we
seek to summarize some of the most salient features of our experiments in three areas:
molecular changes borne by spaceflight, their Earth applications, and sinoatrial nodal
development. Through the experiments described herein, we have been able to uncover
features of the molecular response of early cardiovascular progenitor cells to reduced
gravity conditions. Importantly, these findings contribute to the broad understanding of
how humankind will fare in deep space and provide guidance for the expansion of our
species beyond Earth. Moreover, features of the adaptive response exhibited by CPCs
under simulated microgravity and aboard the ISS suggest augmented therapeutic
potential, as indicated by enhanced proliferation, migration, and stemness marker
expression. These features may continue to be explored and tested on Earth and in space
in an effort to translate these findings into demonstrably effective stem cell-based
cardiovascular regeneration and therapies. In this dissertation, we have already applied
this strategy to the early stages of biological pacemaker development. Future work can
extend these incipient experiments to expand the utility of CPCs in regenerative medicine
on Earth.
As defined in chapter 2, the profound changes in developmental gene expression
and enhanced proliferative potential experienced by CPCs during culture aboard the ISS
are suggestive of augmented therapeutic potential on Earth. This prompted us to identify
the molecular mechanisms by which CPCs adapt to reduced gravity conditions and to
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understand how these effects could be recapitulated in vitro under normal gravity
conditions. In doing so, we found that reduced mechanotransduction coupled with
calcium signaling in a population of early cardiovascular progenitors can induce the
expression of a modestly earlier developmental profile, as described in chapter 3. Finally,
given that sinoatrial nodal cells are theorized to represent embryonic myocardium
maintained in an undifferentiated state, we sought to understand whether the same
signaling events that could induce an earlier developmental state under reduced gravity
conditions could be applied to promote the development of pacemaker cells (chapter 4).
When considered together, these studies advance our knowledge of the mechanisms
governing the molecular adaptation to spaceflight and provide a plausible method for
improving stem cell therapies and for inducing biological pacemaker cells.

Summary and Future Directions
The findings described in this dissertation provide novel insights into the
molecular events underpinning cardiac stem cell function beyond the Earth-bound
context. Yet, further research is needed to ensure the safe and effective application of
these mechanistic findings in future clinical therapies. Moreover, the observations that
simulated microgravity can result in the abnormal accumulation of pacemaker cells
(Hatzistergos, 2018) along with an induction of the sinoatrial nodal gene program (Baio,
2018) merit further research into the incipient molecular events of the sinoatrial node’s
development. In these concluding remarks, we contextualize the findings described
throughout this dissertation by discussing ongoing and future efforts to understand
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cardiovascular development and how primordial cardiac cells can be used to facilitate
regeneration following injury.

Reduced Gravity Conditions Impact Cardiogenesis
As humankind has expanded our presence in low Earth orbit and aims to
undertake missions to deep space, organ system-wide changes have been observed within
astronauts. In addition to bone loss, muscular atrophy, impairment of the immune system,
and deformations in the ocular system, the cardiovascular system has been observed to
undergo remodeling and reduced function in response to spaceflight (Frippiat, 2016;
White, 2001). Researchers have moved to study these effects at a single cell level so as to
develop approaches that improve the likelihood of human survival in deep space. As
these studies have evolved, the potential use of microgravity in maintaining or enhancing
the pluripotent capabilities of cells has benefited subsequent directed differentiation upon
mechanical reloading.
A recent review of tissue engineering under microgravity conditions has
demonstrated the increasing interest in leveraging the reduced gravity environment of
various simulators or the ISS to prepare preliminary vessels, eye tissue, bone cartilage,
and multicellular cancer spheroids (Grimm, 2018). Despite the apparent benefits of
microgravity-inspired stem cell research, few studies have applied space research to
cardiac progenitors or cardiac differentiation (Frippiat, 2016; White, 2001). Although
several studies have successfully developed primitive vessels (Pietsch , 2017; Grimm,
2009; Grimm, 2010; Ma, 2014) from endothelial precursors (EA.hy926 or human cardiac
microvascular endothelial cell types), only recently have researchers turned to studying
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enhanced cardiomyocyte production (Jha, 2016) and augmented cardiac precursor
stemness (Fuentes, 2015) under conditions of microgravity. Thus, our study of the effects
of spaceflight on cardiovascular progenitors represents an important advance not only for
cardiac adaptation and development in space, but also for identifying key mechanisms
involved in the enhanced stemness that may represent a foundation for future methods of
generating cardiac tissue.
In summary, we found that microgravity exerts broad effects on the
developmental status, proliferative potential, and migratory ability of CPCs, some of
which occurred in an age-dependent manner. In particular, neonatal CPCs exhibited
increased expression of early developmental markers, enhanced proliferative potential,
and increased migratory capacity following spaceflight. These findings suggest that broad
cytoskeletal modifications resulting from reduced mechanotransduction impart improved
migratory and adhesion capabilities and that CPCs can propagate or experience additional
intracellular signaling events (e.g., calcium signaling) that modify their developmental
status. Until now, most studies of cardiovascular adaptation to spaceflight have focused
on terminal cardiomyocytes or organ system-wide alterations (Hughson, 1985; Blue,
2015; Hughson, 2017; Negishi, 2017). Conversely, studies of stem cells have focused
largely on embryonic or induced pluripotent stem cells (Blaber, 2015; Shinde, 2016; Jha,
2016). Thus, our findings provide unique information on the effects of spaceflight on
cardiac lineage development. In the context of cardiovascular stem cell therapy, these
results represent one avenue by which to procure a cardiac-committed stem cell with
enhanced regenerative properties. This follows from increasingly strong evidence that
supports the use of progenitors that are only nascent in their commitment to the
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cardiovascular lineage in promoting cardiovascular repair. Thus, research in
cardiovascular regenerative medicine must also consider methods that enhance the
regenerative potential of CPCs.
In a study of repair following myocardial infarction in non-human primates, Blin
et al. (2010) studied the efficacy of an early-stage cardiovascular progenitor that
expressed stage-specific embryonic antigen 1 (SSEA-1), mesoderm posterior 1 (MESP1),
and OCT4. In doing so, the researchers observed differentiation of these early cells into
ventricular cardiomyocytes, thereby healing approximately 20% of the scar tissue. The
use of such a progenitor was demonstrated to be efficacious in a rodent model of
myocardial repair (Bellamy, 2015). Meanwhile, Menasché et al. (2015) reported the first
clinical case report of treatment using this early cardiovascular progenitor cell type. In
brief, transplantation of SSEA-1- and Islet1-expressing CPCs derived from embryonic
stem cells resulted in improved cardiovascular function. As shown in Table 2, studies of
stem cell-based cardiovascular repair have revealed an emerging pattern in which an
earlier cardiovascular progenitor more effectively improves cardiovascular function.
As future research into cardiovascular progenitor adaptation to spaceflight
evolves, key questions must be answered. First, what are the most critical signaling
components that account for the CPC response to spaceflight and subsequently enhanced
stemness? Second, can these effects be recapitulated in vitro on Earth in the absence of
simulated microgravity or ISS-borne laboratories? Although these questions have been
addressed, at least in part, through our work in this dissertation, further questions persist.
What is the optimal “dose” of microgravity for stem cell-based repair and, as a corollary,
does low Earth orbit (e.g., the ISS) and deep space (e.g., a mission to Mars) produce the
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same effects? Finally, what implications do these findings have for cardiac development
in the context of extraterrestrial conception and in utero development? We are only
beginning to uncover the wide-ranging implications of spaceflight for human biology.

Signaling Events Involved in CPC Adaptation
to Spaceflight Can Be Applied on Earth
As described above, the molecular mechanisms underpinning the adaptation of
CPCs to spaceflight and simulated microgravity will facilitate the enhanced use of these
cell types in ground-based therapies. Thus, we worked to identify the involvement of key
signaling pathways in this process. As summarized below, the involvement of calcium
and Akt signaling in primordial cardiovascular cells are critical to this process.
In the context of cardiogenesis, studies performed in both embryos and ESCderived cardiomyocytes have shown a critical role of Ca2+ in regulating multiple steps of
heart formation (Pucéat, 2005). For example, induction of Ca2+ oscillation promotes
proliferation and, upon transplantation, enhances engraftment and expansion (FerreiraMartins, 2009). In this way, our observed shift in expression of markers of early cardiac
development is likely the result, at least in part, of modified calcium signaling activity
within neonatal CPCs. Furthermore, research into Mesp1-expressing pre-cardiac
mesoderm derived from human ESCs identified enriched activity along the calcium,
extracellular matrix-receptor, and Wnt signaling pathways at day 5 of development (den
Hartogh, 2016), which is supported by our observed increase in markers of such a state of
development after culture aboard the ISS (chapter two) and using SMG (Baio, 2018).
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Interestingly, the ability of spaceflight to impact epigenetic regulation is only in
its nascent stages of study, but, when further understood, may provide insights into the
mechanisms governing enhanced differentiation potential under conditions of
microgravity. In human lymphoblastoid cells, DNA methylation patterns were found to
be widely altered by simulated microgravity (Chowdhury et al, 2016), with Singh et al.
(2010) reporting that simulated microgravity preferentially induces hypomethylation in
human lymphocytes. It could be speculated that microgravity can induce
hypomethylation in cardiovascular progenitor cells, and further study in this area
represents one interesting avenue for future research. As demonstrated in this
dissertation, cardiomyocytes were induced from CPCs using treatment with 5azacytidine, which inhibits DNA methyltransferase and results in near global
hypomethylation. While the exact mechanism of this treatment is unknown, Notchrelated signaling components, which promote cardiomyocte induction by inhibiting
canonical Wnt signaling during the early stages of cardiogenesis (Gessert & Kühl, 2010),
remain uniquely hypomethylated following removal of 5-azacytidine from cell culture
(Ramos et al., 2015) suggesting that hypomethylation events are important to
differentiation processes. Thus, the role of microgravity-induced alterations in epigenetic
control of stem cells, and of methylation events in particular, merits further study.
In addition to identifying the role of calcium signaling in mediating some of the
changes experienced by neonatal CPCs, we also found that spaceflight impacted adult
CPCs in a manner that may not yet be fully appreciated. Therefore, the mechanisms of
CPC biology appear to be age-dependent. The findings outlined in this dissertation can be
used to guide future experiments that characterize such changes and ultimately develop
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therapies that can enable the use of adult-derived CPCs in an autologous manner. Recent
work in our own laboratory (Fuentes, 2013) has identified functional differences in
signaling pathways pertinent to many of the processes observed under simulated
microgravity. Similarly, the secretome of adult and neonatal CPCs were recently
compared using liquid chromatography tandem mass spectrometry (Sharma, 2017). In
this study, researchers identified elevated protein expression in pathways related to stem
cells maintenance, differentiation, heat shock proteins (i.e., stress response),
proliferation/growth, anti-apoptosis, and calcium regulation in tissue culture media of
neonatal CPCs. Conversely, tissue culture media of adult CPCs was found to be enriched
in proteins related to aging, senescence, and anti-proliferation.
This prompts an important line of inquiry to understand the molecular basis for
functional differences between adult- and neonate-derived cardiovascular progenitor
cells. While we have shown here that CPCs derived from both age populations can
similarly express developmental markers and exhibit an ability to differentiate (though to
differing extents), their functional differences in response to various conditions, including
simulated microgravity (Fuentes, 2015), spaceflight, hypoxia (Hernandez, 2018), and
myocardial infarction (Sharma, 2017), indicate fundamental differences in the
mechanisms governing age-dependent CPC function.
Notably, both Sharma et al. (2017) and Hernandez et al. (2018) detected a
difference in the induction of heat shock proteins between neonatal and adult CPCs.
Moreover, the former research group demonstrated that heat shock factor 1 is an
upstream regulator of many of the pathways uniquely enriched in the neonatal CPC
secretome. Thus, the age-dependent response of CPCs to various conditions, including

172

spaceflight, may be a reflection of the age-dependent readiness of cells to mount a stress
response and induce down-stream effects. Experiments that assess the delayed response
of adult CPCs to spaceflight may refine this hypothesis and provide a plausible path for
enhancing the utilization of adult patient-derived cells. This is particularly important
given that adult patients would more regularly require regenerative therapies for the
heart.
Ultimately, future research will continue to uncover the utility of microgravitytreated CPCs in cardiovascular repair. Our observed enhancements in migration and
proliferation along with the induction of an earlier developmental state compliment the
emerging trend of early cardiac progenitor cell transplantation. As we have elucidated the
involvement of key signaling pathways in the process of CPC adaptation to spaceflight,
we can begin to leverage the observed enhanced therapeutic potential of spaceflown or
simulated microgravity-exposed cardiac progenitors on Earth. As shown in this
dissertation, one unique application of such findings is the development of an in vitro
biological pacemaker.

The Sinoatrial Node Can Be Induced
in Early Neonatal Cardiovascular Progenitor Cells
Some astronauts experience arrhythmias during spaceflight (Anzai, 2014). The
mechanisms by which these irregularities in heart rhythm develop are unknown, but
researchers speculate that diet imbalance and neurohormonal dysregulation are possible
causes. Among the latter, regulators of heart rhythm, such as angiotensin II (Delpón,
2005; Watenpaugh, 2001; Xu, 2009), are differentially regulated by spaceflight and merit
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further attention. Reduced gravity conditions have also been implicated in the
dysregulation of myocardial and sinoatrial nodal gene program expression in endogenous
progenitors. Indeed, simulated microgravity has been shown to induce the sinoatrial
nodal gene program in neonatal CPCs (Baio, 2018) and neural crest progenitor cells
(Hatzistergos, 2018). Such alterations to cardiac pacing and progenitor developmental
gene expression under reduced gravity prompted us to further explore the means by
which signaling events under these conditions may promote sinoatrial nodal
development. Interestingly, non-canonical Wnt signaling, particularly Wnt11, is critically
involved in the regulation of neural crest cell development and migration (De Calisto,
2005) along with the induction of CD166 (Gessert, 2006), which marks the precursor
population of sinoatrial nodal cells (Scanone, 2013). Thus, the use of angiotensin II to
induce non-canonical Wnt/Ca2+ signaling in early neonatal cardiovascular progenitor
cells logically follows from the observed activation of calcium signaling under
microgravity and the ability of non-canonical Wnt to enrich the sinoatrial nodal precursor
population. Furthermore, the induction of TGFB1 expression under SMG (Baio, 2018)
also supports the observation that Tgfβ-activated kinase signaling in embryonic stem
cells faithfully induces functional sinoatrial nodal cells (Brown, 2017).
When considered together, this evidence suggests that sinoatrial nodal induction
requires a sufficiently developmentally early cell type. This is supported by observations
by Bressan et al. (2013), who traced sinoatrial nodal development in an avian model and
found that the SAN developed from a tertiary heart field that did not express Nkx2-5 or
Isl1. Importantly, early mesodermal cues were able to promote the development of this
specialized region shortly after gastrulation, prior to the onset of cardiac morphogenesis.
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This is reflected by the nearly unanimous use of embryonic or induced pluripotent stem
cells in engineering biological pacemaker cells. Thus, our findings that angiotensin II
treatment can induce the sinoatrial nodal gene program and elicit a sinoatrial nodal-like
phenotype in CPCs provides plausible evidence that a sufficiently developmentally early
cardiovascular progenitor may be suitable for pacemaker cell induction.
Importantly, further work must be performed to determine if angiotensin IItreated cells can retain a SAN-like phenotype beyond the period of treatment and,
ultimately, following transplantation and integration into the host myocardium. Other
laboratories have induced a sinoatrial nodal-like phenotype by transforming ventricular
myocytes in a pig and guinea pig with TBX18 transfection using an adenoviral vector (Hu
et al., 2014; Kapoor et al, 2013). In these studies, researchers observed a decline in
pacemaking efficacy approximately two weeks after injection, which was speculated to
be the result of immune-mediated clearance of the adenovirus. Meanwhile, in fetal mice,
TBX18 was found to be insufficient to induce SAN differentiation of chamber
cardiomyocytes, thereby suggesting that the transcription factor may be relevant to
sinoatrial nodal development, but not specific to its fate nor sufficient for its induction
(Greulich et al., 2016). This complicates our ability to accept the reliability of TBX18
induction as being sufficient for sustained sinoatrial nodal reprogramming. Furthermore,
recent work from the Keller group (Protze et al., 2017) demonstrated that functional SAN
induction and subsequent integration following transplantation into rodents is possible,
but similarly only assessed the in vivo efficacy after two weeks. Thus, longer-term studies
(i.e., > 2 weeks) are needed to ensure that induced sinoatrial nodal cells are able to
maintain their phenotype, successfully interdigitate with the surrounding working
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myocardium, and serve as a reliable and non-arrhythmogenic pacemaker following
transplantation.
Meanwhile, work by the Foley group (Brown et al., 2017) demonstrated an
important role of Tgfβ signaling early in development, which resulted in the induction of
HCN4 within days of embryoid body formation. Interestingly, this follows from the
identification of a distinct and temporally early population of mesoderm that gives rise to
the sinoatrial node (Bressan et al., 2013). Furthermore, our finding that 72 hours of
treatment with angiotensin II was sufficient to induce a pacemaker-like phenotype in a
CPC population, as described in chapter four, overlaps with the timeline of HCN4
induction in Brown et al. (2017). While Protze et al. (2017) and the TBX18 transfection
studies either successfully reprogramed myocytes or induced cardiomyocytes into cells
with pacing potential, these derivatives still retain features of cardiomyocytes and may
therefore be susceptible to the extracellular environment of the surrounding myocardium
following transplantation, which may revert sinoatrial nodal-like cardiomyocytes back
into working cardiomyocytes. Although neither the Foley group nor our laboratory have
tested SAN-like cells in vivo, doing so would be critical to test this hypothesis as both
groups have prepared pacemaker-like cells that exhibit repression of working myocardial
genes and may thus be able to sustain the pacemake phenotype beyond two weeks.
Ultimately, these findings merit further research into the mechanisms governing
the early events of sinoatrial node development, which will enable the ultimate
construction of a biological pacemaker. Furthermore, the observed relationship between
simulated microgravity/spaceflight and sinoatrial nodal gene program/pacemaker cell
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accumulation indicate that pre-cardiovascular developmental stages, such as the incipient
mesodermal or mesendodermal stages, merit further research.

Conclusions
As humans prepare to expand our presence in space, it is imperative to deepen our
understanding of the nature of cellular adaptation to reduced gravity so that we may
develop mechanisms by which these molecular changes in cardiac cell types can be
countered. As experiments into the mechanisms governing human development and
function in spaceflight evolve, it will be imperative to continue to apply these findings to
regenerative therapies and tissue engineering. Ultimately, further exploration of the
therapeutic potential of space-flown cardiovascular progenitor cells may one day yield
substantial benefits for cardiac repair on Earth.
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